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ABSTRACT 
MICHAEL HARRISON. SCHOOL OF HEALTH AND HUMAN 
PERFORMANCE. 
ACUTE EXERCISE AND POSTPRANDIAL TRIGLYCERIDE METABOLISM: 
MECHANISMS FOR THE EXERCISE EFFECT AND IMPLICATIONS FOR 
ENDOTHELIAL FUNCTION 
Acute exercise has consistently been shown to reduce postprandial lipemia, 
an independent risk factor for atherosclerosis. In a series of three studies, this 
thesis sought to 
I. compare the Influence of acute exercise on postprandial metabolism in 
normal weight, overweight and obese insulin resistant men 
2. determine the influence of acute exercise on endothelial micropartlcles and 
soluble adhesion molecules, plasma biomarkers of endothellal dysfunction, in 
the fasted and postprandial states 
3. investigate the mechanisms mediating the exercise attenuation of 
postprandial lipemia, and in particular the role of skeletal muscle lipoprotein 
lipase (LPL) and the importance of glycogen depletion. 
In all three studies, recreationally active men (aged 22-45) consumed a high 
fat mixed meal on the morning following prolonged exercise at 70% V02max, 
or no exerclse. One study involved two exercise trials, wlth the influence of 
exercise determined wlth and without post-exercise carbohydrate refeedlng. 
A 700kcal exercise bout reduced postprandial lipemia similarly (-20%) in 
normal weight, overweight and obese men, with the magnitude of the 
attenuation positively related to V02max. Exercise also reduced postprandial 
insulin though this was unrelated to the reduction in lipemia. 
Enodthelial microparticles increased postprandially, indicative of endothelial 
dvsfunction. but this resoonse was not attenuated bv exercise. Soluble 
aihesion mb~ecu~es d ~ d  nbt change postprandially or following exercise. 
The exercise attenuation of lipemia was largely reversed by post-exercise 
carbohydrate refeeding that repleted muscle glycogen However, LPL activity 
was not significantly influenced by exercise or by carbohydrate refeeding. 
Considerable inter-individual variation was evident in the LPL response to 
exercise, with changes in LPL actlvity inversely related to changes in 
postprandial lipemia. 
Taken together, these studies confirm that single bouts of exercise can reduce 
postprandial Ilpemia, but without enhancing endothelial function. This 
attenuation is likely to be mediated by changes in muscle LPL activity but also 
by unknown factors associated with glycogen depletion. 
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Atheroclerosis IS a vascular disease that occurs principally in the large and medlum 
sized elastic and muscular arteries Specific s~tes in the arter~al tree lnclud~ng branch po~nts 
and curvatures are particularly predisposed to atherosclerosis (Ross, 1999) Atheroscerot~c 
lesions develop in the subendothel~al space of the arterlal intima The earllest type of lesion, 
the fatty streak, conslsts of l~pid-laden macrophages and lymphocytes If hyperl~pidem~a 
persists and inflammatory conditions prevail, the lipid rich core can grow and the artery 
typically remodels and enlarges outwards, thus preserving lumen d~arneter The inflammatory 
conditions can degrade the collagen matr~x of the intima, weakening the fibrous cap and 
maklng the lesion vulnerable to rupture Such ruptures br~ng blood in contact with tlssue 
factor and result in a thrombus formlng that can occlude the vessel result~ng in infarction 
Alternat~vely, if f~br~nolyt~c mechanisms prevail, a lim~ted thrombus results and the clot IS 
resorbed Into the les~on as the wound heals. The release of growth factors from thrombus 
platlets leads to smooth muscle m~gration from the med~a, smooth muscle prol~feratlon and 
collagen product~on. This thickening of the les~on stab~lises the cap but the growth is often 
Inwards, decreasing lumen d~ameter The evidence from cl~n~cal 0bse~ations suggests that 
atheromas grow discontinuously with sudden lesion progression, probably relatrng to lesion 
disrupt~on and thrombus formahon (Llbby, 2002). 
The pathophys~ology of atherosclerosis IS closed linked to lip~d and l~poprote~n 
metabol~sm. Low denslty l~poproteln (LDL) IS regarded as the pr~ncipal atherogen~c 
lipoprotein but chylomicron and very low density lipoprotein (VLDL) remnants are also rich in 
cholesterol and have been shown to penetrate the endothelium (Mamo et al, 1998). The 
importance of dysllpldemia as a mediator of atherosclerosis IS evident from a wealth of 
experimental tr~als uslng animal models of atherosclerosis, and more recently from clinical 
intervention trials using statins to lower plasma cholesterol (Steinberg, 2005) However LDL, 
even in high concentrations, does not lead to foam cell formation in vitro (Brown and 
Goldstein, 1983) whereas LDL oxid~sed by incubatron with endothelial cells, smooth muscle 
cells or macrophages, is taken up by macrophages rapidly Hypercholesterolemia IS likely to 
be a permissive factor for atherogenesis Although the major~ty of individuals with coronary 
artery disease (CAD) in the US have average levels of cholesterol, such average levels 
probably exceed by far normal levels for our species (Libby, 2002) 
Atherosclerosis IS an inflammatory disease Modlfied llpoproteln particles In the 
arterial intlma are a key trlgger for Inflammation The mechanistic links bebeen oxidised 
lipoproteins and inflammation are emerging. Endothelial cells in contact with blood normally 
resist leukocyte adhesion, but when subject to oxidative stress, express spec~fic adhes~on 
molecules including vascular cell adhesion molecule (VCAM-1) and ~ntercellular adhes~on 
molecule (ICAM-1). Chemoattractant cytokines (chemoklnes) specific for monocytes and T 
lymphocytes are released by activated endothelial cells, smooth muscle cells and leukocytes 
already resident in the atheroma, to attract additional monocytes and T lymphocytes Into the 
arterlal intima. Chemokines for monocytes Include monocyte chemoattractant prote~n (MCP- 
1) and interleukin-8 (IL-8) Interferon y (IFN-y) lnduclble chemoklnes attract T lymphocytes 
into the intima. The activated endothelium also releases macrophage colony stimulating 
factor (M-CSF) facilrtating the conversion of the monocytes entering the subendothelial space 
to lipid-laden macrophages as well as macrophage proliferation (Libby, 2002). Together, 
these cytokines are responsible for the adhesion, migration, activation, accumulation and 
survlval of monocytes and T lymphocytes in atheromas. Oxidised LDL (oxLDL) accumulates 
rapidly in macrophages via a scavenger receptor that is not down regulated with increasrng 
lipid content, resulting in the lipid-laden macrophage or foam cell, characterrstic of fatty 
streaks. 
Macrophages release a variety of substances that result in lesion progesssion and 
complication Pro-inflammatory cytokines including tumour necrosls factor-a (TNF-a) and IL-I 
amplify the local inflammatory response in the lesion and on the endothelium Reactive 
oxygen species lead to greater oxidation of atherogenic lipoproteins present in the intima 
Proteolytic enzymes particularly matrrx metalloproteinases (MMP) degrade the interstitial 
collagen matrix and the sub-endothelial basement membrane, weakening the fibrous cap of 
the lesion Tissue factor creates a thrombogenic environment and in the event of lesion 
disruption, contact between tissue factor and circulat~ng coagulation protelns leads to 
thrombus formation. Growth factors including vascular endothelial growth factor (VEGF), 
transforming growth factor P (TGF-P) and platlet derived growth factor (PDGF) result in 
smooth muscle migration into, and proliferation in the int~ma, Increased activrty of these 
grawth factors thickens the fibrous cap of the lesion 
Recent evidence suggests that acute phase inflammatory proteins of hepatic origin 
are not only markers of Inflammation but may be dlrect mediators of atherosclerosis (Chart et 
al , 2005). Both C-reactive protein (CRP) and serum amyloid A protein (SAA) are positive 
acute phase proteins that are secreted by the liver in response to IL-6, IL-I and TNF-a. 
Evidence from cell culture studies suggests that CRP may increase synthesis of atherogenic 
molecules lncludlng cell adheslon molecules, MCP-1, IL-8, reactlve oxygen specles, tissue 
factor and MMPs (Chait et al , 2005) CRP is emerging as a risk factor for cardiovascular 
disease that is independent of traditional llpid risk factors. SAA is an apolipoproteln carried in 
the circulation prlmanly on the HDL partlcle and d~splaces apo A-l from HDL In vltro 
(Husebekk et al , 1987) It is predictive of cardiovascular dlsease in prospectlve and cross- 
sectional studres (Jousilahtl et al, 2001) SAA present on HDL facilitates particle uptake by 
macrophages, transforming HDL fom being an anti-atherogen~c to a pro-atherogenic 
lipoprotein part~cle (Artl et al , 2000) It can trigger the expression of MMP in fibroblasts with 
implications for plaque stability (Migita et al., 1998) and act as a chemoattractant for 
monocytes and neutrophils (Xu et al , 1995) 
A number of anti-inflammatory, antioxidant and lipid lowering mechanisms exist that 
are atheroprotectlve and relevant to an understanding of atherosclerosis A number of 
atheroprotective genes have been identified that appear to be upregulated by shear stress 
due to orderly laminar blood flow Endothelial nitric oxide synthase (eNOS) and superoxlde 
d~smutase are both expressed at higher levels in regions of laminar flow Superoxide 
dismutase combats oxidative stress and may limit VCAM-1 expression and other endothelial 
inflammatory pathways (Topper and Glmbrone, 1999). Nitric oxide (NO) has been shown to 
reduce VCAM-1, ICAM-1 and E-selectin expression on human endothelial cells and reduce 
the release of IL-6 and IL-8 (DeCaterlna et al , 1995) Genes for ICAM-1 (Nagel et al , 1994), 
PDGF (Resnick et al , 1993) and tissue factor (Lln et al , 1997) are also responslve to shear 
stress, resulting in reduced expression It is l~kely that the sites predisposed to 
atherosclerosis including the branch polnts of arterles are those that experience turbulent 
rather than lamlnar blood flow (Libby, 2002). 
Serum levels of HDL-cholesterol have long been associated wlth a lower risk of 
card~ovascular dlsease One protectwe pathway involves the reverse transport of cholesterol 
from cells to the liver The HDL partlcle is small enough to penetrate the endothelium and 
apo A-l removes cholesterol from Ilp~d-laden macrophages by a transport process medlated 
by ATP bindlng cascade A1 proteln (ABCAI) However, the HDL particle may also have antl- 
Inflammatory and anti-oxidant properties. It has been shown to Increase NO bioavailabllity 
(Spleker et al , 2002), block the expresslon of adheslon molecules on the endothellurn (Barter 
et al , 2002), inhlblt LDL oxIdation (Parthasarathy et al , 1990) and transport oxldlsed llplds 
from the periphery to the liver (Fluiter et al , 1996). 
Many of the pathophys~ological pathways previously outl~ned are further perturbed in 
obese, lnsulln resistant or dlabetic states. The dysllpidemla central to these conditions 
typically involves higher levels of trlglycerides (TG), TG-rich lipoprotein remnants, a 
preponderance of small dense LDL particles, and lower levels of HDL-C LDL-C can also be 
elevated Advanced glycation end products (AGE) seen In dlabetes are know to Increase 
modlficatlon of LDL and their uptake by macrophages. Free fatty acids and glucose are also 
elevated In these states As endothelial cells do not become insulin resistant, they have no 
means of protecting themselves from free fatty acld and glucose overload (Ceriello and Motz, 
2004) Nutrient-driven Increases in Kreb's cycle activity are believed to fuel superoxlde 
radical generation along the electron transport chain The resultant oxidative stress is now 
considered to be a major source of macrovascular and microvascular damage (Brownlee, 
2005). A number of ~nflammation-related proteins including TNFa, IL-6, IL-I, IL-8, IL-10, SAA 
and plasminogen activator ~nhib~tor-I (PAI-1) are secreted by adlpose tissue (Trayhurn and 
Wood, 2004) contributing to chronic low grade inflammation. It IS likely that the metabolic 
changes associated with obeslty, the metabolic syndrome and diabetes, together induce 
changes in the vasculature that result not only in endothelial dysfunction, but also increased 
propensity to vascular injury and atherogenesls (Ritchie et al , 2004). 
1.2 Lipoproteins 
As lipids are virtually insoluble in water, their transport in the bloodstream requires 
their incorporation into amphipathic macromolecules of lipid and protein known as 
lipoproteins. These particles have a hydrophobic lipid core consisting of triglyceride and 
cholesterol ester and a surface of amphlpathic molecules, namely apollpoproteins 
(apoprote~ns) and phospholipids These surface molecules are arranged with thelr hydrophillc 
regions faclng outwards and hydrophobic regions facing inwards, interacting with the lipid 
core There are four general lipoprotein classes that differ in terms of origin, structure and 
function (Table 1.1) Collectively chylornlcrons and VLDL are termed triglyceride-rich 
lipoproteins 
The apoproteln component 1s a vital part of the l~poprotein particle. Its amph~path~c 
nature contr~butes to lipoprote~n structural stab~l~ty. Apoproteins also funct~on as recognltlon 
s~tes for lipoprote~n and l~poproteln remnant receptors and act as co-factors for varlous 
enzymes Involved in llpoproteln rnetabol~sm (Table 1 2) The ab~l~ty of a l~poproteln to ~nteract 
w~th hepat~c and extrahepat~c receptors and enzymes 1s determined by spec~f~c apoprotelns 
Table 1.1 Composition and characteristics of plasma lipoproteins 
I Chylomicrons VLDL LDL HDL 
I 





Particle mass 1 0 4 - 3 0  10- 100 2 - 3 5  1 7 5 - 3 6  
f~altons'10~b 
Transport of Transport of Dellvery of Reverse 
d~etarv fat endoaenous fat cholesterol to transport of 
- 
t~ssues cholesterol from 
t~ssues 
>400 60 - 400 0 - 1 2 ,  
<O 95 0 95 - 1 006 1.019-1063 1063-1210 
~ ~ o l i ~ o p r o t e i n s  A-I, 848, C-I, C- 8100, E I BlOO 11, C-Ill, E 
Composrfion 
(% particle mass) 
Triglyceride 








Adapted from Gurr et al. (2002) and Durr~ngton (1989) 
Table 1.2 Characteristics o f  the major apolipoproteins 




Structural proteln of VLDL, IDL and LDL L~ver 
L~gand for blndlng to LDL receptor 
Activates LCAT L~ver 
Funct~on S~te of synthes~s 
Structural prote~n of HDL L~ver and intest~ne 
Actlvates LCAT 
Act~vates hepat~c l~pase, lnh~b~ts LCAT L~ver 
C-ll I Activates LPL Liver 
C-Ill I Inhib~ts LPL. Act~vates LCAT Liver 
E I Liaand for blndlng of remnants to LDL L~ver I receptor and LRP 
Abbreviafrons. Lecithrn Cholesterol Acyl Transferase (LCAT), Lipoprotern lipase (LPL), LDL 
receptor-related protein (LRP) 
Adapted from Gurr et al. (2002) and W~tztum and Stelnberg (2004) 
1.2.1 Chylomicrons and chylomicron remnants 
Chylom~crons transport lrplds of d~etary orlgln In the bloodstream They are the most 
llpld rrch of the llpoproteln classes wlth over 80% tr~glycerrde content by we~ght The products 
of fat d~gestion are re-esterlf~ed In the enterocytes of the small intestme, and incorporated Into 
a nascent chylom~cron The surface coat of th~s nascent chylomlcron contalns apo B48, apo 
A-I, apo A-ll and apo A-IV (Witztum and Stelnberg, 2004) Nascent chylomlcrons are 
released into the lymphatic system and travel through the lacteals, enterlng the bloodstream 
vla the thoraclc duct Chylom~crons can be ~dent~f~ed by apo B48 (one per chylomicron 
particle) whlch remalns wlth the particle throughout its metabolism and 1s not present on any 
other lipoprote~n Once In the clrculat~on, chylomlcrons acquire apo C-I, C-ll, C-Ill and apo E 
from VLDL and HDL particles They are not capable of lnteractlng wlth the enzyme 
I~poprotein lipase on the vascular endothellurn unt~l apo C-ll 1s acquired. L~poprotein l~pase 
(LPL) IS the key enzyme respons~ble for the hydrolys~s of triglycer~des to fatty ac~ds and 
glycerol for uptake by the local tlssue LPL has a greater afflnlty for chylomicron than for 
VLDL part~cles and consequently, chylomrcron part~cles have a relatively short half-llfe of less 
than 5 min (Durstine and Haskell, 1994). The appearance of chylomlcrons in the circulat~on 
can almost abollsh VLDL-TG clearance (Bjorkegen et al , 1996) As the core shrinks, surface 
materials become too crowded and there IS a net transfer of apoproteins, phospholrpid and 
free cholesterol to HDL (Durr~ngton, 1989) HDL acts as a crrculatlng reservoir for C 
apoproteins These apoprotelns are transferred to nascent chylomicrons from HDL and back 
agaln durlng chylomlcron catabolism (Durr~ngton, 1989). A cholesterol-enriched, potentially 
atherogen~c chylomlcron remnant remains, after 70-90% of the tr~glyceride content has been 
removed 
1.2.2 Very Low Density Lipoproteins and Low Density Lipoproteins 
In the fasted state, chylomlcrons are absent from the circulation However, durlng 
this tlme, TG and cholesterol are syntheslsed endogenously by the liver and secreted in 
VLDL All VLDL contaln one apo BlOO particle whlch remalns wlth the lipoprotein throughout 
its metabol~sm Tr~glycer~de 1s synthes~sed in the liver from free fatty acid and glucose 
precursors. Free fatty ac~ds (FFA) released from adipose tlssue are the major source of 
substrate for hepatic lipogenesis FFA not trapped by local t~ssues following the hydrolysis of 
circulating postprandial triglycerdes by LPL, also contr~bute to circulating FFA concentrat~ons 
(Frayn et al., 1994) VLDL-TG secret~on depends on circulating FFA precursors but also on 
the balance between FFA re-esterif~cation and ox~dat~on I  the llver (Ruderman et al., 1999). 
D~ets high in slmple sugars (Hudgins et al , 1998) and carbohydrate overfeeding (Schwartz et 
al , 1995) can increase hepat~c de novo lipogenesis and VLDL-TG secretlon Hepatlc 
triglyceride synthesis does not cease in the postprand~al per~od but IS suppressed by insulln, 
at least in insulln sensltlve ~ndlv~duals. Hepat~c de novo llpogenesls IS elevated in the lnsulln 
reslstant state, even w~th high fat, low carbohydrate dlets (Schwarz et al , 2003) In the 
~nsulln reslstant state, Insulin does not effectlvely inh~b~t Mlcrosomal Tr~glycerlde Transfer 
Protein (MTP) gene expresslon or effectlvely st~mulate ER60 expresslon (Adell et al., 2001). 
(MTP catalyses the transfer of tr~glycer~de to nascent apo B part~cles ER60 1s a protease that 
degrades apo B prior to secretlon ) 
VLDL are catabol~sed slm~larly to chylom~crons w~th the progressive removal of TG by 
LPL, the transfer of surface components to HDL and the generat~on of a cholesterol enriched, 
potentially atherogen~c remnant particle VLDL particles have a lower affinity for LPL and 
consequently have a longer half-l~fe of 2-4 hours (Durstlne and Haskell, 1994) The remnants 
are known as lntermed~ate dens~ty lipoproteins (IDL) Ev~dence exists that VLDL are not a 
homogenous specles wlth Independent regulat~on of both the product~on and catabolism of 
the large tr~glycer~de-r~ch VLDL, and small cholesterol-rich VLDL2 subclasses (Packard and 
Shepherd, 1997) Future stud~es may need to cons~der the metabolism of each subclass 
separately. 
IDL are e~ther taken up by hepat~c receptors or further catabolised to LDL. Thrs latter 
pathway requlres the further hydrolysis of IDL by hepatlc l~pase and LPL (Tasklnen and Kuus~, 
1987) Apo E acts as a ligand for lnteractlon of IDL part~cles w~th hepat~c receptors and IS 
cruclal for both the uptake of IDL and the conversion to LDL (Wltztum and Stelnberg, 2004) 
With most of the trlglycer~de core removed and surface components transferred to HDL, the 
LDL partlcle IS cholesterol ester enriched, wlth apo BlOO the only apoproteln now present 
Belng small enough to penetrate the vascular endothellurn and come In contact wlth nearly 
every cell in the body, LDL IS respons~ble for the dellvery of cholesterol to cells for membrane 
growth and repalr, and to spec~al~st tlssues lncludlng the gonads, adrenals and skln, and for 
hormone and Vltamln D synthes~s LDL concentratlon in extracellular flu~d IS approxlmately 
10% of that in plasma (Durrington, 1989). Particles have a half-l~fe of approxlmately 2.5 days 
1.2.3 LDL and remnant removal 
Chylomlcron remnants, some IDL and LDL are removed from circulat~on principally by 
the her ,  rned~ated by two key receptors, the LDL receptor (which recognlses apo 8100 and 
apo E) and the LDL receptor-related proteln (whlch recognlses apo E) Chylomlcron 
remnants are rap~dly taken up as a result of blndlng between apo E moleucles, st111 present on 
the Ilpopmtecn partlcle, and thecr affin~ty for both hepatic receptors Apo E IS also cruc~al for 
the removal of IDL from the clrculat~on lnd~viduals with apo E isoforms that blnd less 
efficiently to receptors can accumulate remnants in plasma (Wltztum and Stelnberg, 2004) 
The remalnlng IDL are further dellpldlsed and converted to LDL, w~th apo BlOO the sole 
surface component Approx~mately 75% of the uptake of LDL occurs vla the LDL receptor 
pathway in the llver and in other cells w~th a cholesterol requirement Approxlmately two- 
thlrds of LDL is cleared by the llver (Witztum and Stelnberg, 2004) The expression of the 
LDL receptor is downregulated in all cells by the accumulation of intracellular cholesterol 
However, LDL can also enter cells by a non-receptor-medlated pathway that involves binding 
to the cell membrane and subsequent internalisatlon This non-receptor-mediated but 
gradient-related pathway may be particularly important in adult humans who have higher 
circulating levels of LDL-C than animal species (Durrington, 1989) 
1.2.4 High Density Lipoprotein 
The HDL particle differs from chylomlcrons, VLDL, IDL and LDL in a number of 
important respects HDL is the smallest and most dense of the llpoproteln species The 
nascent particle, secreted by the liver, increases in size as it travels in the circulation 
Furthermore, it is associated with the removal of excess cholesterol from peripheral tissues 
and its transport back to the liver. The precursors of mature HDL particles are disc-shaped 
bilayers of phospholip~d embedded with apo A-l and A-ll These are fully formed in the 
circulation by the transfer of surface components from chylomicrons and VLDL during their 
catabolism. Two distinct subspecies of HDL exist, HDL3 and HDL, The enzyme lecithin 
cholesterol acyl transferase (LCAT) activated by apo A-I, catalyses the esterification of free 
cholesterol on the HDL surface. This enables it to move into the hydrophobic core, 
maintaining a gradient for the uptake of more cholesterol The increasing lipid content 
changes the small HDL3 particle to the larger less dense HDL, Despite a five-fold difference 
is serum HDL-cholesterol and LDL-cholesterol concentrations, partlcle concentration are often 
similar. The SR-B1 receptor has been implicated in the hepatic binding of HDL, facilitating 
the transfer of cholesterol ester out of HDLz in the liver The particle is converted the back to 
HDL,, and released back Into circulat~on (Wltztum and Stemberg, 2004). The liver also 
removes complete HDL partlcles. HDL has a relatively long half-llfe of 3-5 days 
1.2.5 Lipid exchange between lipoprotein species 
In add~t~on to the transfer of the surface components between llpoproteln specles, 
there is also a transfer of cholesterol ester and tr~glycer~des between the llpld rich l~poprotein 
cores Thls exchange IS med~ated by cholesterol ester transfer protein (CETP) In particular, 
the exchange between the triglyceride-rich l~poprotelns (chylom~crons and VLDL) and LDL, 
increases the triglyceride content of the latter, the cholesterol ester content of the former and 
the atherogenlcity of both The newly acquired tr~glycer~de is qu~ckly removed from LDL by 
the action of hepat~c l~pase and LPL, resultlng In a small dense, hlghly atherogenic LDL 
part~cle Slrnllarly, there is an exchange of triglyceride and cholesterol ester between 
triglycer~de-r~ch lipoproteins and HDL, resultlng In cholesterol ester depleted HDL partlcle 
These processes are exacerbated in a hyperl~p~demic environment and during the 
postprand~al period Grlffln et al (1994) has suggested that there is an abundance of small 
dense LDL partlcles when fasting tr~glycer~des are above 1.5 mmol L-' 
1.3 Triglycerides and risk of coronary artery disease 
Elevated tr~glycerides constitute a risk factor for card~ovascular dlsease that was flrst 
descr~bed by Albrlnk and Man (1959) Since that t~me, numerous prospective and cross- 
sectional studies have confirmed a unlvarlate assoc~at~on between TG and risk of CAD 
Although this association was usually Independent of total cholesterol and LDL-C, it was often 
eliminated in multlvarlate analyses after adjustment for HDL-C (Austin, 1991) As a result, a 
US Natlonal Institutes of Health Consensus Panel (NIH, 1993) has questioned whether serum 
TG is a risk factor for CAD Independent of HDL-C Pharmacological treatment was only 
recommended when lifestyle modrflcatlons farled to reduce TG below 5 65 mmol L-' 
In a meta-analys~s of 17 populat~on-based prospective studles, based on nearly 
47,000 men and 11,000 women, Hokanson and Austln (1996) found the relatlve rlsk of 
cardlovascular dlsease to be 1.31 In men and 1 76 in women for each 1 mmol L-' Increase in 
TG. After adjustment for a varrety of other risk factors Including HDL-C, the relative risks had 
decreased to 1 15 for men and 1 37 for women, but were st111 significant Thls flndlng 
suggests that the assoclation of TG with CAD 1s only partially explained by HDL-C. 
That accurate assessment of CAD risk, requires attention to TG In addltlon to or in 
conjunction wlth LDL-C and HDL-C, IS demonstrated by the findlngs from the Prospective 
Cardlovascular Munster (PROCAM) study (Assmann, 2001) and the Copenhagen Male Study 
(Jeppesen et al., 1998) Analysrs of PROCAM 10 year follow-up data in the cohort of middle- 
aged men and women, lndlcates that rates of myocardial lnfarctlon (fatal and non-fatal) rose 
wlth increasing LDL-C at basellne, and wlthrn each LDL-C quintile with lncreasrng 
triglycerldes. Data from the Copenhagen study are presented by TG and HDL-C tertiles and 
reveal a slmllar pattern. The incidence of CAD Increased with lncreaslng TG and decreasing 
HDL-C, but within each HDL-C tertlle, the lncldence of CAD and all cause mortality Increased 
wlth lncreaslng TG. Although there appears no relatlon between serum trrglycerldes and 
LDL-C, studles have shown that TG and LDL partlcle srze are closely correlated (rho= -0.71, 
Stampfer et a1 , 1996) Hlgh trlglycerides are associated wlth small dense LDL partlcles 
(sometimes termed LDL phenotype B) that are particularly atherogenlc Recent prospective 
epidemrologic studres found that both TG and LDL particle srze predrcted future CAD 
(Stampfer et a1 , 1996, Gardner et al., 1996, Lamarche et al., 1997) 
The level of fastlng TG that should be regarded as desirable has been a matter of 
debate and revislon The US Natlonal Cholesterol Educat~on Programme Adult Treatment 
Panel Ill thresholds for normal, borderlrne hrgh, hlgh and very hlgh TG concentrations have 
been revised downwards wlth 1 67 mmol C' (150 mg dL") defined as normal (NCEP, 2002) 
Whether further refinement IS needed IS debatable. Results from the Baltimore Coronary 
Long-Term Study (COLTS) lndlcate Increased rrsk of CAD events and reduced s u ~ l v a l  from 
CAD events with TG levels greater than 1.13 mmol C' (Mlller et a1 , 1998) The Copenhagen 
Male Study (Jeppesen et al., 1998) also found an Increased lncldence of CAD and all cause 
mortality across TG tertlles wlth medlan tert~le values of 0 88, 1.33 and 2 45 mmol L-' Even 
at a value of 1 67 mmol C' approximately 60% of LDL partlcles will be small and dense 
(Austln et a1 , 1990) 
In h ~ s  interpretation of the ep~dem~olog~cal evrdence linklng TG to cardiovascular 
dlsease risk, McCarty (2004) adds a caveat. He argues that TG are only pathogenrc Insofar 
as they act as a marker for insulln resistance, a syndrome In whlch central obesity and 
elevated hepatlc TG secretion are key components He polnts out that the frequently clted 
ep~demiolog~cal meta-analysls of Hokanson and Austln (1996) does not Include a valld 
surrogate for lnsulln sensltlvlty, and thus cannot demonstrate that TG increase risk 
Independent of Insulin sensitivity In contrast, he argues that carbohydrate-lnduced 
hypertr~glycerldem~a, that occurs ma~nly from reduced TG clearance, may not be pathogen~c 
A lifestyle ln te~ent~on 1s c~ted (Ornish et al , 1998) In whlch a 10% fat (thus hlgh 
carbohydrate) diet reduced r~sk of cardiac events in pat~ents w~th moderate to severe 
atherosclerosis, desp~te Increases in TG. Parks and Hellerstem (2000) also cautlon agalnst 
drawing erroneous conclus~on rn relation to carbohydrate-~nduced hypertriglycerldemla They 
argue that two types of hypertr~glycer~dem~a exist wlth d~fferent mechan~sms and thus d~fferent 
health r~sks 
1.4 Endothelial function and dysfunction 
The endothellurn has trad~t~onally been considered as a layer of cells whose prlmary 
funct~on IS to fac~l~tate smooth blood flow, and separate clrculat~ng blood from underly~ng 
t~ssue. Landmark studles in the 1980s demonstrated the obl~gatory role of endothel~al cells In 
acetylchol~ne-mediated vasod~lat~on (Furchgott and Zawadsk~, 1980) and In the paradoxical 
acetylchol~ne-med~ated vasoconstr~ct~on of atherosclerot~c vessels (Ludmer et al , 1986) 
The endothellurn IS now recogn~sed as hav~ng a cruclal role in marntalnrng vascular integrity, 
releas~ng of a wide var~ety of substances that regulate leukocyte adheslon, mlgratlon and 
act~vat~on, thrombus format~on and vessel vasomotlon. A del~cate balance between 
antagonlstlc factors IS maintamed by the healthy endothelium. A d~sturbance IS thls balance, 
termed endothelial dysfunction, IS generally considered as an early event in atherosclerosis 
(de Koning and Rabel~nk, 2002) 
1.4.1 Vasomotion 
Although the endothellurn regulates a number of physiolog~cal functions, the majorlty 
of studies have focused on endothellal dependent changes in vasomotlon N~t r~c  ox~de (NO) 
IS one of the key factors released by the endothel~um In both condu~t and res~stance vessels 
lncludlng coronary vessels and IS a potent vasod~lator Activation of the endothellum by 
mechanical and chemlcal stlmull lncludlng shear stress (from lam~nar blood flow), 
acetylcholine, bradyklnln, serotonin and catecholamines result in NO-med~ated vasod~latlon, 
secondary to Increases In endothellal nltrlc ox~de synthase (eNOS) actlvlty Acetylchol~ne- 
Induced vasodilation can be blocked w~th NOS lnh~b~tion by N-monomethyl-L-argln~ne (L- 
NMMA) (Quyyurn~ et al , 1995) The endothellum releases other vasod~lating factors lnclud~ng 
prostacyclln and potent vasoconstrlctlng factors such as endothelrn-I, thromboxane A2 and 
ang~otens~n-ll. 
1.4.2 Inflammation and Coagulation 
The anti-inflammatory properties of the healthy endothel~um are Important In the 
prevention of atheroscleros~s. Endothellal cell activation encompasses the actlve response of 
cells to pro-~nflammatory stimuli includ~ng pro-~nflammatory cytokines and ox~dative stress 
Activat~on of the transcr~pt~on factor nuclear factor kappa B (NF-KB) by ox~datlve stress results 
in the co-ordinated upregulat~on of a number of genes encodlng pro-~nflammatory factors 
(Barnes and Kann, 1987) When activated, these factors are expressed or released lncludlng 
VCAM-1, ICAM-1, E-select~n, 11-6, 11-8, MCP-1 and M-CSF (J~menez et al., 2005) Together, 
these chemoklnes, adhes~on molecules, cytok~nes and growth factors are respons~ble for the 
attraction, adhes~on, m~grat~on, activation, accumulation and survival of monocytes and T 
lymphocytes In the subendothelial space Activated platelets adherlng to the endothellum can 
promote vasoconstrrct~on (Gollno et a1 , 1991), induce MCP-1 secretion and ICAM-1 surface 
expression (Gawaz et al., 1998) In addit~on to med~atlng endothelial dependent vasod~lat~on, 
NO appears to have ant[-~nflammatory propert~es and has been shown to lnh~blt leukocyte 
adhesion (Kubes et al , 1991) NO also lnhlb~ts platelet aggregat~on at the vessel wall 
(Radomskl et al., 1987) When NO bloavallabl~ty 1s reduced, endothellal dependent 
vasodilation 1s l~kely to be ~mpa~red and endothellal cell actlvatlon Increased 
The endothellum also releases a number of factors that promote coagulation 
(thromboxane A2, plasrninogen activator inhlbitor-I (PAI-1) and von Wlll~ebrand factor (vWF)) 
and ~nhlb~t coagulat~on (prostacyclln) The endothellurn also releases b~oact~ve molecules 
that promote f~brlnloys~s including t~ssue plasmlnogen activator (tPA) 
1.4.3 Assessment of endothelial function 
Condu~t vessel endothellal funct~on IS usually determined by assessing flow-rnedlated 
vasod~lat~on (FMD) of the brach~al artery FMD measures the Increases In brach~al artery 
d~ameter in response to Increased blood flow following 5 rnln of arterial occlus~on. Resistance 
vessel endothel~al funct~on 1s usually determined by quantlfylng Increases In forearm blood 
flow (FBF) uslng venous occlusion plethysmography (VOP), following lnfuslon of endothel~al 
dependent vasodilators (EDD) such as acetylcholine (Ach) or metachollne (Mch) Endothel~al 
independent vasodllatlon (EID) 1s measured by adminlster~ng glyceryl trlnltrate subllngually In 
FMD stud~es or lnfuslng sodium n~troprusside (SNP) ~n FBF stud~es Although a d~rect 
assessment of coronary conduit and resistance vessel endothelial function is also possible by 
Infusing acetylcholine and measuring changes in conduit vessel dlameter by angiography 
(Ludmer et al , 1986) or coronary blood flow using intravascular ultrasound (Doucette et al , 
1992), endothellal function is normally assessed in the peripheral circulation A close relat~on 
has been demonstrated between endothellal funct~on in the human coronary and brachial 
arteries in CAD patients and healthy controls (Anderson et al , 1995; Takase et al , 2005) 
FMD is non-lnvasive but expensive requiring a high-resolution ultrasound scanner, 
high frequency vascular transducer and internal ECG monitor. Some (Suwaidi et al , 2000) 
but not all (Palmer et al., 1987, Schachinger et al , 2000) laboratories have reported good 
accuracy and reproducibility using FMD. Ultrasonograph~c assessment of the brachial artery 
IS unrquely challenging and must be performed by well-trained, skilled technic~ans (Alam et 
al., 2005). The quantification of vasodilator-mediated increases in FBF can be regarded as 
moderately invasive as it requires chemical agents, to be introduced directly into the brachial 
artery using a small (27G) cannula (Alam et al , 2005) However, authors report good 
reproducibil~ty (Petrle et al, 1998, Roberts et al, 1986) and it should be regarded as the gold 
standard for resistance vessel endothel~al function assessment (Alam et al , 2005). 
A number of novel techniques for assessing endothelial function are appearing in the 
l~terature With one such method, dilat~on of the cutaneous m~crocrrculat~on rs triggered by 
iontophoresis of Ach and SNP (ED and EID agonists) lontophores~s involves the transdermal 
delivery of ionised drugs under the influence of an electrical field Changes in skin perfusion 
are quant~fied uslng laser Doppler lmaglng Whereas rontophoresls of ED and EID agonrsts 
increases skin perfuslon, iontophoresis of saline has been shown to be ineffective (Ramsay et 
al , 2002). Thls technique has been described as a well-tolerated and non-invasive method 
for assessing resistance vessel function (Gill et al , 2003a) 
1.4.4 Adhesion molecules 
Three groups of adhesion molecules have been identified, integrins, selectlns 
(including P-selectin and E-selectin) and immunoglobulins (including VCAM-1 and ICAM-1) 
Accumulating data suggest that selectins are involved in the initial rolling and tethering of 
leukocytes on the endothelrum whereas VCAM-1 and ICAM-1 are ~nvolved in thelr 
transendothelial migration (Schram and Stehouwer, 2005). Levels of soluble E-selectin, 
ICAM-1 and VCAM-1 in plasma are directly associated with their membrane-bound 
expression (Leeuwenberg et al , 1992, Schmidt et al, 1995) True soluble adhesion 
molecules are released from the extracellular matrlx by proteolytic enzymes including 
metalloproteases and sheddases (Horstman et al., 2004a). However much of that detected 
using standard ELlSA techniques is in fact membrane bound, released on endothelial 
micropa~ticles as a result of membrane budding (Horstman et a l ,  2004a). The release of 
these molecules from the endothelium may serve to limit the inflammatory process Soluble 
molecules are not simply the products of degradation but can Inhibit leukocyte recruitment 
into the intima by blnding with their ligands in the circulation (Blankenberg et al , 2003). 
1.4.5 Adhesion molecule expression 
Adhesion molecules have been shown to be upregulated by pro-inflammatory 
cytokines and in particular TNF-a, advanced glycation end products (AGE) and oxidised 
lipoproteins Following incubation of endothelial cells wlth inflammatory cytokines, SICAM-1 
and sE-selectin were expressed on endothelial cell membranes and were also found in 
supernatant (Blankenberg et al, 2003). Cell surface expression was d~rectly correlated with 
supernatant concentrations. Maximal levels of sE-select~n and SICAM-1 were detected 6-12 h 
and 24 h respectively after activation by cytokines Despite being linked to endothelial 
activation and inflammation, the relations between the various soluble makers are relatively 
weak Correlations between sVCAM-1 and SICAM-1 (r= 0 17, p=O 004), sE-selectin and 
SICAM-1 (r= 0 22 p= 0001) and sVCAM-1 and sE-selectin (r= 0 006, p=O 92) were found in a 
subset of 316 healthy control subjects from the Atherosclerosis Risk In Communities (ARIC) 
study (Hwang et al., 1997). 
1.4.6 Adhesion molecules in  disease states 
Soluble forms of adhesion molecules have been shown to be elevated in a range of 
disease states including CAD (Hwang et al , 1997, Ridker et al , 1998) hypertension (Cottone 
et al., 2002), and type I1 diabetes (Stenier et al , 1994) In addition, prospective cohort data 
suggests that elevated levels of adhesion molecules can predict cardiovascular mortality and 
all cause mortality in type II diabet~cs (Jager et al , 2000; Becker et al , 2002) From their 
review of large prospective studies, Blankenberg et al (2003) found SICAM-1, but not sVCAM- 
1, to be a good predlctlve marker of cardiovascular risk In healthy lndlvlduals, correlating with 
levels of CRP In contrast, sVCAM-1 emerges as a strong predlctor of future events In 
individuals wlth pre-existlng endothellal dysfunction or vascular dlsease Studles in peripheral 
artery disease patlents also suggest that SICAM-1 IS a better predlctor of dlsease presence, 
with sVCAM-1 predicting dlsease seventy (Peter et a1 , 1997, Pradhan et al , 2002) 
Cross-sectional studles generally show elevated levels of at least one soluble 
adheslon molecule in obeslty (Ferri et al , 1999, Rohde et al., 1999, Weyer et al , 2002), 
hypertrlglycerldernla (Hackman et a1 , 1996, Abe et al , 1998), hypercholesterolemia 
(Hackman et a1 , 1996, Kvasnicka et al , 2001) and lnsulln resistance (Chen et al., 1999, 
Weyer et al , 2002) However, some reports are confllctlng Welght loss results In a 
decrease In SICAM-1, sVCAM-1 and sE-selectln (Ferri et al , 1999, lto et al , 2002, Pontiroll et 
a1 , 2004) Thls effect may be mediated by a decrease In TNF-a and IL-6 release from 
adipose tlssue 
1.4.7 Adhesion molecules and endothelial dysfunction 
Endothellal functlon IS routinely assessed uslng soluble cell adheslon molecules 
These biomarkers are easy to determine in large populations, are Independent of observer 
variability and,less tlme-consuming However, the valldlty of this approach IS based on a 
number of assumptions. First, cell types other than endothelial cells must not be an Important 
source of the markers used Second, synthesis of these adheslon molecules must be more 
Important than clearance In determining plasma concentrations Thlrd, endothellal function In 
the microcirculation must parallel that In the large arterles as the m~croc~rculat~on has a very 
large surface area lnformat~on on the val~d~ty of these assumptions IS scarce (Schram and 
Stehouwer, 2005) 
A number of stud~es (Table 1 3) have documented the relationship between soluble 
markers of arterial ~nflammat~on a d a direct measurement of endothel~al function, or between 
changes in these soluble markers (usually in response to pharmacological treatment) and 
changes In d~rectly measured endothel~al funct~on. Case-control studles generally show a 
moderate relationsh~p between condu~t vessel endothel~al functlon and soluble adheslon 
molecules (Lupattell~ et al , 2000, Brevetti et al , 2001, Nawawi et al , 2003, Glow~nska- 
Olszewska et al , 2005) though not always (Van Haelst et al , 2003) In add~tlon, FMD and 
soluble adhesion molecules have been shown to change in parallel (inverse relation) dur~ng 
pharmacological treatment (Alonso et al , 2001, Marches1 et al., 2003, Nawaw~ et al , 2003, 
Cerlello et al , 2005, d~etary supplementat~on (Lupattell~ et al , 2004) and postprand~al lipemla 
(Marches1 et al , 2003), further ev~dence of a common physiology 
The relat~on between resistance vessel endothel~al functlon and soluble adhes~on 
molecules 1s weaker and sornet~mes not ev~dent, due in part to the variety of methodologles 
employed in these stud~es In a study involving type II d~abetics, Koga et al (2005) 
demonstrated a weak relat~on between slCAM-1 and acetylchol~ne-med~ated increases in 
coronary vessel diameter (r= -041) and blood flow (r= -0.46) Interestingly, the relatlon 
between coronary endothel~al funct~on and endothelial rnicropart~cles was considerably 
stronger Holmlund et al (2002) reported a weak relat~on between resistance vessel 
endothel~al function and SICAM-1 but not w~th sVCAM-1 or sE-selectin John et al (2000) 
Table 1.3 Summary of studies that assess endothelial dependent dilation directly and using serum biomarkers 
Siudy Subjects Main findings 
John et al 2000 52 HC patients and 43 
healthy controls 
Lupattelli et al. 2000 16 HTG patients and 
Alonso et al 2001 
Brevetti et al 2001 
Holmlund et al. 2002 
16 controls 
25 FH patients 
34 IC patients with and 
14 controls 
59 healthy adults 
Gill et al 2003a 8 endurance athletes 
Marchesi et al 2003 10 HTG patients 
Nawawi et al. 2003 27 FH and 47 NFH 
Datients 
Van Haelst et al. 2003 35 FH patients 
Brown et al. 2004 23 FH pat~ents 
FBF response to Ach infusion not related to adhesion molecules, FBF-Ach vs 
SICAM-1, r= -0 02; FBF-Ach vs sVCAM-1, r= 0.16, FBF-Ach vs sE-selectin, r=-0 10 
FMD vs sVCAM-I, r = -0 61, FMD vs SICAM-1, r = -0 38 
Parallel increases in FMD and decreases in sE-select~n with pharmacolog~cal 
treatment 
FMD lower in those with higher levels of both SICAM-1 and sVCAM-I 
FBF-MchlFBF-SNP vs SICAM-1 r=-0 31, No relationship with IMTc, sVCAM-1, 
hsCRP and sE selectin. 
Skin perfusion in response to iontophoresis of Ach (microvascular EDD) decreased 
PP, without parallel changes in adhesion molecules 
PP changes in FMD vs TG (r= -0 34), PP changes in FMD vs SICAM-1, r=-0 66 
Increase in FMD in parallel with decreases in TG, SICAM-1 and sVCAM-1 following 
3months pharmacological treatment 
FH group FMD vs SICAM-1 r= -0 58 
NFH group. FMD vs SICAM-1, r= -0 47, FMD vs IL-6, r= -0.25. Parallel changes in 
FMD and SICAM-1 during pharmacological treatment 
No relationship between FMD and adhesion molecules, FMD vs CRP, rho = -0 14, 
vs SICAM-1 rho= -0 21, vs sE-select~n, r= 0 15. 
Changes in FMD with pharmacological treatment without parallel changes in 
SICAM-1, sVCAM-1, sE-selectin, hsCRP or IL-6. 
Lupattelli et al 2004 28 HTG patlents Parallel Increase FMD and decrease both SICAM-1 and sVCAM-1 following dietary 
supplementat~on wlth artlchoke julce A FMD vs A SICAM-1, r= -0 62, A FMD vs A 
sVCAM-1, r= -0 66 
Ceriello et al (2005) 20 T2D patients Parallel Increase in FMD and decreases m SICAM-1, NT, IL-6 and CRP following 4d 
pharmacolog~cal treatment in the absence of changes In any lipld parameters 
Glowlnska-Olszewska et al 76 T I  D adolescents FMD vs sE-selectln, r= -0 33 
(2005) and 33 controls lMTc vs sE-selectln, r=O 32 
Abbreviations Hypercholesterolem~a (HC), forearm blood flow (FBF), acetylchol~ne (Ach), hypertnglyceridem~a (HTG), flow-medlated vasod~lation (FMD), 
familial hyperchqlesterolemia (FH), non-familla1 hypercholesterolemia (NFH), high sensrtiv~ty C-reactive proteln (hsCRP), metacholine (Mch), sodium 
nrtroprusside (SNP), nitrotyrosine (NT), carotid artery intrma med~a th~ckness (IMTc), postprandial (PP), type I diabetic (TID), type I1 diabetrc (T2D), soluble 
~ntercellular adhes~on molecule-I (SICAM-I), soluble vascular cell adhesion molecule-I (sVCAM-I), interleukm-6 (IL-6) 
found no ev~dence of a relatlon between resistance vessel functlon and any adheslon 
molecule. 
Interleuk~n-6 1s generally descrlbed as a plelotropic cytok~ne ~nvolved In a wlde range 
of blolog~cal act~vltles ~nclud~ng ~nflammat~on, sepsls, oncogenesls, hematopolesis, bone 
metabollsm and fat metabollsm (Song and Kellum, 2005) IL-6 has been shown to be 
elevated in aglng (Dobbs et al , 1999), obes~ty and type II diabetes (Vgontzas et al , 2000) 
Levels of IL-6 are related to all cause mortality, cardiovascular mortal~ty (Harr~s et al , 1997) 
and myocard~al Infarction (R~dker et a1 , 2000) 
1.5.1 lnterleukin-6 and Inflammation 
The role of IL-6 in ~nflammatory processes is controversial and it has been descrlbed 
as both a pro- and anti-~nflammatory molecule It acts alongs~de other cytok~nes and 
Inflammatory markers lncludlng TNF-a and CRP IL-6, TNF-a and CRP Intercorrelate in 
healthy older adults (Ballou et a1 ,1996) IL-6 is best characterlsed as a pro-inflammatory 
cytok~ne. It IS the key tr~gger for the production of CRP, the acute phase reactant that 1s a 
potent marker and med~ator of endothel~al ~nflamrnatlon (Szmltko et al , 2003) Recent c l~n~cal  
trials of toc~lizumab, that functions to block the IL-6 receptor, have shown slgnlf~cant 
Improvement In rheumatold arthr~tls, an ~nflammatory cond~tion, along w~th reduct~ons in CRP 
( M a n  et al., 2006) 
Evldence IS also available that IL-6 has ant[-inflammatory properties Although lts 
production can be triggered by TNF-a, it appears to have a role in regulating levels of TNF-a 
In the circulatlon Levels of TNF-a are elevated in IL-6 knockout mlce and IL-6 lnh~blts 
llpopolysaccharide Induced TNF-a productlon in human monocytes In vitro (Mizuhara et a! ,  
1994, Schlndler et al., 1990) The infuslon of recombinant IL-6 has also been shown to lnhiblt 
endotoxln-lnduced Increases in TNF-a In healthy humans (Starkle et al , 2003) In addition, 
IL-6 stimulates the release of ant[-inflammatory cytoklnes including IL-10, IL-I receptor 
antagonlst (IL-Ira) and soluble TNF-a receptors but not TNF-a (Tllg et al , 1997) 
Both TNF-a and IL-6 are produced in adlpose tlssue The high levels assoclated wlth 
the metabolic syndrome are assoclated with vlsceral adlpose tlssue. Gwen that TNF-a can 
trlgger IL-6 release in adlpose tlssue, it has been suggested that TNF-a is actually the maln 
driver of the metabolic syndrome wlth locally produced TNF-a causlng systemlc increases In 
IL-6 (Petersen and Pedersen, 2005) Consequently, chronically elevated levels of IL-6, IL-Ira 
and CRP are llkely to reflect ongoing local TNF-a productlon, even though an elevation In 
systemic TNF-a IS not always detectable 
1 S.2 Exercise and substrate metabolism 
Unllke during sepsls where TNF-a and IL-I are the flrst cytoklnes to be produced In 
the cytokine cascade, IL-6 is the first cytoklne to appear in the circulation durlng exerclse 
(Petersen and Pedersen, 2005) Levels of IL-6 in the circulatlon can Increase up to 100 fold 
durlng exercise depend~ng on exerclse intensity, duratlon and muscle mass recruited 
(Petersen and Pedersen, 2005) These Increases can occur in the absence of muscle 
damage. Low pre-exerclse muscle glycogen has been shown to further enhance IL-6 gene 
transcr~ption (Steensberg et al , 2001), indlcatlng an energy senslng role for muscle-der~ved 
IL-6 (Petersen and Pedersen, 2005) Such an effect might be mediated vla an effect on AMP- 
activated proteln klnase (AMPK), another putative sensor of cellular energy status 
lncubatlon of skeletal muscles wlth IL-6 Increases the phosphorylation of AMPK (an Indicator 
of its actlvatlon) and that of its target molecule acetyl CoA carboxylase (ACC) The authors 
suggest that the actlvatlon of AMPK may be dependent on the presence of.lL-6 (Kelly et al , 
2004). The phosphorylatlon of ACC by AMPK ultimately serves to lnhlblt malonyl CoA 
synthesis, facilitating greater entry of fatty aclds into the mltochondrla for oxldatlon 
(Ruderman et al , 2003) Dlrect evidence exists of a role for IL-6 in regulating substrate 
metabolism. The lnfuslon of recombinant IL-6 lnfuslons has been shown to Increase llpolysls 
and fat oxldatlon In humans without causing hypertrlglyceridemla (VanHall et a1 , 2003) 
Although TNF-a also increases Ilpolysis, only IL-6 has been reported to also Increase fat 
oxldation (Petersen and Pedersen, 2005) 
Although the preclse blologlcal actlon of muscle-derlved IL-6 has yet to be fully 
elucidated, it appears to act durlng exercise in a hormone like manner to Increase adlpose 
tissue lipolysis, hepatlc glucose production and muscle fat oxldation Consequently it has 
been suggested that muscle could be regarded as an endocrine organ and the term myoklne 
applled to IL-6 and other cytoklnes released by skeletal muscle (Pedersen et al , 2003) 
1.6 Microparticles 
The ex~stence of subcellular ves~cles In the bloodstream has been known slnce the 
1960s However, only recently has the role of these m~croparticles in a range of physiolog~cal 
processes, and thew elevation in a range of d~sease states, been appreciated M~cropart~cles 
were flrst described by Wolf (1967) uslng electron mlcroscoplc techniques when studying a 
subcellular factor or~g~nating from platelets They are small membranous veslcles or blebs 
(c1.5pm in d~ameter) that are shed from a variety of cells The majorlty of m~cropart~cles In
the circulation or~grnate from platelets, with smaller quant~ties from endothel~al cells, smooth 
muscle cells, leukocytes and erythrocytes 
1.6.1 Microparticle release and composition 
M~croparticles are shed in response to two cellular processes, cell actlvation and 
apoptosis A var~ety of agonists can result in cell activat~on and micropartlcle formation 
Human umb~llc~al veln endothelial cells (HUVEC) release m~croparticles in vltro when 
stimulated by cytoklnes Including TNF-a and IL-1P (Mutln et al , 1997) and by PAI-1 (Brodsky 
et al., 2002) An early slgn of cell actlvatlon, permlsslve for m~cropartlcle release, IS an 
increase in cytosollc calclum concentrat~on (Van W~jk et a1 , 2003). Increases In intracellular 
calcium activates the proteolyt~c enzyme calpaln and the degradation of the membrane 
skeleton (Miyosh~ et a l ,  1996) Apoptosis is character~sed by cell contraction, DNA 
fragmentat~on and membrane blebbing Apoptot~c m~cropartlcles may therefore contaln 
fragments of DNA (Van Wijk et al., 2003) The membrane blebbing IS related to contract~on of 
actin-myosin structures In the membrane skeleton, following actlvation of the effector 
molecule rho-associated k~nase (ROCK 1) by caspase-3 in the apoptot~c cascade (Coleman 
et al , 2001) 
Microparticles cons~st of a phospholipid b~layer embedded w~th protelns, cons~stent 
wlth the~r or~gin as cell membrane blebs These protelns serve as b~omarkers and can 
~nd~cate the parent cell of origin Present on m~cropartlcles are const~tut~ve protelns typ~cally 
found in the parent cell membrane under rest~ng cond~tions, and Inducible pmtelns that are 
translocated to the membrane dur~ng cell activatlon The phosphol~p~d b~layer of cell 
membranes a arranged asymmetr~cally w~th negatively charged phosphollplds such as 
phosphat~dylser~ne (PS) located on the Inner surface A promlnent manlfestatlon of cell 
apoptosls is the reversal of this asymmetry Negatively charged phosphollplds can therefore 
be found on mlcropartlcles shed in response to apoptos~s, perm~tt~ng m~croparticle b~nd~ng 
wlth annexln V, a phospholip~d-b~nding protein that can be labelled w~th fluorescent dyes It 
has been argued that the need for annexln V posit~v~ty favoured by some research groups, 
when enumerating or indeed defin~ng m~cropartlcles is unwarranted, as thls approach 
excludes a large proport~on of micropart~cles formed as a result of cell activat~on (Horstman et 
al , 2004a) Evidence ex~sts of heterogene~ty even among micropart~cles shed from the same 
parent cell. Endothel~al cells have been shown in v~tro to release m~cropart~cles that are 
phenotyp~cally different in response to actlvat~on and apoptos~s (Jlmenez et al , 2003) 
Endothel~al cell actlvat~on resulted in Increases in mlcroparticles expressing induc~ble 
markers, lnclud~ng CD62E, CD54 and CD106. Endothel~al cell apotosls resulted in Increases 
In mlcropartlcles expressing the constitutive marker CD31 and In annexin V b~nd~ng The 
response to cell actlvat~on and apoptosls was also d~fferent In renal m~crovascular, braln 
microvascular and coronary artery macrovascular endothelial cell ltnes Thus the llpld and 
proteln composlt~on of mrcroparticles can tnd~cate the parent cell of orlgln and the cellular 
processes andlor agonists trrggering thetr formatron (Ahn, 2005). 
1.6.2 Quantification 
The majority of stud~es to date have quant~f~ed m~cropartlcles using flow cytometry 
With thls method, slzing beads (e~ther 1 0 or 1.5 pm) are used to set the upper mtcropart~cle 
d~ameter llm~t and to gate out larger non-m~cropartlcle materlal from the analysis. 
Micropart~cles from different parent cells are then dtfferentlated using monoclonal antlbod~es 
labelled w~th fluorescent dyes aga~nst cell-spec~f~c b~omarkers As a biomarker may be co- 
expressed on m~cropart~cles shed from d~fferent parent cells, two colour flow cytometry can be 
employed to enumerate m~cropart~cles carrylng two speclflc b~ornarkers (+I+) or one 
b~omarker but not another (+I-) Annexln V, a phosphol~p~d-b~nding proteln also labelled w~th 
fluorescent dyes, has been used to enumerate total rnicroparttcle number as it blnds to all 
negatively charged microparttcle membranes Possible shortcomtngs of thts approach have 
already been h~ghl~ghted 
As collect~on and assay protocols vary considerably between laborator~es, direct 
comparisons are difficult (Horstman et al., 2004a). D~fferences exlst In terms of how blood IS 
collected, centrifuged and processed Some laborator~es only assay fresh plasma wh~le 
others freeze samples Some groups Isolate rn~cropartlcles by pelleting and washlng wh~le 
others assay mlcropart~cles in platelet poor plasma Assay protocols also vary, wrth no 
agreement on a deflnltlon of mlcroparticle size, the need for annexin V positlvlty or the 
comblnatlon of antibodies to be employed to dlfferentlate microparticles of endothellal, platelet 
and leukocyte orlgin. In a number studles, endothellal mlcropartlcles (EMP) have been 
defined as those wrth CD31 but not CD42b present on their surface (CD31+ICD42b-) 
Platelet endothellal cell adheslon molecule (CD31) IS expressed on both platelets and 
endothel~al cells with CD42b speclfic to platelets only. VE-Cadherln (CD144), CD146, 
CD62E, CD51, ICAM-1 (CD54) and VCAM-I (CD106) have also been employed as antlgens 
to dlstlngulsh EMP from other mlcropartlcle specles 
1.6.3 Biological Functions 
Although the physiological and pathophys~olog~cal roles of m~cropart~cles are not fully 
understood, it IS likely that they are lnvolved in the transfer of blologlcal information between 
cells (Martinez et al., 2005). Most of the exchange of lnformatlon takes place wlth endothellal 
cells (MartInez et al , 2005) There is evldence that m~croparticles play a role In inflammation, 
coagulation and endothellal dysfunct~on, key features of atheroscleros~s (Van W I J ~  et al , 
2003) These functions are llnked to molecules on the mlcropartlcle surface and wlthln therr 
cytoplasm (MartInez et al . 2005) 
1.6.3.1 Inflammation 
M~cropart~cles hed from activated endothelial cells can amplify inflammatory 
processes Mlcroparticles shed from TNF-a activated endothellal cells have been shown to 
activate cultured monocytes In vltro, wlth only weak activation from apoptotlc EMP (Jy et al , 
2004) The ~nteractron of CD54 (ICAM-1) on EMP wlth its monocyte receptor may be cruclal 
for rnonocyte act~vatron, as act~vatlon was largely inhrbrted by anti-CD54 As EMP-monocyte 
complexes were more easily able to cross an endothelral monolayer, the authors concluded 
that at least one functlon of EMP IS to increase leukocyte act~vat~on and transendothellal 
m~gratlon 
Leukocytes microparticles are upregulated by inflammatory st~rnulatron and behave 
as lnflammatory med~ators for therr parent cells (Mesri and Alt~er~, 1999) Micropart~cles shed 
from monocytes are a major secretory pathway for the pro-rnflammatory cytoklne IL-1P 
(MacKenzie et al , 2001) Few lnflammatory effects have been described for platelet 
rnicroparticles However, prror ~ncubat~on of endothel~al cells w~th platelet rn~cropartlcles 
(PMP) has been shown to result in the upreguiatron of ICAM-1 and Increased monocyte 
adhes~on (Barry et al , 1998) Although the precise pathways are unclear, the lnflammatory 
effects of microparticles on endothellal cells and leukocytes may be rned~ated by ox~d~sed 
phosphollplds present on the m~cropartlcle membrane or vla the dellvery of arachldonlc ac~d 
to these cells (VanWijk et al., 2003) Ox~d~sed phospholip~ds exert their actlons vla platelet 
activating factor receptors exposed on endotheliai cells and leukocytes (Patel et al , 1992) 
while arach~donic ac~d sits at the top of the arachidonic acrd inflammatory cascade and can 
Increase cytok~ne transcr~pt~on 
1.6.3.2 Coagulation 
A major role of mrcropart~cles, particularly PMP is pro-coagulant act~vity. The 
potential of PMP to Initiate coagulation was recogn~sed at the outset by Wolf (1967). PMP 
generated in vltro and harvested in vlvo have been shown to Initiate and support thrombln 
generation In vltro (Berckmans et al , 2001). Tissue factor (CD142) 1s a key actlvatlng proteln 
in the coagulation cascade and IS present on platelet and other micropart~cles. Membranes 
exposing negatively charged phospholipids espec~ally PS also play an Important role In 
coagulation, facll~tatlng factor Vlla - tlssue factor bindlng and the formation of prothromblnase 
complexes Thus, PMP both actlvely ln~tiate and passively support coagulation (Horstman et 
al., 2004b) Mlcroparticles expressing tlssue factor are present In atherosclerot~c plaques and 
are a prlmary source of procoagulant activity w~thin a les~on (Mallat et al , 1999) There 1s 
ev~dence that these m~cropart~cles are shed from plaque leukocytes (Mallat et al , 1999) and 
from apoptot~c smooth muscle cells (Bnsset et ai , 2003) 
1.6.3.3 Endothelial dysfunction 
Microparticles from acute myocardial infarct~on pat~ents (Boulanger et al , 2001) and 
women wlth pre-eclamps~a (van W~jk et al , 2002) have been shown to Impair endothel~al 
dependent reiaxatlon In Isolated arteries Although the mechanisms and pathways by whlch 
EMP impalr endothelial function are unclear, there 1s some evidence that oxidative stress may 
be a culprlt Oxidlsed phosphol~pids are present on rnicroparticles released from endothellal 
cells subject to ox~datlve stress (Huber et al , 2002) and ox~dised phosphat~dylchollne has 
been shown to Induce endothel~al dysfunction In Isolated arterles (R~k~take et al , 2000) 
Brodsky et al (2004) also demonstrated an Impairment of endothel~al dependent relaxation in 
rat aortlc rings that were Incubated wlth EMP generated In vitro Thls was accompan~ed by 
increased superox~de production In the aort~c rlng endothellurn and a decrease in NO 
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membrane protelns are typically elevated in the acute phase of dlsease (J~menez et al , 
2005), with CD31 (a constitut~ve protein) the notable exception 
1.7 Postprandial period and atherosclerosis 
The concept of atherosclerosis as a postprand~al phenomenon was first proposed by 
Zilversmit (1979) In h ~ s  landmark paper, he proposed that cholesterol-enriched chylomicron 
remnant particles were atherogen~c and that the metabolism of chylomicrons at the arterlal 
wall, facilitated the movement of remnants into the arterlal intlma. In an extension of this 
hypothesis, M~esenbock and Patsch (1992) postulated that postprand~al triglyceride (TG) 
transport was crltlcal for the development of atheroscleros~s and more revealing of r~sk than 
fastlng values S~nce then, research interest in postprandial metabolism has developed in 
parallel with advances in our understand~ng of the pathophysiology of atherosclerosis 
Whereas earller hypotheses focused on the role of l~pids and l~poproteins, current research 
ernphaslses postprand~al oxidative stress, endothelial inflammat~on and impalred endothel~al 
function 
1.7.1 Lipids and Lipoproteins 
Evidence exists from an~mal and human studies that the remnants of trlglyceride-rich 
lhpoproteins (TGRL) are atherogen~c Apo E knockout mice have been shown to experience 
TGRL remnant accumulat~on and severe atherosclerosis (Zhang et al , 1994) Remnant 
uptake and retention has been demonstrated in rabbit coronary arteries when perfused in situ 
wlth rad~o- or fluorescently labelled chylomicron remnants (Mamo and Wheeler, 1994; Proctor 
and Mamo, 1998) Rapp et al (1994) found direct evldence that TGRL remnants are 
deposrted m human atherosclerot~c leslons by examining lesions removed dunng aortlc 
surgery. One third of the apo B associated cholesterol came from VLDL and IDL However, 
apo 648 was not detected 
In addltlon to the generation of atherogenlc remnants, TGRL may contribute lndlrectly 
to the development of atherosclerosis via an Influence on other llpoproteln specles When 
compared to the fasted state, the postprandial state is dynamlc and nonsteady, wlth rapld 
remodelling of llpoprotelns (Hyson et al , 2003) Cholesterol ester transfer proteln (CETP) 
mediates the reciprocal transfer of cholesterol ester and TG between llpoprotelns In the 
postprandial tr~glycer~de-rich environment, TG IS transferred from TGRL to HDL and LDL with 
cholesterol ester exchanged in the opposlte dlrectlon, resultrng in cholesterol-enr~ched 
chylom~crons and VLDL, and tr~glycer~de-enr~ched, cholesterol-depleted LDL and HDL The 
TG content of LDL and HDL IS rapidly hydrolysed by hepatlc Ilpase resulting in small dense 
LDL and HDL 
The Inverse assoclatlon consistently found between TG and HDL-C, In particular wlth 
HDLTC, can be explained by thls neutral llpid exchange. One research group has previously 
suggested that hlgh HDL-C may not be protectlve per se, but slmply reflect an efficient 
metabolism of TGRL (Mlesenbock and Patsch, 1991) More recent evidence suggests that 
the HDL partlcle IS protectlve per se (Parthasarathy et al , 1990, Flu~ter et al , 1996, Barter et 
al , 2002; Spleker et a l ,  2002) The cholesterol enr~chrnent of the TGRL is pro-atherogen~c 
as cholesterol ester cannot by metabolised by llpoproteln Ilpase The reduction in LDL 
particle size is also pro-atherogenic, allowing it to more easily cross the endothelium, and 
increasing its susceptibility to oxidation (Diwadkar et al., 1999). Small dense LDL are hlghly 
predictive of CAD and present in 40-50% of all patients with CAD, despite normal LDL-C 
(Griffin et a1 , 1994) 
The postprandial nature of atherosclerosis is supported by epidemiolog~cal studles 
(Patsch et al., 1992, Sharrett et al , 1995, Groot et al , 1991) showing higher postprandial 
lipemia and remnant lipoproteins in CAD patients compared to matched controls Triglyceride 
concentrations in the late postprandial period have been shown to distinguish CAD cases 
from controls with an accuracy of 68% and to remain significant in a multivariate model after 
the ellminatlon of fasting TG and HDL-C (Patsch et al , 1992). S~milar results were found in 
the ARlC study (Sharrett et al ,  1995) where higher postprandial increases in TG and TGRL 
remnants were observed in those wlth asympomatic atherosclerosis (based on lMTc 
measurements) compared to matched controls A surprising finding however, confirmed by 
Ginsberg et al (1995) was the lack of association of postprand~al markers with disease status 
in obese men and women It was suggested that the marker function of postprandial TG for 
TGRL remnants may be abolished in the obese state, when TGRL are particularly large and 
less dense 
A shortcoming of all cross-sectional studies is their inability to determ~ne causality It 
could be argued that the presence of atherosclerosis in some way impairs postprandial TG 
metabolism. Prospective studies of those with established CAD indlcate that dlsease 
progression is related to TGRL and their remnants Karpe et al (1994) found an association 
(r= 0.51, pcO 05) between the progression of atherosclerosis over a 5-year period determined 
by coronary angiography, and postprandial levels of small chylomicrons at baseline In the 
Montreal Heart Study, hepatic TGRL remnants predicted the progression of atherolsclerosis 
(Havel, 1994) A cross-sect~onal study comparing healthy offspring of CAD patients with 
matched controls, demonstrated higher TG levels in the late postprandial per~od in the CAD 
offspring, despite similar fasting TG (Uiterwaal et al , 1994). The authors suggested that 
delayed clearance of TG m~ght be associated wlth famrl~al r~sk of CAD 
1.7.2 Atherogenic component of postprandial lipoproteins 
Evidence from numerous in vitro studies suggests that TGRL andlor their llpolysis 
products (TGRL remnants and free fatty aclds) are toxlc to endothel~al cells Studies have 
shown Increased endothelial permeablllty from TGRL extracted from postprandlal but not 
fasting serum, and incubated with llpoproteln llpase (Henn~g et al , 1992, Chung et al., 1998). 
The components of postprand~al llpoprotelns that Increase endothelial permeabil~ty, and 
tr~gger the expression of adheslon molecules are not fully clear However, the lipolysls 
products of oxid~sed chylom~crons have been Identifled as potentral culpr~ts Chylomicrons 
obtained from postprandial serum and oxidised in vitro have been shown to be cytotoxlc to 
endothelial cells and stimulate adhesion molecule expression (Jagla and Schrezenrneir, 1998, 
Mabile et al , 1995; Kurtel et al . 1995) Non-oxidised chylomicrons did not stimulate 
endothelial monocyte adhesion in rat venules and the cytotoxicity of oxidlsed chylomicrons 
was blunted by pre-treatment with the antioxidant enzyme superoxide dismutase (Kurtel et al , 
1995) Chylomicron cytotoxicity has also been shown to relate to lipoprotein fatty acid 
composition Chylomicrons obtalned followlng meals rrch In polyunsaturated fats were more 
easlly oxidlsed In vltro and consistently Induced hlgher levels of adheslon molecule 
expression (Jagla and Schrezenmelr, 1998, Mablle et al , 1995) Slmllarly, Chung et al 
(1998) found FFA released llpolyt~cally from postprandial serum to be more ln]urlous to 
endothelral cells and macrophages followlng a meal hlgh In polyunsaturated fatty aclds 
compared to saturated fatty ac~ds. 
lndlvrdual fatty acids have been shown to stlmulate and to protect agalnst endothellal 
cell actlvatlon In vltro Llnolelc ac~d, the most abundant polyunsaturate In the dlet, has been 
shown to Increase cellular oxidative stress, actlvate NFKB, Increase IL-8 production and 
ICAM-1 expresslon (Young et al , 1998). Its hydroxy- or hydroperoxy- derivatives, have been 
shown to stlmulate E-select~n, ICAM-1 and VCAM-1 expresslon (Sultana et al , 1996) Prlor 
lncubatlon of endothellal cells wlth llnoleic ac~d has been shown to Increase cytoklne-lnduced 
adhesion molecule expression (Toborek et al , 1996). In contrast, lnh~bltory (protectwe) 
effects have been shown for the omega-3 docasahexaenolc ac~d (Weber et al , 1995) and the 
monounsaturate olelc acld (Carluccio et al , 1999) In summary, evidence from a number of 
in vitro studles lndlcate that the lrpolys~s products of postprandial TGRL Increase ox~datlve 
stress in endothellal cells and are therefore cytotoxlc lndlvlduals fatty aclds, and In particular 
llnolelc acld may also actlvate Inflammatory pathways vla Increased oxldatlve stress or other 
unknown mechanlsms 
1.7.3 Postprandial endothelial activation and dysfunction 
Early proponents of the link between postprandial metabolism and atherosclerosis 
identified the postprandial period as a critical time of heightened risk However precise 
mechan~stic explanations were lackrng Slnce then, advances in our understanding of 
atheroscleros~s have revealed a key role for the endothellurn in regulating vascular function, 
with endothelial dysfunction an early indicator of disease. Studies of postprandial endothelial 
function provide evidence of a threat to vascular health by the metabolites of high fat meals 
This evidence comes from studies that have shown 
1 endothelial dependent dilation (EDD) to be impaired during the postprandial per~od 
2. postprandial increases in circulating adhesion molecules, cytokines and endothehal 
microparticles 
3 ev~dence of endothelial cell activation In vitro when incubated with postprandial serum 
In 25 of 30 studies reviewed, EDD of the conduit vessel was impalred follow~ng a high 
fat or high glucose load This finding was evident in a variety of populations including young 
healthy, older healthy and clinical cohorts (Table 1 4) The maxlmum impairment in 
endothelial function typically occured postprandially at the 4 h timepoint, coinciding with the 
peak TG concentration During oral glucose tolerance tests (OGTT), the maximum 
lmpalrment occurred earlier, coinciding with the peak glucose concentration. Other frequent 
observations in these studles were the interrelationships in flow-mediated dilation (FMD), 
postprandial llpemla and oxidative stress A number of studies reported inverse correlations 
between the postprandial changes m FMD and the changes in TG (r= -0 34 to -0.70, median 
r= -0 47) The postprandial changes in oxidative stress were also associated with the 
changes in FMD (r= -0 784) and TG (r= 0 664) Collectively, these studies suggest that the 
postprandial impairment of EDD is related to postprandial oxidative stress, and varies in 
proportion to postprandial hypertriglyceridemia However, postprandial endothelial function 
can be improved without reductions in lipemia The postprandial impairment of FMD is 
consistently prevented when high doses of antioxidant vitamins are administered with the fat 
and glucose challenges (Plotnick et al , 1997; Title et al., 2000, Ling et al , 2002, Bae et a l ,  
2003) Short-term treatment with statins can also attenuate endothelial dysfunction before 
changes in blood lipids occur (Ceriello et al , 2005), evidence of a lipid-independent 
mechanism of action However, endothelial function is further improved with changes in TG 
and HDL-C following months of statin or fibrate treatment (Marches1 et at., 2003, Ceriello et 
a1 , 2005) 
Hypertriglyceridemia and hyperinsulinemia have both been shown to increase conduit 
vessel diameter and forearm blood flow (Gokce et a1 , 2001; Lind et a1 , 2002). The Increases 
in triglycerides and insulin that occur postprandially may therefore pose methodological 
problems when assessing postprandial endothelial function. Gokce et al (2001) observed an 
apparent decrease in FMD following a high fat meal (FMD calculated as the percentage 
difference between pre- and post-occlusion diameters). However, pre-occlusion brachial 
artery diameters were higher in the postprandial state with post-occlusion diameters similar in 
the fasted and postprandial states. The authors concluded that EDD was consequently not 
impaired postprandially and suggested that the changes reported by others may be an 
artefact Verlficatlon of this obse~ation in the studles rev~ewed here 1s not possible as many 
only report the pre- to post-occlus~on percentage change 
The Influence of h~gh fat and high glucose challenges on reslstance vessel functlon 
has been less frequently studied In add~tion, the studies that exrst have employed a wlder 
range of rnethodolog~es (Table 1 5). Of 3 stud~es that assessed changes in FBF in response 
to Infusion of Ach or Mch, only one (Steer et al ,  2003a) was able to demonstrate a 
postprand~al impairment, and only at the 1 h postprandlal t~mepoint It has therefore been 
suggested that endothel~al functlon may only be Impaired postprand~ally In condu~t vessels 
(de Koning and Rabellnk, 2002) More research is clearly needed glven the relatively small 
number of studles that have examlned reslstance vessel funct~on Postprand~al mpalrments 
in reslstence vessel function funct~on have been shown using other rnethodolog~es (GIII et a1 , 
2003a; Schinkov~tz et al., 2001) However, the extent to whlch Increases in Ach-medlated 
sk~n perfus~on and Increases In reactlve hyperemla reflect reslstance vessel EDD is uncertain. 
Postprand~al changes in endothelial funct~on have also been ~nvest~gated uslng 
circulating markers of endothel~al act~vat~on and lnflarnmation lnclud~ng soluble adhes~on 
molecules, cytokines, leukocytes and more recently endothel~al rnicropart~cles (Table 1 6) 
Postprandlal Increases in soluble adhes~on molecules have consistently been shown in 
clln~cal populat~ons, Including cohorts w~th type II diabetes and hypertriglycer~dem~a (Nappo et 
a1 , 2002, Marches1 et a1 , 2003, Cer~ello et al , 2004, Cer~ello et al , 2005) Small increases 
have been shown in some stud~es lnvolvlng apparently healthy indlvlduals (Nappo et al , 
2002, Cerlello et al, 2004), but not in others (GIII et al., 2003a, Tsa~ et al., 2004) 
Table 1.4 Influence of postprandial lipemia and glycemia on conduit vessel endothelial function 
Study Subjects Main findings 
Plotnick et al 1997 20 healthy adults, FMD lower 2, 3 and 4 h PP, 21% (baseline) vs 8% (4hrsPP) 
No change in FMD when Vit C and E given with meal 
Vogel et al 1997 10 healthy adults FMD lower at 2, 3, 4 h PP, 21% (baseline) vs 11% 
A FMD vs A TG, r= -0.47 
Djousse et al 1999 13 healthy adults No PP change in FMD, 9 5% (baseline) vs 6.8% (P=NS) 
W~llrams et al 1999 10 middle-aged 
healthy adults 
Marches1 et al 2000 10 young healthy 
men 
Raitakari et al. 2000 12 young healthy 
adults 
Title et al 2000 10 young healthy 
adults 
FMD lower PP (5 8 vs 0.8%) only afler meal cooked in used fat 
FMD lower 2 and 4 h PP 
A FMD vs A TG, r= -0 70 
No change in 3 h PP FMD, 4 2 vs 3 2%, p=O 11 
PP increase in pre-occlusion arterial diameter 
For changes in resistance vessel function see table 5 
FMD lower 2 h PP following 759 glucose load, 6 5-3 7% 
No PP change in FMD dVit C and E administered w~th glucose load 
Vogel et al 2000 10 healthy adults FMD lower PP only following meal rich in olive 011 rich (1 of 5 test meals) 
FMD decreased 14 3% to 9 9% 
A FMD vs A TG, r= -0 47 
Wilmink et al, 2000 20 young healthy FMD lower PP, 10 6% (baseline) vs 5.8% (4hr PP), 
adults No PP change in FMD following 2wks folic acid treatment 
Anderson et al 2001 12 T2D patients FMD decreased 4hr PP, in healthy controls (6 3 vs 4 77%) and T2D patients (2 65 vs 1.45%) 
and 12 healthy A FMD related to baseline lipids and A lipids 
controls 
Wilmink et a1 2001 15 young healthy FMD lower PP, 9 1% (baseline) vs 4 3% (4 h PP) 
men Changes in FMD related to RLP-C rather than TG 
3 wks treatment with statins but not fibrates reversed the PP impairment of FMD 
Bae et al 2001 a 20 middle-aged FMD lower PP, 13 7% (baselme) vs 8.2% (2 h PP) 
healthy men Leukocyte superoxide anlon (0;') production 34% h~gher PP 
A FMD vs A TG, r= -0 65, A FMD vs A O;', r= -0 784 
Bae et al 2001 b 11 CAD patlents No PP change in FMD A TG vs A 0;' production, r= 0 664 
Gaenzer et al 2001 17 healthy men, FMD lower PP 
PP FMD vs PP TG, r= -0 81 
D~urnal variation in FMD observed, with lowest values at 8am 
Gokce et al 2001 14 healthy adults FMD lower PP, 14 7% (baseline) vs 10.6% (PP) 
No difference between fasting and PP post-occlusion artery d~ameter, 
PP % decrease due to increase in pre-occlusion artery diameter 
Katz et al 2001 50 healthy adults Brachial artery reactivity (ultrasound assessment of brach~al artery 
blood flow post-occlusion) lower 3 h PP 
No PP changes in BAR follow~ng meal ~ngested wlth Vlt E 
Schillaci et al. 2001 10 young healthy No PP change of FMD 
women Conclus~on. Gender effect evident (repeat of Marchesi et al , 2000 study) 
Wlll~ams et al 2001 14 adults No PP change in FMD following olive or safflower heat-modified oil meals 
Marches1 et al. 2001 7 young healthy FMD lower 2-4 h PP 
men Baseline FMD vs TG (r= -0 426), Baselme FMD vs GSH (r=O 48) 
Effect partly reversed bylOd L-arglnine supplementat~on 
Zhao et al 2001 50 CAD patients & FMD lower PP 3% vsl 7% in patients, 6 6% vs 4 9% ~n controls 
25 healthy controls 
Cer~ello et al 2002 30 T2D and 20 FMD lower PP follow~ng high fat and glucose loads in T2D and healthy controls 
healthy controls Biggest PP decrease following combined fat-glucose load 
Short term (3-6 d) statin therapy improved fasting and PP FMD in T2D without changes in lipids 
Long term statin therapy reduced l~pids w~th further ~mprovements in FMD 
De Roos et al 2002 21 healthy men No PP change in FMD following meals r~ch in saturated FA and trans FA 
Funada et al. 2002 24 adults No PP change in FMD Baseline FMD vs A RLP-C, r= -0 588 
Lee et al 2002 12 T2D FMD lower PP following with high fat (13 1 vs 7 3% 4 h)or glucose load (13.2 vs 7 3% 1 h) 
lncrease in PP 0;' production 
No PP changes in fat and glucose loads adm~nistered with Vlt E 
Ling et a1 2002 74 CAD pat~ents FMD lower 4 h PP in CAD patients and healthy controls 
and 50 controls A FMD vs A TG, r= -0 545 
No PP change FMD in e~ther group if Vit C adm~nistered with test meal 
Slepi et al 2002 10 postmenopausal FMD lower 2 h PP, 7 7 vs 2 3% 
women GSH also decreased PP in parallel with FMD 
A FMD vs A TG, r=-0.37 
Bae et al 2003 10 young healthy FMD decreased PP, 13.3% (baseline) vs 6 6% (2 h PP), 7.1% (4 h PP) 
adults No PP change in FMD if Vit E administered with meal 
AFMDvsATG r = 4 5 4  
For changes in resistance vessel function see table 5 
Marchesi et al. 2003 10 HTG pat~ents FMD lower 2-6 h PP, 4.3% (baselme) vs 1 3% (6 h) 
A FMD vs A TG r= -0 34, A FMD vs A SICAM-1, r=-0 66. 
Baseline FMD higher following 3months fibrate treatment 
Tsai et al 2004 16 healthy adults FMD lower 2-6hrs PP 
lncrease in PP oxidative stress (from assessments of 8-PGF,. and GSH) 
No PP change in adhesion molecules 
Ceriello et a1 2005 20 T2D patients FMD lower PP following high fat and glucose loads, biggest PP decrease following comb~ned fat- 
glucose load 
Baseline FMD higher and baseline SICAM-1, IL-6, NT and CRP lower following 4d combined 
atorvastatin-irbesartan treatment prior to changes in lipids 
Abbreviations: Flow-mediated vasodrlatron (FMD), postprandral (PP), type I1 drabetrc (T2D), remnant l~poprotern padcle-cholesterol (RLP-C), superoxrde 
anron(O,"), reduced glutathione (GSH), coronary artery drsease (CAD), 8-epr-prostaglandm F2alpha (8-PGF,J, soluble intercellular adhesion molecule-l 
(slCAM-l), soluble vascular cell adhesion molecule-I (sVCAM-I), mteileukin-6 (IL-6) 
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Table 1.5 Influence of postprandial lipemia and glycemia on resistance vessel endothelial function 
Study Subjects Main findings 
Gudmundsson et al 15 young healthy 
2000 adults 
Raitakari et al 2000 12 young healthy 
adults 
Muntwyler et al. 2001 12 young healthy 
adults 
Schinkov~tz et al 2001 11 healthy adults 
Bae et al 2003 10 young healthy 
adults 
Gill et al 2003a 8 endurance- 
trained men 
Steer et al 2003a 26 young healthy 
adults 
Gill et al 2004 10 lean and 10 
obese middle-aged 
men 
EDD evaluated as A FBF from resting in response to Ach and bradykinin 
No difference in EDD 2-4 h PP following consumption of high and low fat meals. Changes in EDD 
pre- to postprandial not determined Increase in plasma glucose PP following low fat meal 
Reactive hyperemia (post-occlusion FBF) h~gher at 3 & 6 h PP 
Baselme blood flow (pre-occlusion FBF) higher 3 & 6 h PP 
A FBF vs A TG r= 0 77, A FBF vs A insulin, r= 0 80 
For changes in conduit vessel function see table 1 4 
EDD evaluated as absolute Ach-FBF and A Ach-FBF from resting values 
No change EDD 4 h PP 
Reactive hyperemla (increase in FBF following arterial occlusion) lower at 2 h PP 
No change in 2 h resting FBF 
Reactive hyperemia (FBF following venous occlusion) higher PP but baseline blood flow (FBF pre- 
occlus~on) also higher PP Effects on EDD thus inconclusive 
For changes in condult vessel function see table 1 4 
Skln perfusion follow~ng iontophoresls of Ach (EDD) 17-22% lower 4hrs PP No PP change in skin 
perfusion of SNP (EID). IL-6 increased at 4 & 6 h PP 
EDD evaluated as (1) absolute FBF during Mch infusion and (2) Mch-FBFI SNP-FBF ratio during 
infusion 
EDD measured by both Indices decreased 1 h PP following consumption of 34% fat meal but not 
20% fat meal 
Skin perfusion following iontophoresis of Ach (EDD) 15% lower PP 
Skin perfusion following iontophores~s of SNP (EID) also lower 
Thus evidence of decreased skin perfusion PP but not EDD 
Abbreviations. Postprand~al (PP), endothelial dependent vasod~lation (EDD), endofhelral independent vasodrlaf~on (EID), acetylcholrne (Ach), mefacholine 
(Mch), sodium nltroprusside (SNP), forearm blood flow (FBF), carotid artery Intima media fhlckness (IMTc) 
Table 7.6 Influence of postprandial lipemia and glycemia on soluble adhesion molecules, cytokines, microparticles and other inflammatory markers in 
the circulation 
SlUUy Subjects Main findings 
Nappo et al 2002 20 OW T2D (aged PP increases in sVCAM-I, SICAM-1, IL-6 and TNF-a ~n T2D and controls 
46?5 y) and 20 Basellne values and PP increases more pronounced in T2D 
matched controls 
Gill et al. 2003a 8 endurance-tralned No PP changes in sVCAM-1, SICAM-1 or TNF-a 
athletes PP increases in IL-6 
Marches) et al. 2003 10 HTG pat~ents PP increases in sVCAM-1 and SICAM-1 
Van Oostrom et al 2003 8 healthy young men PP Increases in leukocytes (mainly neutrophils), IL-6 and IL-8 
Ceriello et al 2004 30 OW T2D (aged PP Increases In SICAM-1, sVCAM-1 and sE-selectln following hlgh fat and hlgh 
5423 y) and 20 glucose test meals PP Increases more pronounced following comblned fat- 
matched controls glucose meal. PP Increases more pronounced in T2D 
Tsai et al 2004 16 young healthy No PP changes In SICAM-1, sVCAM-1 or CRP 
adults 
Van Oostrom et al 2004 10 mrddle-aged healthy PP Increase in neutrophll counts PP Increase in actlvatlon of monocytes and 
men leukocytes (increased CDl I b expression) A CDl I b monocyte expression vs A 
TG r= 0 64 
Ferrelra et al. 2004 18 young healthy PP increases in EMP defined as CD31+ICD42- 
adults A EMP vs A TG r= 0.77 
Cerlello et al. 2005 20 T2D patients PP Increases In SICAM-1, IL-6, CRP following hlgh fat and high glucose meals PP 
lncreases more pronounced followlng combined fat-glucose meal 
Tushuizen et al 2006 17 healthy adults PP Increases In total MP (mainly platelet MP) EMP were not detectable In fastlng 
or postprandial samples uslng CD62E, CD106 and CD144 biomarkers 
Abbrevratrons: Overwe~ght (OW), type I1 diabetrc (TZD), hypertrrglyceridemra (HTG), soluble rntercellular adhesion molecule-I (SICAM-I), soluble vascular cell 
adhesron molecule-? (sVCAM-I), mterleukrn-6 (IL-6). fnterleukrn-8 (IL-8), tumour necrosis factor-a (TNF-a), C-reactive protein (CRP), mrcroparticle (MP), endothelral 
mrcropart,cle (EMP), cluster of d~fferentratron molecule (CD) 
Although increases In adheslon molecules have been demonstrated In type I1 diabetics 
following a high fat and a h~gh glucose challenge, the greatest increase occurred following a 
comblned high fat-glucose challenge (Ceriello et al , 2004). Peak values coincided with peak 
TG durlng the OFTT and w~th peak glucose during the OGTT. In some studles, the 
postprandial Increases In soluble adheslon molecules have mlrrored the lmpalrment of EDD 
(Marches1 et al, 2003, Cerlello et al, 2004) though not in others (GIII et al , 2003a). 
Postprandial Increases In IL-6 (Nappo et al., 2002, Glll et al , 2003a, Van Oostrom, 2003) 
leukocyte counts (Van Oostrom et al , 2003, Gill et al , 2004, Van Oostrom et al , 2004) and 
leukocyte activation (Van Oostrom et al . 2004) have also been demonstrated An Increase in 
TNF-a has been shown in one study (Nappo et al , 2002) but not another (GIII et al ,2003a) 
Only two studies have examlned postprand~al changes in clrculatlng microparticles 
Ferreira et al (2004) reported a postprandlal increase in EMP deflned as CD31+ICD42-, In 
young healthy volunteers following a high fat but not a low fat test meal. The increase In 
serum TG was related to the Increase In EMP (r= 0 77) Tushuizen et al (2006) 
demonstrated a postprandlal Increase In total mlcroparticles (annexln V posltive events) and 
In markers of oxidative stress, along wlth a decrease in FMD However, EMP were not 
detectable In the fastlng or postprandlal samples of these young healthy volunteers, when 
CD62E, CD106 and CD144 were employed as blomarkers. 
In summary, FMD in condult vessels has consistently been shown to be lmpalred 
following hlgh fat and hlgh glucose challenges, In young healthy and older cllnlcal 
populations Thls change in endothelial funct~on 1s accompanied by an Increase in 
Inflammatory cytoklnes, leukocyte counts and leukocyte actlvatlon Postprandial Increases in 
adhesion molecules occur in clinical populations Only small Increases if any, occur in young 
healthy populations Postprandlal increases In EMP have been shown In one study involving 
young healthy volunteers but not another EMP may prove to be a more sensltlve marker of 
postprandral endothelial actlvatlon than soluble adhesion molecules In healthy volunteers, 
though more work 1s needed to confirm this 
1.7.4 Postprandial oxidative stress 
A postprandlal increase in oxldatlve stress IS another consistent feature of the 
literature whether determ~ned by changes in nitrotyros~ne (Ceriello et al , 2004, Cerlello et al , 
2005), llpld peroxides (Andersen et al., 2001; Van Oostrom et al , 2003), malondlaldehyde 
(Wllmlnk et al , 2000), secondary lipid radlcals (Andersen et al , 2001), 8-epl-prostaglandin Fzo 
(Tsai et a l ,  2004), glutathione peroxidase (Siepr et al , 2002, Tsai et al , 2004) or leukocyte 
superoxide anlon production (Bae et al , 2001a, Bae et al , 2001b, Lee et al., 2002,) Most 
authors attribute postprandial endothellal dysfunction to the postprandlal Increase in oxidative 
stress Nappo et a l ,  (2002) were not able to demonstrate increases In soluble adheslon 
molecules or cytokines, when the test meals were administered wlth hlgh doses of vltamln E 
Similarly Cerlello et al (2004) demonstrated a decrease In all soluble adheslon molecules 
following 3-6 days of simvastatin treatment before any reduction in llpids occurred. These 
early decreases in adheslon molecules were attributed a reduction In oxidatlve stress, as 
there was a concurrent reduction in nitrotyrosine. Postprandlal oxidatlve stress also 
Increases the oxidation and atherogenecity of circulating and subendothelial LDL particles 
(Ursini and Sevanian, 2001). 
Although its existence 1s well documented, the source of postprandlal oxidative stress 
1s still unclear. McCarty (2003) has proposed that the exposure of endothellal cells to FFA 
and lnsulln results in the accumulation of an lntracellular TG pool that has a detrimental effect 
on EDD Recent landmark papers (Brownlee, 2005, Cerlello and Motz, 2004) also point to 
nutrient-driven Increases In mltochondrial Kreb's cycle activity, and the generation of reactive 
oxygen species along the electron transport cham, as the major source of oxldatlve stress in 
endothelial cells It is likely that nutrient uptake Increases considerably in endothelial cells 
durlng the postprandlal period Unllke adlpose tissue and muscle, endothelial cells cannot 
limit postprandial nutrient uptake as they do not become insulin resistant Studles generally 
show that the maximum lmpalrment of EDD and the maximum increase in endothellal cell 
activation markers colncldes with peak TG and glucose concentrations (Cerlello et al , 2002, 
Cerlelio et al , 2005) 
Evidence of a specific role for FFA in oxldatlve stress-mediated endothelial 
dysfunction comes from a number of Infusion studies. Intralipld-heparin lnfuslons that 
resulted in a seven-fold Increase in FFA have been shown to Impair resistance vessel 
endothellal function (Steinberg et al , 1997; Steer et al , 2003b; Steer et al , 2003c), but thls 
impairment was abolished by the concomitant infusion of vitamin C, L-arglnlne or 
cyclooxygenase (COX) inhibitors (Steer et al , 2003c) Although serum FFA generally 
decrease In the early postprandlal perlod, later rising above fasting values, local endothelial 
concentrations wlll be largely determined by serum TG, which release FFA at the endothel~al 
surface (Jagla and Schrezenmelr, 2001) 
1.7.5 Summary 
In summary, cholesterol-enr~ched remnants of TG-r~ch lrpoprote~ns are generated 
durlng the postprandial per~od that in add~tron to LDL, are known to be dlrectly atherogen~c A 
postprand~al tr~glyceride-r~ch environment is known to exert an atherogenic influence on other 
lipoprote~n specles lncreaslng the preponderance of small dense LDL and decreasing serum 
HDL-C Postprandial ox~datlve stress is a cons~stent flndlng In the literature, lncreaslng the 
oxldat~on and atherogenec~ty of LDL and other remnant l~poproteins Postprand~al oxldatlve 
stress In endothel~al cells, poss~bly med~ated by nutnent overload, also results In endothel~al 
cell actlvat~on and a serles of pro-inflammatory changes that Increase leukocyte attractron, 
adhes~on, transendothelial mlgratlon, prol~ferat~on and survival. These postprand~al 
perturbat~ons may be exacerbated in centrally obese, insulin resistant lndlv~duals, who 
experience a greater degree of Ilpemla, have higher levels of pro-~nflammatory cytok~nes and 
a reduced ab~l~ty o lrmrt endothel~al cell nutrlent overload Twenty-f~ve years on from 
Zilversmlt's orlglnal paper, the proposal that postprand~al ~pemia (and Indeed glycem~a) plays 
a role in the development of atherosclerosis, has been borne out by mult~ple mechanisms 
1.8 Exercise and postprandial triglycerides 
Physical actlvlty and physical fitness are assoc~ated with a lower inc~dence of CAD 
In a meta-analys~s of prospectlve stud~es, the relatlve r~sk of death from CAD in the most 
active individuals was approximately half that of their sedentary counterparts (Berlin and 
Colditz, 1990). The cardioprotective effect of exericse may be mediated in part by an 
influence on triglyceride metabolism 
1.8.1 Effect of a single exercise bout 
There is clear evidence that a single bout of prolonged exercise that occurs prior to 
feeding can reduce postprandial TG concentrations. This finding is consistent in young adult 
(Aldred et al., 1994), older male (Gill et al, 2001a, Gill et al , 2004), postmenopausal female 
(Gill and Hardman, 2000), sedentary (Tsetsonis et al , 1997), trained (Tsetsonis et al , 1997), 
overweight (Murphy et al , 2000, Gill et al , 2004) and hypertriglyceridemic (Zhang et al , 
2006) populations Acute exercise typically results in a 20-30% decrease in the area under 
the TG-time curve, with reductions in the chylomicron-TG, VLDL,-TG and VLDL,-TG 
subfractions (Malkova et al , 2000, Gill et al , 2001b, Gill et al , 2006) Decreases in 
postprandial lipemia have been shown with exercise bouts of only 30 min duration at 60% 
V0,max (Murphy et al , 2000) A small number of studies employing low to moderate 
intensity exercise bouts of short duration, have failed to demonstrate any influence of acute 
exercise on postprandial lipemia (Pfeiffer et al , 2005, Pfeiffer et al , 2006, Teixeira et al , 
2006) 
Some (Gill et al ,  2001b; Malkova et a l ,  1999) but not all (Maikova et al , 2000, Herd 
et al , 2001) studies have reported a decrease in postprandial insulin following acute exercise 
Reductions in postprandial insulin have been demonstrated in centrally obese but not in lean 
middle-aged men (Gill et al , 2004) and in trained but not in untrained women (Tsetsonis et 
al., 1997). The test meals employed In these stud~es were high In fat and carbohydrate, 
resulting in a pronounced lnsulln response that peaked at 30-60 min postprandlally. 
Postprandial l~pem~a was reduced similarly In all studies regardless of the exerclse effect on 
postprand~al insulin 
The timlng of the exercise bout In relation to the oral fat tolerance test (OFTT) may be 
an important cons~derat~on. S~xty mlnutes of exerclse at 60% V0,max has been shown to 
reduce postprand~al ipemla when undertaken 12 h but not 24 h prlor to feedlng (Zhang et al. 
2004) Katsanos and Moffatt (2004) reported slm~lar decreases in postprandial llpemla when 
exerclse was completed 30 mln before or commenced 90 mln after meal lngestlon In 
contrast, Zhang et al (1998) found decreases in postprandial l~pemia from exerclse bouts that 
commenced 1 h and 12 h pre-feeding but not 1 h post-feed~ng. In the majorlty of stud~es In 
this revlew, exerclse sessions were conducted on the day prior (16 h approximately) to the 
test meal 
In a retrospectlve exammation of the data from 7 prevlous stud~es, 90 mln exercise at 
60% V0,max reduced fast~ng TG, postprand~al TG and the postprandlal TG Increment (AUC 
above baselme) by 18 2k2 2%, 21 5 f l  5% and 21 9k3 I%, respectively (GIII et al ,  2002a) 
The attenuat~on of fastlng and postprand~al TG was slmllar In men and women and In apo 
E312, E313 and E314 genotypes In these stud~es, approximately 10% of subjects experienced 
no change or even an increase In postprand~al TG as a result of exerclse. A strong 
relationsh~p ex~sted between the exerc~se-~nduced changes in fastlng and postprand~al 
triglycerides (r= 0 82, p<O 01) wlth no s~gn~f~cant relationsh~p between the changes In fastlng 
TG and the postprandial TG Increment (r= 0 16, p=O 16). A relationsh~p was also evident 
between the exercise-lnduced changes In postprand~al TG and V02max (r=0 33, p<0 OI), 
though the authors suggest that this may reflect differences In energy expend~ture dur~ng the 
experimental exerclse bout Acute exercise attenuated fastlng lnsul~n in men but not women 
However, postprand~al insulin was reduced similarly in men (13%) and women (17%) 
The avallable evldence suggests that energy expendlture may be more crltlcal than 
exerclse ~ntenslty In lnfluenclng postprand~al triglycer~de metabolism Gill et al (2002b) 
demonstrated a dose-dependent decrease in postprand~al l~pemia of 9 3% and 22 8% 
respect~vely from 60 mln and 120 mln walklng at 50% V02max Slm~larly, Tsetson~s et al 
(1996a) found the attenuat~on of postprandial lipemla to be greater followlng 90 min at 60% 
V02max compared to 90 mln at 30% V02max In a related study, lsocalorlc exerclse bouts at 
two different lntens~ties (90 min at 60% V02max vs 3 h at 30% V02max) resulted In slmllar 
decrease in postprandial l~pemia (Tsetson~s et al , 199613) In contrast, Zhang et al (2006) 
found postprand~al ~pem~a to be attenuated s~milarly In 10 hypertr~glyceridem~c men followlng 
60 min exercise at 40%, 60% and 70% V02max. 
The avallable ev~dence also suggests that exercise benefits can be accumulated over 
the course of a day in two or three shorter bouts. Stud~es have demonstrated similar 
reductions in llpemla following one 90 min and three 30 min bouts at 60% V02max (GIII et a1 , 
1998), one 30 mln and three 10 min bouts at 60% VOzrnax (Murphy et al , 2000) and one 30 
min and ten 3 mln bouts at 70% V02max (M~yashita et al , 2006) In one study, only 
, 
Intermittent exercise resulted in slgnifrcant reductions In llpemia (Altena et al , 2004) The 
possibility of accumulating benefit with multiple short bouts has major public health 
implications 
The majority of the research studles have employed aerobic exercise, typically 
treadmill walking, jogging or cycle ergometry However, a recent study has demonstrated a 
reduction in postprandlai TG in young adults following four 15 min bouts of ~ntermittent games 
activity, that was comparable to that achieved with four 15 min bouts of uphill treadmill 
walking (Barrett et al , 2006) The influence of resistance exerclse is less clear Single 
sessions of resistance exercise have been shown to result in a decrease (Petitt et al , 2003), 
no change (Burns et al., 2005, Shannon et al , 2005) and even an Increase (Burns et al , 
2006) in postprandial iipemia. 
Two recent studles have documented qualitative changes in postprandial TGRL 
following acute exerclse, with potential pro- and anti-atherogenic effects Gill et al , (2006) 
reported a lower postprandial ratio of apo CllllapoB in the VLDL, fraction following acute 
exercise, indicating fewer apo Clll apoproteins per VLDL particle. The apo Clll content of apo 
B lipoproteins has been shown to be an independent predictor of coronary lesion progression 
(Hodis et al , 1994) This reduction in apo Clll content is likely to inhibit CETP-mediated 
neutral lipid exchange and facilitate LPL-mediated I~polysis, as apo Clll activates CETP and 
inh~b~ts LPL action (Wang et al , 1985; Jong et al , 1999) Accord~ngly, favourable changes 
were observed post-exercise in the CElTG ratios of the VLDL, and HDL2 fractions. In 
contrast, Magkos et al , (2006) demonstrated an increase in IDL on the morning after 2 h 
cycling at 60% VOzmax. A decrease In VLDL-apo B secretion was observed but in the 
absence of changes In VLDL-TG secretion Thls polnts to VLDL particles that are fewer In 
number but r~cher In TG content and thls qualltatlve change may account for the potentially 
pro-atherogen~c Increase in IDL remnants 
1.8.2 Effects of endurance training 
The effect of endurance tralning on postprand~al triglycer~de metabol~sm IS not SO 
clear Cross-sect~onal stud~es have shown postprand~al lipemla to be lower In endurance- 
tralned lndivlduals compared to non-exercisers (Merlll et al , 1989, Cohen et al , 1989). 
However, cross-sectional studles cannot prove cause and effect. The results of tralning and 
detraining stud~es are confllct~ng When assessments are made at least 48 h after the last 
tra~n~ng bout, some studies report a decrease in fastlng and/or postprand~al TG (Altekruse 
and W~lmore, 1973, Wlrth et al , 1985) In contrast others have found postprandlal llpemla to 
be unchanged following 4-13 weeks of trainlng (Aldred et al , 1995, Herd et al , 1998, Altena 
et al , 2006) Hardman et ai (1998) examined the effect of seven days de-tralnlng on 
postprand~al triglycer~de metabol~sm, wlth OFTTs conducted 15 h, 60 h and 6 5 d after the last 
tralnlng bout Most of the benef~t was lost between the 15 h and 60 h tnal, suggesting an 
acute effect of exerclse on postprand~al tr~glycer~de metabol~sm lastlng less than 3 d Thls 
conclusion IS supported by the results of a cross-sectional study of tralned and untrained 
young adults (Herd et al., 2000) When OFTTs were undertaken two days after the last 
exerclse bout, postprandlal llpemla was not affected by trainlng status Although the major~ty 
of studies underllne the importance of acute over chronlc exerclse, tralnlng w~ll undoubtedly 
be of lndlrect benef~t as increases In f~tness will enable acute bouts of greater Intensty, 
durat~on and frequency to be completed Tsetsonls et al (1997) compared the effects of a 
s~ngle exerclse bout of equal relatlve lntenslty and durat~on In tra~ned and untralned women 
As a result of differences in f~tness, energy expenditure during exerclse was 48% hlgher In the 
trained women w~th  postprandial l~pemia attenuated by 30% and 16% respectively In the 
tra~ned and untralned groups 
. ~ 
1.8.3 Interaction with diet 
Stud~es that examlne the ~nteract~on of dietary man~pulat~ons and exercise have 
Important ~mpl~cations for public health but can also shed light on the mechanisms by whlch 
acute exerclse Influences trlglycer~de metabolism G~ll and Hardman (2000) compared the 
effect on postprand~al ~pem~a of an energy deflclt Induced by previous day exerclse, and an 
equivalent energy defic~t Induced by prevlous day d~etary restriction The effect of exerclse 
was cons~derably greater suggesting that the hypotriglycer~dem~c effects of acute exerclse are 
largely Independent of the overall energy def~clt However, the authors polnt out that energy 
deficlts achieved were i~kely to have occurred In d~fferent stores 
H~gh carbohydrate (CHO) d~ets are known to Increase serum TG (Abbasi et al., 
2000) In a three trial study, Koutsar~ et al. (2001) compared postprand~al llpem~a In 
volunteers who on the 3 d prevlous followed e~ther a low CHO diet with no exerclse, a h~gh 
CHO (Isocalor~c) diet wlth no exerclse or a h~gh CHO d~et accompan~ed by 60 mln exerclse 
Postprandial lipemla was slmllar In the low CHO no exerclse trlal and the hlgh CHO exerclse 
trlal but was 33% higher in h~gh CHO no exerclse trlal These results suggest that the 
exerclse can prevent the hypertrlglycendemla assoc~ated wlth high CHO - low fat diets 
It IS plausible that the exerclse effect on serum TG may relate to changes in muscle 
and/or liver glycogen, glven that exerclse typically decreases and carbohydrate feedlng 
increases glycogen stores It mlght therefore be expected that the attenuation of postprandlal 
llpemla would be greater following exerclse bouts that maxlmlse the contrlbutlon of CHO to 
exercise metabolism. Although Malkova et al (1999) successfully manipulated substrate 
utlllsatlon durlng exercise by admlnisterlng elther placebo or aclplmox, a nlcotlnlc acld analog 
and powerful inhlbltor of adipose tlssue llpolysis, prlor to exerclse, postprandial llpemla was 
slmilar In the placebo and aciplmox trials. Whereas, the magnltltude of the addltlonal fat 
oxldatlon was considerable In the aclpimox trlal (+76%), the magnltltude of the addltlonal 
CHO oxidation in the placebo trial (+16%) was small Dlfferences in post-exerclse glycogen 
stores following the two exerclse trials are therefore llkely to have been small and may not 
have been sufflclent to signlflcantly Influence llpemla 
1.8.4 Influence on postprandial endothelial function 
To date, only two studles have tested the hypothesis that the exerclse attenuatlon of 
postprandial llpernla mlght also enhance postprandlal endothelial functlon In a study 
lnvolvlng endurance-tralned men, Gill et al , (2003a) found the postprandlal lmpalrment of 
microvascular endothellal function to be slmllar before and after 7d of detraining, even though 
postprandial lipemla was 53% higher in the detrained state There were no changes in 
sVCAM-1 or SICAM-1 in response to the test meals or follow~ng detralnlng In another study 
(GIII et al., 2004), a slngle sesslon of exerclse reduced fasting and postprandlal TG in middle- 
aged men, and enhanced mlcrovascular endothelial functlon in the fasted state The 
Influence of acute exercise on postprandial m~crovascular function was unclear as 
postprand~al changes were observed in both EDD and EID More work 1s clearly needed 
examining the Influence of acute exerclse on dlrectly measured endothellal functlon and 
blomarkers of endothel~al actlvatlon, w~th reference to changes in postprand~al Ilpemla. 
Postprandial Increases In whlte blood cell count and IL-6 were also documented In these 
stud~es but values were not influenced by acute exerclse or trainlng status 
1.8.5 Mechanisms for exercise effect 
Fig 1.1 Influence of acute exercise on muscle, adipose, hepatic and vascular tissue: 
putative mechanisms by which serum triglycerides are reduced 
4 VLDL-TG secretion 
release o f  act~ve LPL Into c~rculat~on 7 
(hepann-llke effect) 
? Skeletal muscle blood flow 
The mechanisms med~ating the effect of acute exerclse on TG metabolism are stlll 
unclear One possibility is that TG are cleared faster from the c~rculat~on following acute 
exerclse med~ated by an acute increase in the activity of skeletal muscle lipoprotein lipase 
(LPL). This enzyme is located in every caprllary bed, but particularly in muscle and ad~pose 
tissue lncreases in LPL mRNA and LPL proteln have been demonstrated in muscle, 4-8 h 
post-exercise (Seip et al , 1997) Results from short-term trainlng and detraining studies 
provide ev~dence of pre-translational (Seip et al , 1995) and post-translational (Simsolo et al , 
1993) regulation of skeletal muscle LPL actlvity 
The influence of acute exerclse on skeletal muscle LPL (SM-LPL) activity, post- 
heparin LPL (PH-LPL) activlty and triglycer~de clearance rate IS controversial lncreases In 
SM-LPL activity lasting up to 3-5 days have been shown in young, trained volunteers 
followlng prolonged bouts of exercise (Lithell et al , 1979, Taskinen and N~kkila, 1980; L~thell 
et al , 1981, L~thell et al , 1984, Kiens et al., 1989; K~ens and R~chter, 1998). lncreases in PH- 
LPL activity have been demonstrated 24 h post-exercise but not at earlier tlmepoints (Zhang 
et al., 2002) Early studies have shown the clearance rate of an exogenous triglyceride 
lnfus~on to be increased followlng prolonged bouts of exercise that included a marathon race 
(Sady et al , 1986), a 4 h orlenteerlng race (Brandt et al , 1984) and a 3 h runnlng test 
(Dufaux et al., 1981) In one study, the Increase in trlglyceride clearance rate was 
accompanied by an increase in PH-LPL activity 
In contrast, G~ l l  et al (2001a) found no effect of 90 mln exercise at 60% V0,rnax on 
the rate of clearance of an intrallpid lnfusion in untrained middle-aged men, even though the 
same exerclse bout attenuated postprandial l~pemia by 18% Annuzzl et al. (1987) reported 
Increases in intral~pid clearance rate following 3 h but not 90 mln exerclse at 77% HRmax In 
untrained men Three studles have demonstrated decreases in postprand~al ipemla followlng 
90 mln of moderate Intensity exerclse in the absence of changes In SM-LPL or PH-LPL 
activity (Herd et al , 2000, G~ll et al , 2003b, Katsanos et al , 2004) In two of these stud~es, 
cons~derable Increases in LPL activity were ev~dent In some sub~ects, wlth strong correlations 
between the exerc~se-~nduced changes in LPL actlvity and postprand~al ~pemia (Herd et al , 
rho= -0.79, Gill et al , r= -0 77) These data suggest that increases In LPL activity and 
triglycer~de clearance rate are not permlsslve factors for reduct~ons in l~pem~a but where 
increases occur, the attenuatlon of l~pemia will be of greater magnititude 
Malkova et a1 (2000) observed a 34% decrease in postprand~al lpemla on the day 
followlng a prolonged bout of exerclse. Posprandial TG uptake across leg muscle, 
determined from arter~o-venous differences, was not slgn~f~cantly Increased by exerclse, 
though leg TG clearance (TG uptake I arterial concentrat~on) Increased two-fold The 
clearance stat~stic was cons~dered a fa~rer reflect~on of the efficiency of TG removal, as TG 
values were lower in the exerclse tr~al The authors suggested that the observed Increase In 
TG clearance m~ght serve to maintain a supply of FFA to the exerc~sed tlssue durlng the post- 
exercise per~od, in the presence of lower arter~al TG concentrations. 
The exerclse attenuation of fastlng and postprand~al TG may also be med~ated by a 
reduct~on in hepatlc TG synthes~s and VLDL-TG secretion. Early tralning stud~es in rats can 
prov~de some valuable rns~ghts Into the changes in tr~glycer~de metabolism that accompany 
exercise, as all post-training assessments were conducted w~thln 48 h of the last tralnlng 
bout. In three stud~es, exerclse tralnlng has been shown to reduce VLDL-TG secretlon In rats 
by 32-50% w~th s~m~lar reduct~ons In serum TG (Slmonelli and Eaton, 1978, Mondon et a1 , 
1984, Fukuda et al , 1991) Ev~dence from these studies supporting an lncrease In TG 
clearance post-tra~ning was not as conclusive Mondon et al. (1984) attnbuted the lower rates 
of hepat~c TG secretion in the exerclslng rats to lower concentratlons of lnsulln Hepatlc TG 
secretion was slmllar In the tralned and sedentary rats, when livers were perfused wlth similar 
concentratlons of Insulin S~monelli and Eaton (1978) suggested that the ratio of lnsulln 
glucagon should be ~nvest~gated further as a potent~al med~ator of the difference In TG 
secret~on In thls study, dlfferences In insulin were only observed between obese tralned and 
obese sedentary rats whereas dlfferences In glucagon (but not insulln) were observed 
between lean tralned and lean sedentary rats In another study, the exerclse attenuat~on of 
hepat~c tr~glycer~de secretlon was accompan~ed by an Increase in the hepatic product~on of 
ketones (Fukuda et al , 1991), lnd~catlve of increased hepat~c fatty ac~d ox~dat~on The 
authors attnbuted the hypotrlglycerldemic effect of exerclse to altered part~t~onlng of long 
chain fatty acids wlth a decrease In ester~fication and Increase in ox~dation 
Llmlted lndlrect ev~dence in humans supports thls vlew In an ultracentrlfugatlon 
study 79*10% of the reduct~on in l~pem~a following acute exercise occurred In the VLDL 
fraction (Gill et al., 2001b) Thls study also documented exerclse trlal Increases In whole 
body fat ox~dat~on, exogenous fatty ac~d ox~datlon (quant~f~ed by lncorporatlng labelled fatty 
ac~ds Into the test meal) and ketogenes~s The authors attrrbuted the exerclse attenuation of 
lipemia to the hepat~c repartitioning of circulating fatty acids toward ox~dat~on a d ketogene~s 
and away from esteriflcatlon and secret~on. 
To date, only two stud~es have exam~ned the influence of acute exerclse or exerclse 
tralnlng on VLDL k~netlcs In humans In a SIX month tralnlng study involving type I1 d~abet~cs, 
Alam et a1 (2004), observed a decrease In VLDL-apo B secret~on rate but not VLDL-apo B 
fractional catabol~c rate, wlth the changes in apo B secretion related to the changes in serum 
VLDL-TG (r= 0 64) Fast~ng values for TG, FFA, lnsulln, glucose, HbAlc and the HOMA,, 
also decreased with training, lnd~catlng an increase In sensitivity The authors attr~buted the 
reduction In VLDL-apo B secret~on to an increase In lnsulln senslt~vlty and the reduced 
ava~labil~ty of FFA for hepatic TG synthes~s One Important difference must be noted however 
between acute and chronrc exercrse Chronic exerclse tralning typically results in a decrease 
in serum FFA (Alam et al., 2004) whereas FFA release from ad~pose and serum FFA have 
both been shown to be elevated on the mornlng after acute exercise (GIII et a1 , 2001b, 
Magkos et al , 2006) Gwen that FFA are the substrate for hepat~c TG synthes~s, decreases 
in VLDL-TG secret~on may be more easlly demonstrated follow~ng chron~c exerclse 
In contrast, Magkos et a1 , (2006) found VLDL-TG fract~onal catabolic rate to be 40% 
h~gher In young men on the mornlng after prolonged acute exerclse, wlth VLDL-TG secretion 
rate unchanged Thls Increase in clearance occurred In the absence of a change in LPL 
protein in elther the heparln releasable or heparln non-releasable muscle fractions However, 
serum LPL concentrations were 20% h~gher followlng exerlcse In thls study, the 
hypotriglyceridem~c influence of acute exerclse was attributed to LPL upregulation, not 
detectable in muscle protein due to the release of newly syntheslsed LPL into the circulation, 
but detectable from increases in serum LPL mass Oscai et al (1992) has suggested that 
acute exercise can have a heparin-like effect onLPL, at least in rats, displacing it from the 
vascular endothelium into the circulation In this study, exercise resulted in large increases in 
pre-heparin LPL activity and reductions in post-heparin LPL activity, with the majority of LPL 
activity st111 residing in pre-hepar~n plasma 24 h post-exercise The post-exercise decreases 
In serum TG and increases in FFA m~rrored the changes in pre-heparin LPL activlty Any 
release of functional LPL into the circulation following acute exercise, could account for the 
decreases in lipemia and increases in FFA that are frequently reported in humans, in the 
absence of changes in SM-LPL or PH-LPL actlvity 
Although acute exercise has been shown to reduce postprandial TG and postprandial 
lnsulln concentrations, it is unclear if these changes are related Insulin is known to play a 
key role in regulating postprandial l~pld metabolism, lnhibltlng the release of FFA from adipose 
tissue (hormone sensitive lipase inhibition) and inhibiting hepatic VLDL-TG secretion, (Lewls 
et al , 1995), decreasing LPL activity in skeletal muscle and activating LPL in adipose tlssue 
(Lithell et al., 1978). Consequently, hypertr~glycer~dem~a is a key component of the ~nsulin 
resistant (metabolic) syndrome. It is plausible that increases in the sensitivity of these 
processes to postprandial insulin following exercise might result in altered rates of TG 
secretion andlor clearance. However, in their retrospective examination of seven studies, Gill 
et al (2002a) found no relationship (r= 0 04, p=0.70) between the exercise-mediated changes 
in postprandial lipemia and postprand~al insulin It should be noted that the cohorts in these 
studies differed considerably in terms of age, sex and fitness. It has been suggested that 
d~fferent mechanisms might explain the exercise attenuation of postprandial lipemia in young 
healthy populations and in older obese populations (Miesenboch and Patsch, 1992) 
Separate studies to eluc~date these mechanisms in insulin-resistant and ~nsulin-sensitive 
populations are justified. 
Collectively, these studies suggest that an increase in triglyceride clearance can 
occur in response to acute exercise, mediated by an increase in SM-LPL activity However 
such increases are most llkely to be evldent followrng prolonged, vigorous exercise bouts in 
well-trained individuals It is equally clear that exercise bouts of a more moderate lntenslty 
and duration can reduce postprandial lipemla in the absence of increases in triglyceride 
clearance or LPL actlvlty. Thus other mechanlsrns must exist Gill and Hardman (2003) 
conclude that acute exercise is  llkely to attenuate postprandial lipemia by two mechanisms, 
decreased TG secret~on and increased TG clearance, and that the relatlve importance of 
each is likely to depend on factors such as age, sex, degree of body fatness and training 
status 
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INFLUENCE OF ACUTE EXERCISE ON 
POSTPRANDIAL LlPEMlA AND ENDOTHELIAL 
DYSFUNCTION IN NORMAL WEIGHT, OVERWEIGHT 
AND OBESE MEN 
2.1 INTRODUCTION 
Since Zilversmit first postulated that atheroscleros~s was a postprandial phenomenon 
(1979), research interest in postprandial metabolism has developed in parallel wlth advances 
In our understanding of the pathophyslology of atherosclerosls Whereas earller hypotheses 
focused on the importance of postprandial lipoprotein remnants (Zilversmlt, 1979) and the 
remodelling of llpoproteln species (Mlesenbock and Patsch, 1992), current research 
emphasises a postprandial environment that is pro-~nflammatory and pro-coagulant (Hyson et 
al , 2002; van Oostrom et al , 2004) in which endothelral dependent vasodilation IS impaired 
and oxidatlve stress is increased (Bae et al , 2001) 
The expression of adhesion molecules by endothelial cells is a critlcal step in 
atherogenesls, facilitating the adheslon and transendothellal mlgratron of leukocytes 
Concentrations of soluble adhesion molecules have been shown to correlate with membrane 
expression (Leeuwenberg et al , 1992, Schmidt et al., 1995), and are routinely employed in 
research studies as biomarkers of endothelial function Studles generally show postprandral 
Increases rn SICAM-1 and sVCAM-1 rn diabetlc or hypertr~glycer~dernic populations (Nappo et 
al., 2002; Marchesi et al , 2003, Ceriello et al , 2004, Ceriello et al , 2005) Some studies 
have shown small postprandial increases in SICAM-1 and sVCAM-1 in healthy volunteers 
(Nappo et al , 2002, Ceriello et al., 2004) w~th others showing no change (Gill et al , 2003, 
Tsai et al., 2004) The influence of high fat meals on soluble adhesion molecules in obese, 
Insulin resistant populations is unclear 
Insulin plays a key role in regulating postprandral triglyceride metabolism, activating 
lipoprotein lipase (LPL) in adipose tissue and inhibit~ng LPL in skeletal muscle (Lithell et al , 
1978), inhibiting the release of FFA from adipose tissue and Inhibiting hepat~c apo B synthesis 
and VLDL-TG secretion (Lewis et al., 1995) These actlons may be impalred In centrally 
obese insul~n resistant individuals, contr~buting to postprandial hypertriglyceridemia 
(Jeppesen et al , 1995) Acute exerclse is known to reduce postprandial lipemia (Gill et al., 
2002a). It has been suggested that exercise may regulate tr~glyceride metabolism differently 
in young lean h~ghly actrve and older obese ~ndiv~duals (Miesenbock and Patsch, 1992. Gill 
and Hardman, 2003). As the majorlty of studies of acute exercise and postprandial lipemla 
have been conducted in young, lean and active populations, comparative studies with obese 
and more clinical groups are justified, given the increasing prevalence of obes~ty worldwide 
It is also unclear if the exercise attenuation of postprandial l~pemia is sufficient to reduce 
SICAM-1 and sVCAM-1. Such a finding would contribute to an understand~ng of the 
mechanisms by which regular exercise lowers cardiovascular disease risk Gill et al (2003) 
found no changes in soluble adhesion molecules following 7 d of detraining, desp~te a 53% 
increase in lipemia However, the subjects in this study were young, lean, highly tra~ned and 
presumably insulin sensitive ind~viduals 
Although the mean attenuation of postprandial lipemla following prolonged acute 
exerclse is -20%, considerable lnterindiv~dual variation has been shown to exist in this regard 
(Gill et al , 2002a). A weak correlation has been demonstrated between maxlmum oxygen 
uptake and the exercise attenuat~on of lipemla (Gill et al , 2002a). However, as subjects in 
this study exerc~sed for a set per~od (90 mln) at a f~xed Intensity (60% VO,max), the 
correlation was attributed to higher levels of energy expendrture in the high fit individuals 
The magnitude of the exercise attenuation of l~pemia has been shown to Increase wlth 
exercise of Increasing energy expenditure (GIII et al , 20026). To our knowledge, no studies 
have been conducted examlnlng the influence of an  soc caloric exercrse bout on postprand~al 
lhpemia 
The purpose of thls study was to examlne the Influence of a high fat m~xed meal on 
b~omarkers of endotheliai funct~on and Inflammation In normal we~ght overweight and obese 




Thirty men (10 normal welght, 10 overweight and 10 obese) aged 30-45 y 
volunteered for the study (table 2 1) Volunteers were excluded if they engaged rn endurance 
training or compet~tlve sports, were smokers, had cardiovascular dlsease or d~abetes or were 
taking medlcat~on known to Influence carbohydrate or l~pid metabol~sm Ethical approval was 
granted by the Dublin Clty Unlvers~ty Ethics Committee and wrltten lnformed consent was 
obtalned (Append~x A l )  
Study design 
Subjects made four v~s~ts  o the laboratory Dur~ng a prel~m~nary v~s~t ,  maximum oxygen 
uptake was determ~ned and anthropometr~c measurements made, following a medical 
examination Subjects subsequently underwent two oral fat tolerance tests (OFTT) In a 
random~sed des~gn, separated by 7 d approximately (Fig 2.1). On the evening prlor, subjects 
either rested at home (control tr~al) or completed a 700 kcal bout of treadm~ll exercise at 70% 
V02max (exerclse trlal) 
Table 2.1 Description of normal weight, overweight and obese groups 
Normal we~ght Overweight Obese Combined 
(n=10) (n=10) (n=10) group 
(n=30) 
Age (Y) 38.4k1.5 36.7k1.6 37.121 6 37 4k0.9 
Height (crn) 175.4i1.5 176.2k1.4 177.5k2.4 176 4+1 0 
We~ght [kg) 71 7 t 1  5 a 84 0+1 8 b 105 1+23c 86 8+2 7 
BMI (kg r f 2 )  23 320 4 a 27OfO4 b 33 420 7 c 27 9+0 8 
Body surface area (m2) 1 88+0 03 a 201t0 03 b 2 22+0 04 c 2 04iO 04 
Walst circumference (cm) 82 5+1 1 a 88 7k5 4 a 113 9k2.4 b 94 6 t3  3 
Wa~st-hip ratlo 0 86+0 01 a 0.92k0 01 b 1,0220.02 c 0.93rt0.01 
(ml kg-' m~n-') 
V02max (L m~n-') 
Values are mean t SEW 
a, ab, b Different letters denote values that are s~gnificantly d~fferent (p<O 05) Values 
denoted as ab are not s~gnificantly different to values denoted a orb. 
Fig 2.1 Schematic representation of the experimental design 
OFTT day -1 
Control tr~al 
Exercise trial 
0 1 2 3 4 5 6  
T~me after ~naestion of test meal (h) 
Meal (breakfast, d~nner or tea) Test meal 
Exercise bout 
700 kcal @ 70% V02max I Blood sample 
Exercise testing 
Maximum oxygen uptake was determ~ned dur~ng a max~mal Incremental treadmill 
walk I run test, uslng a modified Astrand protocol The initial workload and Increments were 
~ndivldual~sed so that subjects would reach exhaust~on between 8 and 12 min. Heart rate was 
mon~tored cont~nuously using 12-lead electrocardiography (CASE, GE Healthcare, UK). The 
experlrnental exerclse bout was conducted between 17 00 and 20 00 h on the evening prlor to 
the OFTT Subjects ranlwalked on a motorlsed treadm~ll at 70% V02max unt~l 700 kcal had 
been expended Exp~red alr was collected cont~nuously dur~ng the exercise using a breath by 
breath metabolic system (Vmax 229 Sensormed~cs, USA) Total energy expenditure was 
estimated uslng the equation of We~r (1949). Carbohydrate and fat ox~dat~on were est~mated 
using the equat~on of and Peronnet and Mass~cotte (1991) Heart rate was contlnuously 
recorded by short range telemetry (Polar Electro Oy, F~nland) and Rate of Perce~ved Exertion 
(RPE) was recorded every 10 mln using the 16 pt Borg scale (Borg, 1973) Water was 
consumed ad l~b~tum followrng exerclse. Food Intake was not perm~tted 
Oral fat tolerance tests 
For 3 d prlor to each OFTT, subjects were required to absta~n from alcohol and not to 
engage in exerclse or heavy phys~cal work Subjects consumed the~r normal d~et for 3 d prlor 
to the first OFTT Food Items consumed along with portion size were recorded on sheets 
prov~ded. This diet was then repl~cated in advance of subsequent OFTTs Subjects arrived at 
the laboratory on the morning of each OFTT following an overnrght (12 - 14 h) fast. A 20 G 
intravenous catheter was inserted Into a forearm vein. This catheter was kept patent during 
the 6 h postprand~al follow-up per~od by flush~ng regularly w~th a 0 9% sallne solut~on. The 
test meal cons~sted of croissants, butter, high fat ice-cream, chocolate and potato crlsps w~th 
a macronutrlent composltlon per 2m2 body surface area of 97 g fat, 124 g carbohydrate and 
1450 kcal Thrs was well tolerated by all Water Intake was ad l~b~tum during the first tr~al 
This pattern of water intake was recorded and repeated during the second trial Subjects 
rested quietly in a room adjacent to the laboratory during the 6 h obse~at ion period 
Blood sampling and analysis 
Blood samples were obtained in a seated position for 5 min with legs uncrossed in 
order to minimise plasma volume shifts. Serum vacutainers were allowed to stand at room 
temperature for 30min before centrifugation Vacutainers were centrifuged at 3000 rpm (1600 
g) for 15 min at 4°C Serum was stored at -80% 
Spectrophotometric and immunoturbidimetric analyses were performed using a 
automated bench-top clinical chemistry system (ACE", Alfa Wassermann B V , Netherlands) 
with appropriate reagents, callbrators and controls (Randox Laboratories, UK). Serum 
triglycerides, total cholesterol, HDL-cholesterol, LDL-cholesterol, 3-hydroxybutyrate, free fatty 
acids and glucose were determined using spectrophotometric assays lmmunoturbimetric 
assays were used to determine concentrations of apo A-I, apo B and apo E Serum insulin 
was determined by fluoroimmunoassay using a commercially available kit (Perkinelmer, 
Wellesley MA, USA) Serum concentrations of sVCAM-1, SICAM-1 and IL-6 were determined 
in duplicate using a quantitative sandwich enzyme immunoassay technique and commercially 
available kits (R&D Systems, Mlnneapol~s, USA). Samples for each subject were analysed in 
the same run The intra-assay coefficients of var~ations were c 3% for all spectrophotometric 
and ~mrnunoturb~d~metric analyses, and 3%, 8%, 8% and 20% for immunoassays of insulin, 
sVCAM-1, SICAM-1 and high sensitivity IL-6, respectively Haematocrlt values, haemoglobin 
concentrations and counts of leukocytes, lymphocytes, monocytes and granulocytes were 
determined from a fresh EDTA whole blood sample uslng an automated haematology 
analyser (AcTdlff2, Beckman Coulter, USA) 
Data analysis 
Summary postprand~al responses to the test meal are reported as tlme-averaged 
postprand~al values uslng the approach of Gill et al (2006). T~me-averaged postprand~al 
values represent the total area under the concentrat~on vs tlme curve (AUC), calculated uslng 
the trapezium rule, dlvlded by the length of the postprand~al perlod (Append~x B). Fastlng and 
t~rne-averaged postprand~al values were compared uslng a two-way (tr~al (2) x BMI subgroup 
(3)) repeated measures analys~s of variance, followed by the Bonferron~ post-hoc procedure. 
When the s~gn~flcance of changes durlng the postprand~al per~od was of Interest (SICAM-1, 
sVCAM-1, IL-6 and leukocyte counts), a three way repeated measures ANOVA was 
performed (tr~al x BMI subgroup x t~me) When the data from the BMl subgroups were 
combined, the s~gnlficance of control and exerclse tr~al d~fferences (n=30) were determ~ned 
uslng paired t-tests The relat~onship between selected variables was determined uslng a 
bwariate or a partlal correlation Data are reported as mean _+ SEM unless othenv~se stated. 
Slgnlflcance was set at pcO 05 
2.3 RESULTS 
The 700 kcal exerclse bout was completed in (mean ? SD) 58.4 k 8 8 min 
Carbohydrate and fat ox~datron during the bout were (mean ? SD) 164 1 + 11 9 g and 10 2 _+ 
4.9 g respectively Mean heart rate was (mean f SD) 82 2 6 9% HRmax As haemoglobin 
(14 3 2 0.3 vs 14 2 f 0 2 g dl-", p=O 68) and haematocrit (42 3 f 0 7 vs 41 7 2 0 6% p=0.31) 
were sirnllar in the control and exercise trials respectively, values were not adjusted for 
changes in plasma volume 
The influence of experimental trial and BMI subgroup on a range of fastlng and 
postprandial variables is shown in tables 2 2 and 2 3 Fasting and postprandial values of TG, 
glucose, insulin and SICAM-1, and the HOMA index of lnsul~n resistance (HOMAIR), increased 
with increasing BMI in both the control trial and exercise trials (significant linear trend, 
pc0.05) Fasting and postprandial values of HDL-C decreased with lncreaslng BMl in both 
the control and exercise trials (s~gnificant linear trend, p<0 05) However, sign~ficant 
d~fferences were generally only evident when the normal weight and obese groups were 
compared. Exerclse reduced postprandial TG and increased postprandial FFA in all BMI 
subgroups (p<O 05) Exerc~se reduced postprandial insulin, SICAM-1 and sVCAM-1 and 
increased postprandlal HDL-C, LDL-C, FFA, IL-6, apo A-l and apo E in single BMI subgroups 
(p<O 05) However no experimental tr~al x BMI subgroup Interaction was ev~dent for any 
fasting or postprandial variables. The remainder of this sectlon details the combined group 
(n=30) response to the test meal and to the exercise intervention 
The combined group control and exercise trial responses to the test meal are 
presented below (table 2 4, fig 2 2 - 2 11) Exerc~se reduced fasting TG ( ~ ~ 0 . 0 5 )  by
19 2+5.2% (range, 75% decrease to 68% increase) (fig 2.2). Exercise reduced postprand~al 
TG by 19.9f4 0% (range, 55% decrease to 24% increase) (table 2.4, fig 2 2). Fast~ng and 
postprandial insulin were also lower (pcO 05) in the exercise trial (table 2 4, fig 2 3) Although 
fasting glucose was lower in the exercise trlal (pcO 05), postprandlal glucose values were 
simllar between trrals (table 2 4, fig 2 4). HOMAIR was lower (p<O 05) rn the exercise trlal 
(table 2.4). Fasting and postprandlal FFA were hlgher (p< 0 05) In the exerclse trial (table 
2.4, flg 2.5). 
Cornblned group values of SICAM-1 and sVCAM-1 dld not change during the 
postprand~al period ( f~g  2 6) Values were slmllar in the control and exerclse trlals at the 0 h 
and 4 h tlmepolnts (table 2 4, fig 2 6) IL-6 Increased durlng the postprandlal perlod in both 
the control and exerclse tr~als (pc0.05) (fig 2 7) Postprand~al IL-6 values were h~gher (pc 
0.05) In the exerclse trlal (table 2.4). Control tr~al counts of leukocytes (p<O 05), lymphocytes 
(pc0.05) and granulocytes (p<0.05) Increased postprandlally and counts of monocytes 
decreased (pc0.05) postprandially (fig 2 8) Leukocytes, granulocytes and monocytes were 
hlgher at 0 h in the exerclse trial (pcO 05) but not at 6 h postprandlally. There was a weak 
posltlve relatlon between BMI and SICAM-1 (r-0 38, p<O 05) and between IL-6 and SICAM-1 
(r=0 34, p=0 07) but sVCAM-1 dld not correlate wlth any body composition, llpld or 
inflammatory marker. 
Total cholesterol dld not change postprandially Cholesterol values were slrnilar in 
the control and exercrse trlals (table 2 4) HDL-C and LDL-C decreased postprandlally 
(p<O 05) from 0 h to 6 h in both the control and exercise trlals (fig 2 9) There were no 
postprandlal changes in apo A-l or apo-B Consequently, the ratlo of HDL-Clapo A-l 
decreased postprandially in the control trial (p<O 05) and the ratlo of LDL-Clapo B decreased 
postprandlally In both the control and exerclse trials (p<O 05) (fig 2 10) HDL-C and LDL-C 
were hlgher in the exercise trial at the 0 h and 6 h t~mepolnts (p<O 05) Apo A-l was h~gher at 
0 h In the exercrse tnal (p<O 05) but not at 6 h There was no drfference in apo B between 
trlals at any tlmepolnt Apo E decreased (p<O 05) from 0 to 6 h postprandially (fig 2.1 1) Apo 
E values were higher In the exercise trlal at the 0 h and 6 h timepoints (p<O 05) (fig 2.11) 
There were strong correlat~ons between fasting TG and Insulin (r=O 80, p<O 05) and 
between postprand~al TG and lnsulln (r=O 67, p<O 05) TG and Insulin were also related to 
BMI, walst circumference and wa~st-h~p ratlo wlth the strongest relat~onsh~ps exlstlng wlth 
waist-hip ratio (table 2 5) Postprandlal concentrat~ons of TG (r= -0.45, p< 0 05) and Insulin 
(r= -0 53, pc0.05) were related to V0,max (ml kg-' min-'). However, these relatronsh~ps were 
no longer evident after controllrng for BMl (TG, r= -0 18, p=O 36, insulin r= -0 30, p=O 10) 
The percentage change In postprandial TG was related to V02max (r= -0 55, p<O 05) and thls 
relat~onship was st111 s~gnificant after controlling for BMI (r= -0 51, p<O 05) There was no 
relation between the decrease in postprand~al TG and the decrease in postprand~al lnsulln as 
a result of acute exerclse (r= -0 16, p=0.42) Postprand~al TG, postprand~al lnsulln and waist- 
hrp ratio were related to fasting HDL-C, fastlng apo A-l and fastlng apo E but not to fastlng 
cholesterol, fasting LDL-C or fastlng apo B (table 2 6) 
Table 2.2 Influence of acute exercise on a range of fasting variables in normal weight, overweight and obese men 
Normal we~ght (n=10) Overwe~ght (n=10) Obese (n=10) 
TG (mmol c') 
SICAM-1 (ng mL-') 
sVCAM-I (ng m~. ' )  
Insulin 
(VIU m ~ ' )  
Glucose (mmol c') 
FFA (mmol L-') 
Total cholesterol 
(mmol L") 





Apo B (rng d ~ ' )  
Control Exerc~se Control 
1 15kO 11 0 88fO 10 1.77fO 19 
191 4rt5.9 182 I f 5  8 214 127 5 
604 0 5f49 1 605.5k58 5 547 5+39 1 
0 70kO 12 0.98f0.28 1 38f 0 48 
3 8 f 0 7  2.9kO 5 7 OkO 8 
4 62f 0 07 4 20+0 08* 4 89+0 10 
0 79fO 15 0 55f0 10 1 52rtO 17 
0 60rt0.05 1 13fO 13* 0 77kO 1 1 
5.46rtO 36 5 55k0.30 5.52f0.35 
1 24kO 07 1.27f0.07 1 06fO 04 
123 2k5.3 125 4k4 2 113 9k4 3 
3 26 f0 35 3 41fO 34 3 28 20 37 
79 8k8 1 77 3+6 6 80 1f7.6 
3 66k0.34 4 39f0 41" 4 96k0.46 
Control 
3 17f0 79 a 
221 7k14 0 
558 4.5234 2 
1 1020 15 
11 7rt2.8 a 
5 17t0 29 
2.94k0.83 a 
0 68+0 03* 
5 46rtO 20 
0.96t0 08 a 
112 7 f 4  1 
3 43rtO 22 
78.5f6 0 
4.59fO 51 
*p<O. 05 compared to control tnal a p<O 05 compared to normal we~ght group (same trial) Bonferroni adpsfment for a// multiple comparisons 
Values are mean rt SEA4 
100 
Table 2.3 Influence of acute exercise on a range of time-averaged postprandial variables in normal weight, overweight and obese men 
Normal we~ght (n=10) Ovetwe~ght (n=10) Obese (n=lO) 
Control Exerc~se Control Exerc~se Control Exerc~se 
TG (rnmol c') 2 10f0.26 1 54fO 24* 3 1820 39 2 61 +O 46' 4 00+0 45 a 3 3220 47* a 
slCAM-1 (ng rn~" )  188 5f6 6 175 8+9 7' 216 4k6.4 220 2+8 4 a 219 2512 1 a 223 3t12 4 a 
IL-6 (pg r n ~ ' )  1 34fO 24 1 63f0.40 2.11+0 46 2 551.0.74 1 54+0.13 2 29tO 40 
lnsulln 19 Of4 4 17 5_+4 0 29 223 8 24 353 3 65 1 ~ 2 1 3  a 50 4f13 7' a 
(VIU m ~ ' )  
Glucose (rnrnol c') 4 6520 13 4 81t0.15 5.35+0 17 a 5 18t0.17 5 68f 0 29 a 5.46fO 30 
FFA (mrnol c') 0 85fO 05 1 0520 13* 0 8520 1 1 0 98fO lo *  0 56fO 03 0 79f0.06" 
HDL-C (mrnol ") 1 21+0.07 1 26+0 07 1 0520 03 1 11+0 05 0 93f0 09 a 1.01f0 08* a 
Apo A-l 123 3+5 6 123.9f5.4 115.2+3.8 1162240 1 14 455.4 119.8+5 5* 
(rng d ~ ' )  
LDL-C 3 19 20 37 3 31fO 37 3 2620 34 3 4850 29 3 26+0 30 3.6120 31* 
(mrnol L-'1 
Apo B (mg dL") 79 7f8 2 77 4f6.6 80 I t 7  6 86.0t5.4 78.526 0 89.255 0 
Ap0 E (mg d ~ ' )  3 11f0 34 3 65+0 43* 3.69fO 27 4.03f0.42 3 80t0 48 4 09+0 58 
p<O 05 compared to control trial. a ~ 4 . 0 5  compared to normal weight group (same trial) Bonferroni adjustment for all multiple comparisons. 
Values are mean + SEM 
Time-avera ed postprandial values represent the total area under the concentration vs time curve, divided by the length of the postprandial period Units 9 are mmolL- 
Table 2.4 Influence of acute exercise on a range of time-averaged postprandial 
variables in  the combined group (n=30) 
CON trial EX trial 
Postprandial TG (rnmol c') 3 09+0 28 2 49+0.29* 
Postprandial SICAM-1 (ng mL") 208.7k5 2 207 5f6.6 
Postprand~al sVCAM-1 (ng mL-') 565.4k25.3 555 2224 6 
Postprandial IL-6 (pg rnL-') 1 67kO 19 2 18rt.O 31" 
Postprand~al insulin (mmol c') 37 8k7 4 30 7f5 O* 
Postprandial glucose (rnmol L") 5 23kO 13 5.15kO 12 
Postprand~al FFA (mrnol L-') 0 76kO 06 0 94kO 06' 
Postprandial total cholesterol (rnrnol.~.') 5 52k0 18 5 6420 16 
Postprandial HDL-C (rnmol L-') 1.06kO 04 1.13kO 04* 
Postprandial LDL-C (rnmol c') 3 2350 18 3 46kO 17' 
'p<O 05 compared to CON trial 
Values are mean k SEM 
7ime-averaged postprand~al values represent the total area under the concentration vs tfme 
curve, dfv~ded by the length of the postprand~al period Unfts are rnmol L-' 
Table 2.5 Correlation coefficients for the association of postprandial TG, postprandial 
insulin with indices of adiposity and aerobic fitness 
BMI Walst Waist-h~p V02max V02rnax 
c~rcumference ratlo (ml kg-' m~n-') (L rnln-') 
Post~rand~al 0 57' 0 57* 0 77* -0 45* -0 14 
Table 2.6 Correlation coefficients for the association of postprandial TG, postprandial 
insulin and waist-hip ratio with various fasting values of various lipids and 
apoproteins 
Total LDL-C HDL-C Apo A-l Apo 8 Apo E 
cholesterol 
Postprandial 0 23 0 33 -0 59* -0.38* 0 11 0 63* 
TG 
Postprandral 0 09 0 19 -0 49* -0 29 0.11 0 38* 
insulin 
Waist-hlp ratlo 0.25 0 34 -0 63* -0 39* 0 13 0 54* 
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Fig 2.4 Influence of acute exercise on the glucose response to a high fat mixed meal 
(n=30) 
651 -4.- Con 
3 0  -1 
0 1 2 3 4 5  6  
Test meal Time (h) 
*p<O 05 compared to same timepoint in exercfse trial 
Fig 2.5 Influence of acute exercise on the free fatty acid response to a high fat mixed 
meal (n=30) 
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Fig 2.6 Influence of acute exercise on the (A) SICAM-1 and (B) sVCAM-1 responses to a 




Fig 2.7 Influence of acute exercise on the IL-6 response to a high fat mixed meal (n=30) 
0 0  -1 
0 2 4 6 
Test meal Time (h) 
*p<O 05 compared to same tfmepofnt in control trial 
i p c ~  05 compared to 0 h timepofnt fn same trial 
Fig 2.8 Counts of total (A) leukocytes, (6) granulocytes, (C) lymphocytes and 
(D) monocytes at the 0 h and 6 h timepoints in the control and exercise trials (n=30) 
*p<O 05 compared to same timepornt m control trral 
t p < ~  05 compared to 0 h trmepornt rn same trral 
Fig 2.9 Concentrations of HDL-C and LDL-C in the control and exercise trials 
at the 0 h and 6 h timepoints (11130) 
p<O 05 compared to same timepofnt in control trial 
'p<0.05 compared to 0 h timepoint in same trial 
Fig 2.10 Ratios of HDL-CI apo A-l and LDL-CI apo B in the control and exercise trials 
at the 0 h and 6 h timepoints (n=30) 
*p<0.05 compared to same trmepomt In control trial 
tp~0.05 compared to 0 h timepoint in same trial 
Fig 2.11 Concentrations of apo E in the control and exercise trials at the 0 h and 
6 h timepoints (n=30) 
Pc0.05 compared to same timepolnl 
tpc0.05 compared to Ohr timepoint m 
m control trial 
same trial 
2.4 DISCUSSION 
The influence of exerclse on indicators of metabolic and vascular health is frequently 
studied in the postprand~al period, when the endothelium is being challenged by the lipolysls 
products of trlglyceride-rlch lipoproteins In thls study, the fat and energy content of the test 
meal were towards the upper end of that typically used in postprandial research, resulting in 
pronounced lipemla The results confirm that acute exercise can reduce postprandial lipemia 
and insulinemia and increase HDL-C However, there is no evidence that these metabolic 
changes are accompanied by a reduction In endothelial activation in e~ther the fasted or 
postprandial states 
A key objective of this study was to compare the influence of acute exercise on a 
range of metabolic variables and markers of endothelial activation, in normal weight, 
overweight and obese men. Although control trial differences were evident in postprandial 
TG, insulin, glucose, HDL-C and SICAM-1 between the normal weight and obese men, any 
exercise effect on these vanables was s~m~lar cross BMI subgroups Slmllar findings were 
reported by Gill et al (2004), when comparing lean and centrally obese middle-aged men. 
Although the magnitude of the exercise-induced changes in postprandial lipemia differed 
considerably between individuals, this effect appears not to be related to BMI. Thus, the 
benefits of acute exercise to postprandial metabolism frequently observed in lean individuals, 
also accrue to overweight and obese men, at least when bouts of equivalent energy 
expenditure are undertaken As no experimental trial x BMI subgroup interaction was evident 
in the analyses, the remainder of this discussion will focus on the combined group data 
To our knowledge, thls a the frrst study that has demonstrated a correlation between 
the change in postprand~al lipemla from lsocalor~c exercise bouts and V02max This suggests 
that the benef~ts of acute exercise to tr~glyceride metabol~sm are greater in hlgh f ~ t  ~ndiv~duals 
In contrast, no relationsh~p exlsted between control trial values of postprand~al lipemla 
(unexerc~sed state) and V02max, after controlling for BMI Th~s latter f~nd~ng IS In line wlth a 
cross-sect~onal study show~ng postprandial l~pem~a to be s~m~lar in tra~ned and untra~ned 
~nd~viduals, when compared 60 h after the last trainlng bout (Herd et al., 2000). Collectively, 
these results suggest that factors assoc~ated with aerob~c fitness such as muscle ox~dat~ve 
capacity and cap~llary density do not influence postprand~al ipemla, but may potentlate the 
effects of acute exerclse on l~pem~a Slmilar conclus~ons were reached by Tsetson~s et al 
(1997) who found postprand~al lpemla to be s~milar in tra~ned and untra~ned women In the 
absence of acute exercise, but lower in the tra~ned women follow~ng acute exerclse. Future 
studles should Investigate the Influence of a slngle lsocalor~c exerclse bout on postprand~al 
Iipemia, before and after endurance traln~ng. The mechanisms underpinning this apparent 
Interaction of acute and chron~c exercise are open to speculation. FFA concentrations have 
been shown In thls study and by others (GIII et al , 2001, G~l l  et al , 2004) to be h~gher 
following acute exerclse The high oxldat~ve capaclty that is characteristic of tralned muscle 
may facilitate Increased oxldat~on of these fatty ac~ds, reduc~ng the fraction available for re- 
esteriflcatlon in the llver Alternat~vely, the high capillary denslty that is charactenstic of 
tra~ned muscle could provide add~tlonal b~nd~ng s~tes for lipoprote~n l~pase after upregulat~on 
by acute exerclse 
Endothellal dependent dllatlon (EDD) has been shown to be lmpalred postprandlally 
(Plotnick et al , 1997, Vogel et al , 1997) In this study, SICAM-1 and sVCAM-1 were 
employed as markers of endothelial activation There was no postprandial change in SICAM- 
1 or sVCAM-1, despite considerable Increases In serum TG and IL-6 Postprandial 
triglyceride-r~ch lipoproteins (Moers et a l ,  1997) and IL-6 (Watson et al , 1996) have been 
shown to Induce adhesion molecule expression m vltro Prevlous studres have consistently 
shown postprandial Increases in adheslon molecules In dlabetlc cohorts (Nappo et al , 2002, 
Cerlello et al., 2004, Ceriello et al., 2005), with only very small (Nappo et al., 2002, Cer~ello et 
al., 2004) or no Increases (GIII et al., 2003, Tsai et al , 2004) In healthy populations 
Endothelial dysfunction and endothelial cell actlvatlon have been postulated to occur durlng 
the postprandial perlod via Increased oxldatlve stress Nutrlent overload has been proposed 
as a major source of endothellal cell oxrdatlve stress (Brownlee, 2005, Cer~ello and Motz, 
2004). It IS posslble that antl-oxldant defences are capable of llmltlng endothellal cell 
actlvatlon postprandially in an obese mildly hypertrlglyceridemlc populat~on but not in a 
drabet~c population, for whom hyperglycemla may be an add~tlonal source of nutrient 
overload 
Alternatively, soluble adheslon molecules may not be a sufficiently sensitlve 
blomarker to detect postprandial changes in endothellal cell actlvatlon In healthy lndivlduals 
EDD and soluble adhesion molecules have been shown to change in parallel (inverse 
relatlonsh~p) durlng pharmacological treatment (Alonso et al , 2001, Marches1 et al., 2003, 
Nawawi et a1 , 2003, Cerlello et al., 2005) and d~etary supplementation (Lupattelll et al , 2004), 
evidence of a common physiology However, case-control studies generally show only a 
moderate relat~onsh~p (Koga et al , 2005, Lupattelll et al , 2000, Brevett~ et al , 2001, Holmlund 
et al., 2002, Nawawl et al., 2003, Glow~nska-Olszewska et al., 2005) between EDD and 
soluble adhes~on molecules or no relationsh~p (Van Haelst et al , 2003, John et al., 2000) 
True soluble forms of adhesion molecules are released from the extracellular matrix by 
proteolytic enzymes including metalloproteases and sheddases. However, much of the 
adhes~on molecules detected by the ELlSA methodology are In fact mlcropartlcle bound 
(Horstman et al , 2004) The inability of current methodologies to dlstlngulsh these soluble 
forms may llmlt thelr ablllty to act as sensltlve b~omarkers of endothellal dysfunct~on. 
Unexpectedly, IL-6, leukocytes and leukocyte subfract~ons were elevated In the 
exerclse trial in a similar study deslgn ~nvolvlng lean and obese men, Gill et al. (2003) found 
the postprandial response of these lnflammatory markers to be unchanged following acute 
exercrse However, the expermental exercise bout employed by G~l l  et al. involved moderate 
Intensity treadmill walking It 1s poss~ble that muscle damage occurred in the present study in 
lndivlduals unaccustomed to strenuous we~ght bearlng exerclse, result~ng in an ~nflammatory 
response However, no physiological or self-report Index of muscle soreness was ut~l~zed in 
e~ther study 
Soluble adhes~on molecules were also unaffected by acute exercise conducted 12-14 
hours prev~ously. Although exerclse tralning has been shown to reduce adhes~on molecules 
(SICAM-1) In older cllnical patient groups (Zopplni et al , 2006; Adamopoulos et al., 2001), 
others have fa~led to find changes w~th exerclse tralnlng when study~ng non cllnical 
populations (Hammett et a1 , 2006, Ostergard et al , 2006) In some instances, soluble 
adheslon molecules have been shown to be elevated when assessed one day after a bout of 
prolonged strenuous weight bearing exerclse, wlth these Increases once agaln attributed to 
muscle damage and Immune actlvatron (Aklmoto et al, 2002) It IS poss~ble that any anti- 
inflammatory effects of acute exerclse mediated by shear stress or changes In blood l~p~ds 
could be negated by the pro-~nflammatory effects of muscle damage and immune actlvat~on 
Although the acute exerclse model IS useful when studylng changes In 11p1ds and rnsul~n 
action, attempts to eluc~date the Influence of vlgorous exerclse on endothellal actlvatlon may 
requlre short-term tralnlng or detralnlng stud~es 
Postprand~al triglycer~des and Insulin were closely related to each other and to all 
lndlces of ad~pos~ty. We found postprand~al tr~glycerldes and rnsulln to correlate more 
strongly wlth waist-h~p ratlo than w~th BMI or wa~st circumference Although walst 
circumference has become the preferred measure for abdominal obes~ty and IS endorsed by 
the WHO (1998), a number of large studles suggest that wa~st-hlp ratlo has the strongest 
correlations wlth CVD r~sk factors (Dalton et al , 2003) and IS superlor In predlctlng CVD 
rnortallty (Welborn et al , 2003) 
The decreases In fast~ng insulln, postprandlal lnsulln and HOMAI, following acute 
exercrse, suggest an Increase in lnsulln sensltlvrty As exerclse resulted In parallel decreases 
In postprandial triglycerides and insulin, and these parameters were closely related In the 
absence of exerclse, it could be postulated that the exercise attenuatlon of each were 
mechan~stlcally llnked In theory lnsulln could more effrc~ently suppress postprandial VLDL- 
TG secretion and activate adipose tissue LPL in the insulin sensitive, exercised state 
However, in this study and in one other (Gill et al , 2002a), no relationship existed between 
the exercise attenuation of postprandial triglycer~des and insulin It appears that the exercise 
attenuation of postprandial lipemla does not depend on changes in insulin sensitivity, at least 
in healthy men It is also possible however that the insulin response to a high fat mixed meal 
is not a sufficiently sensitive measure of insulin sensitivity to detect such a relationship 
In this study, the postprandial increase in serum TG was accompanied by small 
reductions in HDL-C and LDL-C, but not in apo A-l or apo B Consequently, there was a 
small postprandial decrease in the ratios of HDL-C lap0 A-l and LDL-CI apo B These ratios 
have been described as crude indicators of HDL and LDL particle size (Leroux et al , 2000) 
The Quebec Cardiovascular Study observed decreases in these ratios across increasing TG 
quintiles (Leroux et al., 2000). The authors suggested that relatively modest increases in TG 
may rapidly alter the cholesterol content of HDL and LDL particles There is evidence that a 
remodelling of lipoprotein species can occur in lipid-rich postprandial environments with 
neutral lipid exchange of cholesterol ester and TG between the TG-rich lipoproteins and HDL 
and LDL, mediated by cholesterol ester transfer protein (Miesenbock and Patsch, 1992) 
Apo E has a key role in the metabolism of triglyceride-rich lipoproteins, mediating the 
clearance of these lipoproteins and their remnants from circulation. Serum apo E has been 
shown to be related directly to fasting and postprandial TG in this study and by others (Huang 
et al , 1998, Salah et al , 1997) Surprisingly, changes in apo E during the postprandial period 
and following acute exercise were inversely related to changes in TG Apo E decreased 
considerably from 0 - 6 h postprandlally wlth values hlgher In the exercise trlal Previous 
studies have generally shown apo E to be unchanged postprandlally (Blum, 1982, Mero et al , 
1998a, Mero et al , 1998b, Krimbou et al , 2003), although a redlstrlbutlon of apo E between 
lipoprotein specles has been documented (Blum, 1982) 
In the present study, FFA, IL-6 and leukocytes all Increased postprandlally (after 
~nltlal suppresslon of FFA durlng acute ~nsullnemla) and all were hlgher In the exercise trlal 
The parallel nature of these changes warrants further attention FFA released lipolytlcally 
from postprandial serum have been shown to activate lymphocytes and endothelial cells In 
vltro (Chung et al , 1998) and consequently these cells must be considered as a potentlal 
source of IL-6 durlng the postprandlal period However, an alternative explanation of these 
FFA - IL-6 similarltres a also posslble Considerable research interest exists in the 
hormone-llke actions of IL-6 and its Influence on substrate metabolism (Pedersen et al , 
2003) Recombinant IL-6 lnfuslons have been shown to Increase both llpolysls and fat 
oxldation in humans wlthout causlng hypertrlglycerldemia (Van Hall et al , 2003) Thus, 
increases in FFA (ether postprandlally or following prolonged acute exerclse) could In theory 
act as a pro-inflammatory stimulus, triggering the release of IL-6 or conversely, Increases in 
IL-6 could stimulate l~polysis. These parallel increases are likely to be Interpreted differently, 
depending on one's prevarllng view of IL-6 as elther a marker of lnflammatlon or a medlator of 
hpolysis It should be noted that van Oostrom et al (2003) dismissed the postprandlal 
changes in IL-6 and lymphocytes as a dlurnal varlation. In thelr study, slmllar Increases were 
documented following Ingestion of varlous test meals and water 
In summary, we have shown that acute exercise attenuates postprandial lipemla 
similarly in normal weight, 0ve~e lgh t  and obese men The magnitude of this attenuation was 
related directly to V02max but not to the change in postprandial insulin. Despite pronounced 
increases in serum TG and IL-6, there was no evidence of changes in endothelial function in 
the postprandial period or following acute exerclse, even in the obese men. None of the men 
In the obese category were morbidly obese wlth only half meeting the criteria for the 
metabolic syndrome. Thls may be considered a limitation in a study designed to compare the 
effects of acute exercise in lean and obese insulin resistant men The absence of a d~rect 
measure of endothelial dependent d~lation may be considered another limitation of this study. 
The findings need to be considered in the light of similar studies that employ other methods to 
assess endothelial function. However, it is possible that postprandial lipemla does not impalr 
endothelial function and acute exercise does not enhance endothelial function in men under 
45 years that are free of metabolic and vascular disease 
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Chapter Three 
INFLUENCE OF ACUTE EXERCISE ON 
POSTPRANDIAL LlPEMlA AND CELLULAR 
MICROPARTICLES 
3.1 INTRODUCTION 
Endothelial cells play a crucial role in ensuring vascular integrity, maintaining a 
delicate balance between a wide variety of antagonistic substances that regulate leukocyte 
adhesion and transendothelial migration, thrombus formation and vessel vasomotion A 
disturbance in this balance, towards a pro-inflammatory, pro-coagulant, anti-fibrinolytic state 
is termed endothelial dysfunction, and is generally considered an early event in 
atherosclerosis (de Koning and Rabelink, 2002) Endothel~al function has consistently been 
shown to be impaired following high fat meals in healthy (Plotnick et al , 1997) and clinical 
(Bae et al , 2001b) populations. The lrpolys~s products of postprandial triglyceride-rich 
lipoproteins have been shown to activate endothelial cells in vltro (Chung et al , 1998, Kurtel 
et al., 1995) 
Soluble forms of cell adhesion molecules including intracellular adhesion molecule-1 
(ICAM-1) and vascular cell adheslon molecule-? (VCAM-1) are regularly employed in 
research settings as biomarkers of endothelial function Studies generally show postprandial 
increases in SICAM-1 and sVCAM-1 in diabetic and hypertriglyceridem~c populations (Nappo 
et al., 2002, Marchesi et al., 2003; Ceriello et al , 2004; Cenello et al , 2005) Some studies 
have shown small postprandial Increases in SICAM-1 and sVCAM-1 in healthy volunteers 
(Nappo et al , 2002, Ceriello et al., 2004) wrth others showing no change (Gill et al., 2003, 
Tsai et al, 2004) However, the ELlSA methods commonly used to quantify these biomarkers 
do not distinguish true soluble adhesion molecules from membrane-bound forms in the 
circulation (Horstman et al , 2004). 
Mlcroparticles are membranous vesicles shed from formed elements such as 
clrculatlng platelets, leukocytes, and vascular endothellal cells, in response to cell actlvatlon 
and apoptosis They serve not only as markers but also as potentlal mediators of 
inflammation, coagulation and endothellal dysfunction, key features of atherosclerosls (Van 
Wijk et al., 2003) Endothelial mlcroparticles (EMP) are elevated in a number of vascular 
dlsease states lncludlng anglna (Mallat et al., 1999), acute myocardial lnfarctlon (Mallat et al., 
1999), hypertens~on (Preston et al , 2003) and pre-eclampsia (Gonzalez-Qulntero et al , 
2003) Obese women wlth impaired endothellal dependent dllatlon (EDD) also have elevated 
EMP (Esposito et al , 2006) EMP have been proposed as a sensitive blomarker of dlsease 
actlvlty (Ahn, 2005) They are more closely related to coronary endothellal function than 
soluble adheslon molecules (Koga et al., 2005) Ferrelra et al (2004) reported a postprandlal 
increase in EMP in young healthy volunteers. However, Tushuizen et al. (2006) were unable 
to detect EMP in fastlng or postprandlal plasma 
Nitrlc oxide (NO) plays a key role in maintaining vascular functlon In addltlon to 
mediating endothellal dependent dllatlon (EDD), NO appears to have antl-inflammatory 
properties and has been shown to reduce the expression of adheslon molecules on the 
vascular endothellum (Spiecker et al , 1998), inhlblt leukocyte adhesion (Kubes et al , 1991) 
and inhlblt platelet aggregatlon at the vessel wall (Radomskl et al., 1987) Reactive oxygen 
species are generated postprandlally and thought to scavenge NO Bae et al. (2001a) have 
shown the postprandlal Increases in serum TG to be posltlvely correlated wlth increases In 
oxidative stress. The postprandlal changes in TG and oxldatlve stress were each negatively 
correlated with the changes In EDD Postprand~al Increases in serum TG have also been 
shown to be correlated with increases in EMP (Ferreira et al , 2004) As acute exerclse has 
cons~stently been shown to reduce postprandral llpemla (GIII et al , 2004), the poss~blllty exlsts 
that slngle bouts of exerclse may also attenuate EMP 
Platelets are crlt~cal to the pathogenes~s and progresslon of card~ovascular disease 
and In the events leadrng to acute coronary syndromes. In atheromas, activated platelets 
release growth factors that contribute to the prol~feration of smooth muscle cells and les~on 
progression. Activated platelets can accumulate on vessel walls wlth the release products 
promoting vasoconstriction and inflammation in endothellal cells Although a variety of 
methodolog~es have been employed to examlne postprand~al hemostas~s, stud~es generally 
show increased activat~on of platelets and coagulat~on factors following h~gh fat meals (Hyson 
et al., 2002, Larsen et al., 2000) Platelet reactivity IS Increased dur~ng and lmmedlately after 
strenuous exercbse (Ikarugl et al , 2003, Wang et al , 2006), potentially Increasing the r~sk of 
acute coronary events Platelet mrcropart~cles (PMP) may be v~ewed as a marker of platelet 
actlvat~on Thew shedding from parent platelets Increases the anlonlc phospholipid surface In 
the circulation for the assembly of prothrombrnase and tenase complexes (Horstman and 
Ahn, 1999). PMP also stlmulate other cells lnvolved in vascular homeostasis including 
endothel~al cells and leukocytes (Barry et al , 1998) 
The primary purpose of thls study was to examine the Influence of a high fat meal and 
acute exercise on endothel~al function, employ~ng EMP as a novel and sensltlve blomarker. A 




Eight recreat~onally actlve men (mean k SD, age 26 9 2 4 1 y, V02peak 46 8 2 4 9 
ml kg-' m~n-', BMl 26 0 k 3 6 kg m-', % body fat 15 2 f 5 0%) volunteered for thls study 
Subjects were non-smokers, normol~pldem~c, free from card~ovascular dlsease and d~abetes 
and not taklng medication known to Influence carbohydrate or lipid metabol~sm. Eth~cal 
approval was granted by the Dublln C~ty Unlverslty Ethlcs Comm~ttee and wrltten Informed 
consent was obtalned prlor to part~c~pat~on (Append~x A2) 
Experimental design 
Subjects vlsited the laboratory on four occasions Durlng a prel~minary vislt, they 
underwent a phys~cal exam~nat~on, had thelr body composlt~on assessed and maxlmum 
oxygen uptake determined They subsequently underwent two oral fat tolerance tests (OFTT) 
wlth a 6 h obsewatlon period, separated by 7 d approximately (Fig 3 1) On the evenlng prlor 
to the OFTT, subjects either rested at home (CON tr~al) or completed a prolonged bout of 
cycle ergometry exerclse (EX tnal) The order of these tr~als was random~sed 
Fig 3.1 Schematic representation of the experimental design 
OFTT day -1 OFTT day 
I 
Control trial 
Exercise trial 1 ,  
I Time after ingestion of test meal (h) 
Meal (breakfast, dinner or tea) Test meal 
Exercise bout I Blood sample 90 min @ 70% V02max + 10 maximal sprints 
Exercise fest~ng 
Maximum oxygen uptake was determined using an incremental exercise test on a 
cycle ergometer (Monark, Vansbro, Sweden). The initial workload and increments were 
indiv~dualised so that the test was 8 - 12 min In durat~on. The experimental exerclse bouts, 
were conducted between 17 00 and 19.00 h on the evenlng prlor to the OFTT Subjects 
cycled at 70 rpm for 90 min at 70% V02peak, followed by ten 1 mln sprlnts Interspersed wlth 1 
mln of recovery to max~mise glycogen deplet~on. Flywheel res~stance was Increased by 25% 
for the sprints and flywheel revolutlons recorded every 20 sec In order to estlmate energy 
expend~ture 
Expired air was collected cont~nuously during the exerclse bout for determlnatlon of 
VO, and VCO, vla a breath by breath metabol~c system (Vmax 229 Sensormedlcs). Energy 
expend~ture and substrate oxidat~on during the continuous cycling was estlmated uslng 
lndlrect calorimetry Energy expend~ture durlng the sprlnts was est~mated from ACSM 
metabolic equat~on (Amer~can College of Sports Medlclne, 2006) based on flywheel 
reslstance and revolut~ons Heart rate was recorded every 10 mln by short range telemetry 
(Polar Electro Oy, Flnland) Although water was consumed ad l~b~tum followlng exercise, food 
Intake was not perm~tted 
Oral fat tolerance tests 
Subjects were requlred to absta~n from alcohol and not to engage in exerclse or 
heavy physlcal work for 3 days prlor to each OFTT They consumed thelr normal d~et for 3 d 
prlor to the flrst O F T  Food Items consumed along wlth portlon slze were recorded on 
sheets prov~ded. Thls diet was then repl~cated In advance of the subsequent OFTT Subjects 
arrived at the laboratory on the morning of each OFTT followlng an overnight (12 - 14 h) fast 
A 20G Intravenous catheter was then Inserted into a forearm veln to facilitate blood collect~on 
Thls catheter was kept patent durlng the postprandial follow-up perlod by flushlng regularly 
with a 0.9% sallne solut~on The test meal consisted of croissants, butter, high fat ice-cream, 
chocolate and potato crlsps wlth a macronutrient composltlon per 2m2 body surface area of 
97 g fat, 124 g carbohydrate and 1450 kcal The meal was well tolerated by the subjects 
Water ~ntake was ad l~bitum dur~ng the first trlal Thls pattern of water Intake was recorded 
and repeated dur~ng subsequent tr~als. Subjects rested qu~etly In the laboratory durlng the 6 h 
Blood sampling and storage 
Blood samples were obtained wlth subjects In a seated positlon for 5 mln wlth legs 
uncrossed In order to mlnlmlse plasma volume shifts Serum vacutalners were allowed to 
stand for 30 mln before centrifugation at 3000 rpm (16009) for 15 min at 4% Sod~um cltrate 
vacuta~ners were pre-ch~lled In an ice bucket and samples returned to the ice bucket prior to 
centr~fugat~on. Blood for mlcroparticle analysis was collected, prepared and stored according 
to the double centrifugat~on method of Bernal-Mizrach~ et al , (2004) Blood was collected In 
pre-ch~lled sodlum cltrate vacutalners and spun first at 160 g for 9 min to produce platelet rich 
plasma (PRP) Thls was harvested from the top leaving a 0 5 cm layer of plasma und~sturbed 
close to cell debr~s The PRP was centrifuged for a further 9 mln at 1000 g to y~eld platelet 
poor plasma (PPP) PPP was allquoted and stored at -80°C unt~l analys~s 
B~ochem~cal analyses 
Serum tnglycerides, total cholesterol, HDL-cholesterol (HDL-C), free fatty ac~ds (FFA) 
and glucose were determined uslng spectrophotometr~c assays, performed on an automated 
bench-top clinical chemistry system (ACE", Alfa Wassermann B V ,  Netherlands) using 
appropriate reagents, callbrators and controls (Randox Laboratories, UK) Serum insulin was 
determined by fluoroimmunoassay using a commercially available kit (Perkinelmer, Wellesley 
MA. USA). Serum concentrations of sVCAM-1, SICAM-1 and interleukin-6 (IL-6) were 
determined in duplicate using a quantitative sandwich enzyme immunoassay technique and 
commercially available kits (R&D Systems, Mlnneapolls, USA) Haematocnt values, 
haemoglobin concentrations and counts of leukocytes were determined from an EDTA whole 
blood sample using an automated haematology analyser (AcTdiff2, Beckman Coulter, USA) 
Microparticle counts were quantified by flow cytometry uslng CellQuest software 
(FACScan, Becton Dickinson) Microparticles were identified in PPP based on size and 
fluorescence, using 1 0 pm sizing beads and anti-CD144 PE, anti-CD146 PE, anti-CD31 FlTC 
and anti-CD42b PE monoclonal antibodies EMP were defined as either CD144+, CD146+ 
or CD31+/42b- with PMP defined as CD42b+ For analyses based on single endothelial 
markers, 90p1 of PPP was incubated for 20min with either 10 p1 of anti-CD144-PE or 10 p1 of 
anti-CD146 PE For the dual marker analysis, 85 p1 of PPP was incubated for 20 min with 10 
pi of anti-CD31 and 5 yl of antl-CD42b Samples were then d~luted with 400 y1 of PBS and 
analysed on the flow cytometer for 60 sec at medium speed. The flow rate was calibrated 
before each machine run uslng 15 p1 of flow count beads diluted in 485 p1 of PBS 
Fluorescence thresholds were set using PPP incubated with isotype-matched control 
antibodies Samples were analysed in duplicate and microparticle counts are expressed as 
micropartlcles per pl of plasma. 
Samples for each subject were analysed In the same run. The lntra-assay 
coeff~cients of var~at~ons were < 3% for all spectrophotometr~c analyses, 4% and 2% 
respectlvely for flow cytometry counts of EMP and PMP, and 3%, 8%, 8% and 20% 
respectlvely for the immunoassays of insul~n, sVCAM-1, slCAM-1 and high sensltivlty IL-6. 
Data analysis 
Postprand~al responses to the test meal are reported as t~me-averaged postprand~al 
values uslng the approach of Glll et a1 (2006) T~me-averaged postprand~al values represent 
the total area under the concentration vs tlme curve (AUC), calculated using the trapezium 
rule, dlvided by the length of the postprand~al period (Appendix B). The s~gn~flcance of control 
and exerclse tr~al d~fferences for a range of fastlng and summary postprandial parameters 
was determlned uslng palred t-tests. When the s~gn~f~cance of postprandlal changes was of 
Interest, a two way repeated measures ANOVA was performed (tlme x tr~al) with repeated 
measures on both factors, followed by the Bonferron~ post-hoc test The relat~ons between 
selected variables were determlned uslng Pearson correlat~ons Data are reported as mean + 
SEM unless otherwise stated Slgn~f~cance was set at p<O 05 
3.3 RESULTS 
The V02, RER and heart rate durlng the 90 mln of continuous cycling were (mean + 
SD) 33 4 + 1 1 ml kg-' min-', 0 960 + 0 005 and 151 k 3 bmln-' respectively Estimates of 
carbohydrate ox~datlon, fat oxidation and energy expend~ture were (mean + SD) 352 k 21 g, 
15 + 2 g and 1463 + 78 kcal respectlvely As mean haemoglob~n concentrat~ons (13 9 k 0 4 
vs 14.0 + 0.3 g d ~ ' )  and haematocr~t (41.8 rt: 1.0 vs 41 2 * 1.2 %) were slmllar in the CON 
and EX trials respecbvely, values were not adjusted for changes in plasma volume 
The Influence of the test meal on a range of variables In the control and exerclse trials 
- - - ( ' " ' ? ' O * p = w " M  
TG increment TG (table 3 I )  were lower (p<O 05) In the EX tr~al Fastlng HDL-C (table 3 I ) ,  
fasting FFA (table 3 I )  and postprand~al FFA (table 3 I )  were higher (p<O 05) in the exerclse 
trial The changes In postprand~al Insulin (table 3 I )  did not reach statlstlcal slgniflcance 
(p=O 11) wlth fastlng lnsulln slmllar In both trlals (table 3 1) Postprand~al glucose (table 3 1) 
was slmllar In both tr~als but fastlng glucose (table 3 1) was lower (p<O 05) In the exerclse 
tr~al 
CD31+/42b-EMP (f~g 3 6) Increased postprand~ally In the CON and EX trlals (p<O 05). 
However, EMP values were slmilar (p=O 97) between tr~als (table 3 2) EMP expresslng 
CD144 and CD146 were not detectable in fastlng or postprand~al PPP. PMP (flg 3.7) 
decreased postprandially in the EX trial (p<0.05) wlth the changes In the CON trlal 
approaching significance (p=O 07) Postprandial PMP were h~gher (p<0.05) In the EX trlal 
(table 3.2) There were no changes in SICAM-1 or sVCAM-1 postprand~ally Postprand~al 
SICAM-1 and sVCAM-1 values were s~m~lar between trlals (table 3 2) IL-6 (fig 3 8) and 
leukocyte counts ( f~g 3.9) increased postprand~ally (p<O 05). IL-6 values were slm~lar In the 
CON and EX tr~als (table 3 2) Leukocytes were h~gher (p<O 05) In the EX trial at 0 h but 
slmilar between trials at 6 h postprand~ally. Platelet counts d ~ d  not change postprand~ally or 
following exerclse Nelther EMP nor PMP counts were related to SICAM-1, sVCAM-1 or IL-6 
(table 3.3) 
Table 3.1 Fasting and time-averaged postprand~al variables in  the 
control and exercise trials 
CON trial EX trial P value 
Fastlng TG (mmol L-') 0.95 +O 13 0.63 +O 07 0 028 
Postprand~al TG (mmol c') 1.98+029 118+013 0026 
Postprand~al TG increment (mmol c') 1 02 +0.52 0 54 +O 17 0 031 
Fastlng insul~n (mmol.~-I) 4.30 it0 96 3.70 +O 90 0 39 
Postprand~al lnsulln (mmol c') 1945+419 1460+1 89 011 
Fasting cholesterol (mmol.~') 4 58 i0.32 4 69 f0.28 0 31 
Fastlng HDL-C (mmol c') 1 20 i0.07 1 30 f0 08 0 015 
Fastlng glucose (mmol c') 4.75 k0.07 4 40 i0.09 0 012 
Postprandial glucose (mmol c') 4 76 k0 12 4.72 +O 08 0 815 
Fastlng FFA (mmol L-') 066+007 073+006 020 
Postprand~al FFA (mmol c') 0 49 +O 03 0 60 ?O 04 0 014 
Values are mean + SEW 
Time-averaged postprand~al values represent the total area under the concentration vs time 
curve, divided by the length of the postprandial penod. Un1t.s are mmol L-' 
Table 3.2 Time-averaged postprandial values for markers of inflammation 
and coagulation in the control and exercise trials 
CON trial EX trial P value 
EMP (counts x 10' PC') 2.51+0.14 2 52aO 31 0.97 
PMP (counts x 1 o3 PC')  8 4351 5 0  15 31a2 13 0.04 
SICAM-1 (ng m ~ ' )  213.6 a14 7 206 7 a 14 7 0 63 
sVCAM-1 (ng m ~ ' )  738.6 +68 7 750 6 a75 9 0.60 
IL-6 (pg m ~ ' )  2 14 a0 63 2 44 50 51 o 57 
Leukocyte counts (counts xlo9 LC') 6 09 a0 51 6 73 50 62 0 17 
Platelet counts (counts x lo9 c') 215.8 a36 9 223 5 a43.0 0 34 
Values are mean a SEM 
Time-averaged postprand~al values represent the total area under the concentration vs tlme 
curve, divided by the length of the postprand~al penod. Unrts are mmol L-' 
Table 3.3 Correlation coefficients (r) of the associations of EMP and PMP with soluble 
adhesion molecules and IL-6 
slCAM-1 sVCAM-1 I L-6 
EMP 0.20, p=0.63 -0.44, p=0.27 0 59, p=O 12 
PMP 0 13, p=0.75 0 33, p=0.43 -0 05, p=O 91 
Fig 3.2 Influence of acute exercise on the triglyceride response to a high fat mixed 
meal 
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Fig 3.3 Influence of acute exercise on the insulin response to a high fat mixed meal 
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Fig 3.6 Influence of acute exercise on the endothelial microparticle response to a 
high fat mixed meal 
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Fig 3.7 Influence of acute exercise on the platelet microparticle response to a high 
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Fig 3.8 Influence of acute exercise on the IL-6 response to a high fat mixed meal 
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Fig 3.9 Counts of leukocytes at the 0 h and 6h postprandial timepoints in the 
control and exercise trials 
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To our knowledge this is the first study that has examlned the Influence of a high fat 
meal, consumed with and without prior exercise, on EMP EMP increased postprandially, 
indicative of endothelial cell activation, but this response was not attenuated by acute 
exercise, despite a considerable reduction in lipemia 
To our knowledge, only two previous studies have examined changes in EMP in the 
postprandial period following a single high fat meal, or two consecutive meals Ferrelra et al 
(2004) observed a postprandial increase in EMP, similar to that documented In this study, 
wlth the increases in serum TG related to the Increases in EMP In contrast, Tushuizen et al 
(2006) were not able to detect EMP in either fasting or postprandial plasma samples, but 
observed a postprandial increase in total microparticles (annexin V+ events) The key 
difference between these studies relates to methodologies used to quantify EMP and more 
fundamentally, to how micoroparticles are defined In this study and that of Ferreira et al 
(2004), EMP were deflned as CD31+/42b-, with no requirement for annexin V posit~vity. In 
contrast, only annexin V positlve events, coupled with endothelial specific markers, were 
enumerated by Tushuizen et al (2006). Annexin V positivity is indicative of membrane 
asymmetry and the expression of negatively charged phospholipids on the outer microparticle 
membrane It has been argued that this requirement excludes a large proportion of EMP that 
are formed in response to cell activat~on (Horstman et al , 2004) Greater consensus in 
relation to the definition and detection of microparticles would facilitate progress in this fleld 
It should be noted however that the postprandial perturbations observed in this study are 
relevant to clinical risk EMP defined as CD31+/42b- and assayed in platelet poor plasma 
have been shown to be elevated in a number of disease states including coronary artery 
drsease (Bernal-Mizrachi et al , 2003), hypertension (Preston et al , 2003), obesity (Esposito 
et al , 2006), pre-eclampsia (Gonzalez-Qunitero et al , 2003), venous thromboembolism 
(Chirinos et al , 2005), thrombotic thrombocytopenic purpura (Jimenez et al , 2001) and 
multiple sclerosis (Minagar et al., 2001) EMP assayed using this methodology have also 
been shown to distinguish high and low risk coronary lesions (Bernal-Mizrachl et al , 2003) 
EMP expressing CD144 and CD146 were not detectable either in the fasting or 
postprandial samples of our young healthy volunteers In contrast, CD144-EMP and CD146- 
EMP have been detected in the plasma of older (mean ages 56 - 66 years) apparently healthy 
subjects (Koga et al., 2005; Faure et al , 2006) This difference in age profile may account for 
the presence of EMP in plasma bearing proteins that have been shown to regulate the 
structural integrity of the endothellurn, maintaining the cohesion of cell-cell junctions (Bardin 
et al., 2001, Petzelbauer et al , 2000) 
The mechanisms mediating the postprandial increase in EMP are not fully 
understood However, oxidative stress has been proposed to be the pathogenic mechanism 
underpinning postprandial endothelial dysfunction The postprandial impairment of EDD 
(Plotnick et al., 1997) and the postprandial increase in soluble adhesion molecules (Nappo et 
al, 2002) are both preventable when high doses of anti-oxidant vitamins are administered 
With the test meal, or prior to a FFA infusion (Steer et al., 2003) It is unclear if the 
postprandial increase in EMP is also preventable with anti-oxidant vitamin supplementation 
EMP not only reflect endothel~al dysfunction but may play an actlve role In lmpalrlng EDD and 
in ampl~fying ~nflammat~on. EMP generated in vltro have been shown to imparr EDD in rat 
aortlc rings vla an ox~dat~ve stress mechanism (Brodsky et al , 2004) and to facllltate 
transendothel~al leukocyte migration (Jy et al., 2004) This raises an lntrlguing posslblllty 
The protectwe rnfluence of anti-ox~dant vltamlns on postprand~al EDD could conceivably be 
medlated vra a decrease in EMP The mechan~sms llnking EMP, EDD and oxidative stress 
clearly warrant further attention 
The postprand~al Increase in EMP occurred In the absence of changes in soluble 
adhes~on molecules In addltlon, EMP d ~ d  not correlate with either SICAM-1 or sVCAM-1 
Preston et al (2003) found blood pressure to correlate w~th EMP but not with SICAM-1 or 
sVCAM-1 in a group of hypertensive patlents and normotensive controls, wlth EMP only 
weakly related to sVCAM-1 and not to SICAM-1 Koga et al (2005) reported EDD of the 
coronary artery to be more strongly related to EMP than to SICAM-1 EMP appear to be a 
more sensrtive marker of hypertriglycer~dem~a- or hypertension-induced endothelral 
dysfunction. As soluble adhesron molecules and EMP are released from the endothellurn by 
different cellular processes (Horstman et al., 2004), each may be d~fferent~ally regulated by 
r~sk factors for cardiovascular disease 
Desp~te the Increase in EMP that accompan~ed postprand~al ~pem~a, cute exerclse 
dld not attenuate EMP, SICAM-1 or sVCAM-1 In ether the fasted or postprandial states The 
importance of postprandral tr~glycer~des and tr~glycer~de-rich lipoproteins per se in activating 
endothelial cells is therefore unclear In addit~on to their influence on serum TG, high fat 
meals and acute exerclse result in other perturbations in a range of metabolic, hormonal and 
inflammatory factors In thls study, the post-exercise decrease In llpern~a was accompanied 
by an Increase in HDL-C Anti-inflammatory and antl-ox~dant properties have been attr~buted 
to the HDL particle It has been shown to Increase EDD (Sp~eker et al , 2002), block the 
expression of adhesion molecules on the endothellurn (Barter et al , 2002) and to lnhlblt LDL 
oxidation (Parthasarathy et al , 1990) FFA were h~gher In the exerclse tr~al at all timepolnts 
FFA lnfuslons are known to lmpalr EDD (Steer et al , 2003) There was some evldence of an 
Inflammatory response to the exhaustive exercise employed in thls study, with leukocytes 
higher at 0 h In the exerclse trlal. EDD has also been shown to be Impaired durlng acute 
lnflammat~on (Hlngoran~ et al , 2000) Although not measured in this study, systemlc markers 
of oxidat~ve stress have been shown to be elevated for 24 h after prolonged exhaustlve 
exerclse (Thompson et al , 2003) Thus, the mult~ple changes that accompany exhaustlve 
exerclse may exert lnh~bltory and st~mulatory Influences on endothellal cell activat~on status 
Dlrect comparisons of postprandial hypertr~glyceridemia and post-exerclse 
hypotr~glycer~dern~a must be considered with this in mind 
Only a few stud~es have examlned the Influence of acute exerclse on postprandlal 
endothelial funct~on, wlth ~nconclus~ve flndlngs in a study lean and obese mlddle-aged men, 
Gill et al. (2004) found EDD to be enhanced in the fasted state by prlor exerclse However, In 
another study lnvolvlng endurance-trained lndlv~duals, there was no change in EDD or in 
soluble adhesion molecules in either the fasted or postprandlal states, durlng 7 d of 
detraining, desp~te a 53% Increase in postprandial l~pemia (GIII et al , 2003) In their revlew, 
Moyna and Thompson (2004) have suggested that exerclse trainlng only Improves EDD in 
individuals with abnormal function at baseline including the elderly and patients w~th 
cardrovascular disease Future stud~es examining the influence of acute and chronic 
exercse, may only f~nd EMP to be attenuated In these cllnlcal cohorts. 
Although not the prlmary objective of the study, we were also able to document 
changes In PMP, indicative of platelet actlvatlon, durlng the postprand~al per~od and following 
acute exerclse. The use of PMP as indicators of platelet activation has a number of distinct 
advantages The PMP assay IS simple and economical, utll~ses platelet poor plasma, and 
samples can be frozen for analys~s at a later time (Horstman and Ahn, 1999) However, 
Preston et al (2003) observed only a weak relat~onship between platelet CD62 expresslon 
and PMP-CD42b counts PMP decreased postprand~ally durrng the exerclse trial In thls study 
with the decrease In the control trial approaching sign~f~cance. The impl~cations of these 
postprand~al changes are unclear The majorlty of prevrous studies examlnlng the influence 
of hlgh fat meals on hemostas~s have documented Increases in the percentage of platelets 
expressing actrvatlon markers (Hyson et al , 2002, Bro~jersen et al , 1998), the activat~on of 
coagulation factors (Larsen et al , 2000, Mlller et al , 2002, Olsen et al , 2002; Kapur et al , 
1996, Sllvelra et al , 1996) and In intravascular fibr~n formation (Elmas et al., 2007). 
PMP were hrgher in the exerclse trlal The exercise bout used In thls study was both 
vlgorous and exhausting and the Increase In PMP, suggestive of Increased platelet actlvat~on, 
is not surprising Numerous other stud~es reviewed elsewhere (Wang et al , 2006) indlcate 
Increases in platelet actlvatron and aggregatlon followrng intense exercrse Whereas the 
majorlty of these studles focus on platelet functlon during and for a short period after acute 
exerclse, PMP counts In thls study were determined from blood samples collected 12-18 h 
post-exercise However, ~t IS not possible to assess the rlsks associated wlth any Increases In 
platelet actlvatlon, as no lndlces of fibrlnolytlc actlvlty were assessed Further work IS 
needed, employing a varlety of antigenic markers, to determine the utlllty of PMP when 
investlgatlng the Influence of postprandial ilpemla and acute exercise on thrombus formation 
and the progression of atherosclerosis 
In summary, postprandial llpemla 1s accompanied by an Increase in EMP, but not 
soluble adheslon molecules It IS therefore llkeiy that EMF are a more sensltrve marker of 
endothellal functlon than soluble adhesron molecules. A prolonged bout of acute exerclse 
can decrease postprandial llpem~a However, thls exerclse attenuation of llpemla IS not 
accompanied by a decrease in EMP, at least in young healthy volunteers 
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Chapter Four 
INFLUENCE OF ACUTE EXERCISE ON 
POSTPRANDIAL LlPEMlA AND SKELETAL MUSCLE 
LIPOPROTEIN LIPASE ACTIVITY WITH AND WITHOUT 
CARBOHYDRATE REFEEDING 
4.1 INTRODUCTION 
Acute exerclse has consistently been shown to reduce postprand~al lpemla (GIII e l  
al., 2002a). This effect IS frequently attributed to an Increase in the rate of removal of 
triglycer~des (TG) from the circulation, med~ated by an Increase in skeletal muscle llpoprotein 
l~pase (LPL) actlvlty. Stud~es have shown Increases in LPL activity (Llthell et al , 1979, 
Tasklnen et al , 1980, Llthell et al., 1981, Lithell et al , 1984, K~ens et al , 1989, Seip et al , 
1995, K~ens and R~chter, 1998), LPL prote~n (Seip et al , 1997) and In the clearance rate of an 
lntrallpid lnfuslon (Dufaux et al , 1981, Sady et al , 1986, Annuzzi et al , 1987) after prolonged 
strenuous exerclse However, stud~es have also shown reductions In postprand~al ~pemia 
following prolonged exercise of moderate intensty, in the absence of increases in muscle LPL 
actlvlty, post-hepar~n LPL actlvlty or lntralipid clearance rate (Herd et a l ,  2001, Gill et al., 
2003, Katsanos et al , 2004; Glll et al , 2001) The preclse role of muscle LPL actlvity In 
med~atlng the exerclse attenuation of postprand~al l~pem~a remalns unresolved 
In contrast, h~gh carbohydrate (CHO) diets have been shown to increase plasma 
trlglycerldes (Abass~ et al , 2000), decrease muscle LPL actlvlty and decrease TG clearance 
rate (Llthell et al , 1982; Llthell et al , 1985) Kiens et al. (1989) reported a decrease In 
muscle LPL activity durlng euglycaem~c hyper~nsul~nemlc conditions wlth the decrease In LPL 
activlty highly correlated wlth the ~nsul~n-induced increase in leg glucose uptake Acute 
exerclse and CHO feedlng appear to have opposlte Influences on plasma tr~glycer~des and 
posslbly on muscle LPL activlty 
Stud~es of acute exerclse may not represent real l~ fe cond~t~ons, as they are not 
always des~gned to take account of the compensatory changes In energy and carbohydrate 
(CHO) Intake that occur durlng exercise training (Dela et al , 1991) Ong et al. (1995) 
observed an Increase in muscle LPL actlv~ty In rats following exerclse training, an effect 
blunted by feedlng after the last exerclse bout The mechanisms for thls blunted response 
are unclear however, and the changes In serum TG were not reported There 1s some 
ev~dence In humans that muscle glycogen can Influence LPL activity When muscle glycogen 
was manipulated through a combrnatlon of exerc~se and diet, the changes in muscle glycogen 
were closely related to the changes in LPL actlvlty (Jacobs et al , 1982) The importance of 
muscle glycogen as a determinant of muscle LPL actlvlty and postprand~al lpemla warrants 
further attention Although exerclse has been shown to moderate the influence of high CHO 
d~ets on postprandial l~pem~a (Koutsar~ et a1 , 2001), it IS not known if carbohydrate feed~ng 
moderates the Influence of acute exercise on postprandial l~pem~a. These questions are not 
slrnply of academ~c importance. Should the exerclse attenuat~on of postprand~al ~pem~a be
shown to be dependent on glycogen deplet~on durlng the exerclse bout, there would be 
impllcat~ons for exerclse prescr~pt~on 
The purpose of this study was to lnvestlgate the influence of acute exerclse on 
postprand~al lipemia and muscle LPL activity Unl~ke prevlous stud~es thls study lnvolved two 
exerclse tr~als so that the exerclse effects could be determined in a glycogen depleted and 
glycogen repleted state Prolonged exerclse of vlgorous Intensity was employed to maxlmlse 
glycogen depletion and any exercise effect on LPL actlvity 
4.2 METHODOLOGY 
Subjects 
Eight recreatlonally actlve men (mean * SD; age 26 9 ? 4.1 y, V02peak 46 8 * 4 9 
ml kg"mln.', BMI 26 0 k 3.6 kg m-', % body fat 15.2 k 5 0%) volunteered for thls study 
Subjects were non-smokers, normol~pidem~c, free from cardiovascular dlsease and d~abetes 
and not taking rned~cat~on known to influence carbohydrate or llpld metabol~sm Ethical 
approval was granted by the Dublln C~ty Unlvers~ty Ethlcs Cornmlttee and wrltten Informed 
consent was obtalned prior to partlcipatlon (Append~x A2) 
Experimental desrgn 
Subjects vlslted the laboratory on six occasions During a prellrninary vlslt, they 
underwent a phys~cal examlnat~on, had thelr body cornpos~tion assessed and maxlmum 
oxygen uptake deterrnlned. They subsequently underwent three 6 h oral fat tolerance tests 
(OFTT), separated by 7 d approx~mately (Fig 4.1) One the evening prior to one OFTT, 
subjects rested quietly at home (CON tr~al) On the evenlng prior to two OFTTs, subjects 
completed cycle ergometry exercise in the laboratory Following one of these exerclse bouts, 
glucose was consumed to replace the CHO ox~d~sed urlng exerclse (EX-CHO trlal) 
Following the other exerclse bout (EX tr~al), only water was perrn~tted (EX tr~al). The order of 
these trials was randomrsed. 
Fig 4.1 Schematic representation of the experimental design 
Exercise trial I 
OFTT day -1 
Control trial 
Exercise tr~al with CHO refeeding 
OFTT day 
I 
Meal (breakfast, d~nner or tea) Test meal 
m 
0 2 4  
T~me post-exercise (h) 
Exercise bout I Blood sample 90 mln @ 70% V0,max + 10 maxlmal sprints 
- 
0 1 2 3 4 5 6  
Time after ingestion of test meal (h) 
0 carbohydrate feeding I Muscle biopsy 
Exercise test~ng 
Maximum oxygen uptake was determined uslng an Incremental exercise test on a 
cycle ergometer (Monark, Vansbro, Sweden) The ln~tial workload and Increments were 
m d i v ~ & e d s o - t k a t ~ e t e s t ~ ~ - ~ w n - d u ~ ~ ~ ~ c ~ ~ s ,  
were conducted between 17.00 and 19 00 h on the evenlng prlor to the OFTT. Subjects 
cycled at 70 rpm for 90 mln at 70% VO,peak, followed by ten 1 mln sprints Interspersed with 1 
mln of restlng recovery Flywheel res~stance was Increased by 25% for the sprlnts and 
flywheel revolut~ons recorded every 20 sec in order to estlmate energy expenditure. Subjects 
performed these sprlnts at a mean of 93 k 3% V02max. 
Exp~red air was collected cont~nuously durlng the exerclse bout via a breath by breath 
metabol~c system (Vmax 229, Sensormedlcs, Yorba L~nda, CA) Energy expend~ture and 
substrate ox~dat~on dunng the continuous cycllng was estlmated uslng indirect calor~metry 
(We~r, 1949; Peronnet and Massicotte, 1991) and energy expendlture durlng the sprlnts was 
estlmated from the ACSM metabolic equat~on (Amencan College of Sports Med~crne, 2006) 
based on flywheel res~stance and revolut~ons Heart rate was recorded cont~nuously using 
short range telemetry (Polar Electro Oy, Flnland) 
Oral fat tolerance tests 
For 3 days prior to each OFTT, subjects were requ~red to absta~n from alcohol and 
not to engage In exerclse or heavy phys~cal work On the day prlor to each OFTT, d~et was 
strictly controlled w~th  subjects consuming 3 meals prov~ded by the laboratory. These meals 
consisted of breakfast cereal, milk, toast, butter, chocolate biscuits and ham and cheese 
sandwiches This pre-OFTT diet was individualised to provide an energy content equal to 1 4 
times BMR, with 56% as CHO 30% as fat and 30% as protein. BMR was estimated from the 
Harris-Benedict equation (1919) On the two days prior to this, subjects consumed their 
normal diet Food items consumed along with portion size were recorded on sheets provided, 
prior to the first OFTT. This diet was then replicated in advance of subsequent OFTTs 
Following one of the exercise bouts (EX-CHO trial), carbohydrate refeeding was 
undertaken to replehish muscle and liver glycogen stores Subjects consumed 105% of the 
carbohydrate ox~dised during exercise (44 0.4 g.kg-' EM) This was divided into three 
equal boluses and consumed immediately, 2 h and 4 h post exercise The carbohydrate was 
delivered in the form of an 18% carbohydrate drink and 85% glucose confectionary 
Carbohydrate refeeding was complete 4 h post exercise and at least 10 hours prior to the 
subsequent OFTT Water was consumed at equivalent time-points in the CON and EX trials 
Subjects travelled to the laboratory on the morning of each OFTT by motorised 
transport and in a fasted state A muscle biopsy (100-140 mg) was obtained from the midway 
point of the vastus lateralis immediately prior to each OFTT using a Bergstrom needle, with 
manual suction applied. Biopsies were obtained from alternate legs for different trlals after 
local anaesthesia with 2% Iidocarne. Samples were trimmed of any visible fat, snap frozen in 
liquid nitrogen and stored at -80°C unbl analysis. A 20G Intravenous catheter was inserted 
into a forearm vein This catheter was kept patent during the 6 h postprandial follow-up 
perrod by flushing regularly with a 0 9% salrne solutron. The test meal consisted of 
croissants, butter, hlgh fat ice-cream, chocolate and potato crlsps wlth a macronutrlent 
compos~tion per 2mZ body surface area of 97 g fat, 124 g carbohydrate and 1450 kcal The 
meal was well tolerated Water Intake was ad l~bltum dur~ng the flrst trlal Thls pattern of 
water Intake was recorded and repeated during subsequent tr~als. Subjects rested quletly In 
the laboratory durlng the 0bse~atlon period with blood sampled at 30 mln, 1, 2, 4 and 6 h 
Blood samples were obtalned with subjects In a seated posltlon for 5 min wlth legs 
uncrossed In order to mlnlmlse plasma volume shlfts Serum was allowed to stand for 30 mln 
before centrifugation at 3000 rpm (1600 g) for 15 mln at 4OC 
Serum analyses 
Serum tnglycerides, HDL-cholesterol, 3-hydroxybutyrate, free fatty ac~ds and glucose 
were determined uslng spectrophotometr~c assays. The spectrophotometr~c analyses were 
performed on an automated bench-top cllnlcal chemistry system (ACE", Alfa Wassermann 
B.V., Netherlands) uslng appropriate reagents, callbrators and controls (Randox Laboratories, 
UK) Serum lnsul~n was determlned by fluoroimmunoassay uslng a commerc~ally available k ~ t  
(Perkinelmer, Wellesley MA, USA) Haematocr~t values and haemoglobin concentrat~ons 
were determlned from an EDTA whole blood sample using an automated haematology 
analyser (AcTdlffZ, Beckman Coulter, Fullerton, CA) The ~ntra-assay coefflc~ents of 
varlatlons were < 3% for the spectrophotometr~c assays and the fluoroimmunoassay 
Muscle glycogen 
Frozen muscle samples were freeze-drred and d~ssected free of connective tlssue 
Glycogen concentrations were determined in duplicate by a standard enzymatic technique 
- - - - - - - w i K F f l o w - i m e k i c ~ & l ~ ~ - ~ ~ ~ e a t l a n ~ d e W ~ & ~ m ~ ~ e d ~ e d  
muscle was allowed to thaw to -15'~. Muscle was Incubated in 0 5 ml of 2N hydrochloric acid 
for 2 h at 1 0 0 ~ ~ .  Samples were then reconstltuted to orlglnal welght wlth dH20 before being 
neutralised with 1.5 ml of 0 67N NaOH 1 ml of reagent mlx containing Tr~s base, HCI, 
MgCL,, DTT, ATP, NADP, HK and G-6-PDH was added to samples and glycogen content 
determined by fluorlmeter The co-efflclent of var~atlon for thls assay was 3 6% 
For preparation of tissue homogenates for the LPL actlv~ty assay, muscle biopsy 
samples were ground with glass mortar and pestle on Ice The homogenlsat~on buffer 
contained 0 05 M Trls HCI (pH 8.1), aprotlnin (2 pg m ~ ' ) ,  leupeptln (10 pg mL-'), 
benzamidlne (1 mM), pepstatln (I vg.mL-'), EDTA (5 mM), BSA (1 mgm~.'), 
phenylmethylsulfonyl fluonde (0 4 mM) and heparin (5 U r n ~ ' ,  0 025 mg.ml-'). The samples 
were hornogenised at a concentration of 10 mg 350 pL-' buffer 
LPL enzyme actlvity was measured wlth a trloleln containing substrate LPL 
actlvity was measured by the rate of hydrolysis of the [ 3 ~ ]  trloleln containing substrate 
emulsified wlth leclthln, in the presence of pooled heat-lnactlvated human serum as the 
source of apollpoproteln C-ll, and fatty acld-free albumln Assays were performed at 37'C for 
100 mln. Serial dilutions of representative samples verifed that the LPL assay was hear  wlth 
time and amount of enzyme In the range that assays were performed 
Data analysis 
~-~ ~ - - - -  
Summary postprand~al responses to the test meal are reported as t~me-averaged 
postprand~al values (Appendix B) using the approach of G~ l l  et al (2006) Tlme-averaged 
postprand~al values represent the total area under the concentration vs tlme curve (AUC), 
calculated using the trapezium rule, dlvlded by the length of the postprandlal period The TG 
Increment (Appendix B) represents the AUC above basellne, div~ded by the length of the 
postprand~al period 
The s~gnificance of trial dlfferences for the summary postprandlal variables was 
determ~ned uslng a one-way repeated measures ANOVA followed by a Fisher Least 
Slgnifican t Difference post-hoc test. The s~gnlficance of between-trial dlfferences at indlvldual 
tirnepolnts was determined uslng a two-way ANOVA (trial x time), followed by a pr~ori 
contrasts to examine trlal d~fferences only Assoc~ations between selected variables were 
determlned uslng Pearson correlations unless otheiwise stated. Data are reported as mean +- 
SEM unless otherwise stated Sign~f~cance was set at p<O 05 
4.3 RESULTS 
The V02 (33.4 + 1 1 vs 33 2 + 1 0 ml.kg-' mln-'), RER (0 96 + 0 005 vs 0 96 + 0 004) 
and heart rate (151 f 3 vs 150 f 4 b.min-') during the 90 min of continuous cycllng did not 
d~ffer in the EX and EX-CHO trrals respectively. Est~mates of carbohydrate oxidation (352 -+ 
21 vs 347 +_ 17 g), fat oxidation (15 +_ 2 vs 16 +_ 2 g) and energy expendrture (1463 '1 78 vs 
1450 k 66 kcal) in the EX and EX-CHO trial exercise bouts (continuous cycling and sprints) 
were also similar. As mean haemoglobin (p=O 92) and haematocrit (p=0.69) were similar In 
the CON (13 9 + 0.4 g.d~-', 41 8 +_ 1 0 %), EX (14 0 k 0.3 g.dL", 41 2 +_ 1 1 %) and EX-CHO 
(14 0 i: 0.2 g d ~ ' ,  41 5 t 0 7 %) trials respectively, serum concentrations were not adjusted 
for changes rn plasma volume. Muscle glycogen was 40% +_ 4 3 (p<O 05) and 94% + 3 4 
(p=0.24) of control values on the morning of the EX and EX-CHO trrals respectively (fig 4 2) 
Fasting TG were closely related to postprandial TG in the CON (r=O 92, p<O 05), EX 
(r=O 98, p<O 05) and EX-CHO trials (r=0.76, p<O 05). Fasting TG, postprandial TG and 
postprandial TG increment were 33%, 40% and 47% lower respectively (pc 0 05) In the EX 
trral compared to the CON trral (flgs 4.3 & 4 4) In the EX-CHO trial fasting TG and 
postprandial TG were higher (p<O 05) than in the EX trial, and were not different to CON trlal 
values. In the EX-CHO trial, postprandral TG increment did not differ from the EX trial or CON 
trial values (fig 4.4) 
There was an inverse relationship (p<O 05) between muscle LPL activity and fastlng 
TG, postprandial TG and postprandial TG Increment in the CON trial (flg 4 5). LPL activity 
was not related to any index of lipemia in the EX or EX-CHO trials (fig 4 5) Correlations 
approaching significance were observed between V02max (ml kg-' min-') and all indices of 
lipemia in the EX trial but not in the CON or EX-CHO trials (flg 4 6). 
Muscle LPL activity was not srgnificantly different across trials whether values are 
expressed as a percentage of CON trial values (fig 4 7) or in nmol FFA mind g" (fig 4 8) 
There was a strong relationship between LPL activity in the EX and EX-CHO trlals (r=O 93, 
pc0.01) when values are expressed as a % of CON values (fig 4 9) Analysis of indiv~dual 
data (table 4 1) jndrcates that three subjects exper~enced lrttle change in muscle LPL activity 
with exercise ( ~ 2 5 %  change from CON trial values), three experienced considerable 
increases (>loo% increase from CON trial) and two experlenced considerable decreases 
(>50% decrease from CON trial). 
The % change in muscle LPL activity following exercise refers to the % difference 
between EX and CON trial values (EX - CON) unless otherwise stated The % change in 
muscle LPL activity follow~ng exercise was inversely related to initial CON trial LPL actlvlty ( f~g 
4 10) The % change in muscle LPL activity following exercise was also related to the change 
in fasting TG (p=0.055), postprandlal TG (p=O 048) and postprandial TG increment (p=O 061) 
(fig 4 11). Similarly, the % change in LPL activlty between the CON and EX-CHO trials was 
inversely related (r= -0 88, p<O 05) to the change in postprandial TG The % change in LPL 
activity and the change In muscle glycogen were not related between the CON and EX trials 
or between the EX and EX-CHO trials (fig 4.12). 
The influence of the test meal on serum insulin, glucose, FFA and 3-hydroxybutyrate 
in the CON, EX and EX-CHO trials is shown in fig 4 13 Fasting and postprandial insulin were 
not significantly different across trials (p=O 16) with differences between the CON trial and EX 
trlal approaching significance (p=O 11) (table 4 2). Small differences existed in fasting and 
postprandlal glucose across trials. Fasting glucose was similar in the CON and EX-CHO 
trials but lower (pxO 05) in the EX trial Postprandial glucose was higher (pe0.05) in the EX- 
CHO trial than In the EX and CON trlals (table 4 2) Fastlng HDL-C was hlgher (pcO 05) In 
the EX trial than In the CON and EX-CHO trials (table 4.2). Postprand~al FFA and 3- 
hydroxybutyrate were hlgher (p<O 05) In the EX trlal than In the CON and EX-CHO trlal 
Table 4.1 Individual values for SM-LPL activity (nmol ~ ~ ~ m i n - '  g") in  the CON, EX 
and EX-CHO trials 
CON EX Exerc~se Exercise EX-CH0 wlthout CHO wlth CHO 
refeedlng refeedlng 
Subject 1 12.73 12.95 10 60 u tf 
Subject 5 21.43 23 67 19 95 u tf 
Subject 3 22 39 16.89 c-* 
Subject 4 4 25 9 31 15.77 T T 
Subject 8 16 23 39 51 42 07 T T 
Subject 2 14 08 28.94 't 
Subject 6 49 22 11 93 13 30 I 1 
Subject 7 36 50 20.31 13 33 1 1 
changes greater than 25% are noted wlth T I arrows 
Table 4.2 Fasting and time-averaged postprandial values for a range of study 
variables in the CON, EX and EX-CHO trials 
CON trlal EX trial EX-CHO trial 
Fastlng insulin (mmol c') 4 3050 96 ab 3 7020 90 a 5.19i1.30 b 
Postprand~al nsulin (mrnol L") 19.5t4 2 14.6f1.9 18 4k3 4 
Fasting glucose (mmol c') 4 75t0 07 a 4.40i0.09 b 4 75k0 11 a 
Postprandial glucose (mmol C1) 4 76rt0 12 a 4.72t0.08 a 5.11f0.12 b 
Fast~ng HDL-C (mmol c') 1 20k0 07 a 1 30t0 08 b 1 20f0 07 a 
Postprand~al FFA (mmol c') 0 49 i0 03 a 0 60f0 04 b 0 49k0 04 a 
Postprandlal 3-hydroxybutyrate (mmol L") 0.093t0.03 a 0 209t0 03 b 0.063i0 01 a 
Values are mean i SEM. 
a, ab, b Dffferent letters denote values that are s~gnificantly different (p<0.05). Values 
denoted as ab are not s~gnrf~cantly different to values denoted a o rb  
Fig 4.2 Muscle glycogen concentrations in the CON, EX and EX-CHO trials 
CON EX EX-CHO 
'CON vs EX trial pcO 05, t EX vs Ex-CHO trial, pCO.05 
Fig 4.3 Serum TG response to a high fat meal in the CON, EX and EX-CHO trials 
Test meal1 Time (h) 
*CON vs EX trral pcO.05, j EX vs Ex-CHO trial 
Fig 4.4 Time-averaged postprandial TG and time-averaged postprandial TG increment 
in the CON, EX and EX-CHO trials 
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Fig 4.5 Relationship between LPL activity and fasting TG, postprandial TG and postprandial TG increment in the CON, X and EX-CHO trials 
CON trial 
0 0 2  0 4  0 5  0 8  1 12 0 0 0 5 1 0  4 5 2 0 0 0 2 0 4 0 6 0 8  
Fasbng TG (mM) Postprandial TG (mM) Postpand~al TG ~ncrement(mM) 
' I 
Ex-CHo tr~al I 
0 4  0 5  0 8  
Fasbng TG(mM) 
Fig 4.6 Relationship between V02max (ml.kg"'min-') and (A) fasting TG, 
(B) postprandial TG and (C) postprandial TG increment in the EX trial 
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4.4 DISCUSSION 
This study is novel Insofar as it examlned the Influence of acute exercise on 
postprandial l~pem~a and muscle LPL act~v~ty In the glycogen depleted and glycogen repleted 
state The exercise protocol resulted in cons~derable glycogen depletion and the 
carbohydrate refeeding protocol successfully repleted muscle glycogen Acute exerclse 
reduced postprand~al lipemla, though th~s effect was largely ellmlnated w~th carbohydrate 
refeedlng and glycogen replet~on In contrast, exerclse had no slgnlflcant effect on muscle 
LPL activ~ty, and carbohydrate refeedlng dld not moderate the LPL activ~ty response to 
exerclse However, considerable inter-~ndlvldual varratlon was observed In the LPL actlvlty 
response to exerclse 
Unl~ke prevlous stud~es, the present study lnvolved two exerclse trlals so that the 
~nfluence of acute exercrse could be examlned In the presence and In the absence of a post- 
exercise CHO refeeding regime to replete muscle glycogen Regardless of refeed~ng, it IS 
clear that there was no s~gnificant Increase in muscle LPL actlvlty when measured -12 h post- 
exercrse, whether values are expressed in nmol min-' g-' or relative to CON values Although 
the majorlty of studies report an Increase in LPL activ~ty or LPL proteln following acute 
exerclse, thls Increase IS sometimes modest, qual~fied or limlted to certain post-exercae 
tlrnepo~nts Herd et a1 (2001) found muscle LPL actlv~ty to be unchanged 16 h post-exerc~se 
Perreault et al. (2004) demonstrated an increase In muscle LPL actlvrty following exerclse in 
men but not In women One legged knee extens~on exerclse resulted In an Increase in 
muscle LPL actlvlty at 4 h but not at 8 h post-exercrse (K~ens et al , 1989). Se~p et al (1995) 
reported a modest, yet signlflcant 35% Increase In muscle LPL activ~ty (slmilar to the non- 
significant % change in the present study), accounted for by changes in the heparln non- 
releasable fractlon only Whereas Seip et al (1997), documented Increases in LPL proteln at 
8 h but not at 20 h post-exerclse, Magkos et al (2006) found LPL protein to unchanged on the 
morning after a prolonged exerclse bout Although prolonged bouts of acute exerclse have 
consistently been shown to reduce serum TG, wlth lowest values occurring -18 h post- 
exercise (Thompson et al , 1980, Klens and Rlchter, 1998), the exercise effect on muscle LPL 
actlvlty at slmilar timepolnts IS clearly not as robust In their revlew, Gill and Hardman (2003) 
suggest that the ~mportance of LPL-mediated TG clearance in explalnlng the exerclse 
attenuation of postprandial lipemla may be influenced by the energy expended durlng the 
exerclse session A number of the earller studies that documented post-exerclse Increases in 
muscle LPL activlty Involved prolonged bouts of competitive endurance exerclse (Llthell et al , 
1979) and mllitary manoeuvres (Llthell et al , 1981, Llthell et al., 1984) The exerclse protocol 
employed In the present study, finlshlng wlth ten maximal sprlnts, was also exhausting. The 
total energy expenditure approached 1500 kcal. The absence of a significant Increase in LPL 
actlvity should not therefore be attributed to a suboptimal exercise stimulus. 
The results of the present study suggest that muscle LPL actlvity 1s a key determinant 
of serum TG and an Important medlator of the reduction In TG that follows acute exercise 
Muscle LPL actlvlty was strongly related to fastlng TG, postprandlal TG and the postprandlal 
TG Increment in the unexerclsed state (CON trlal) The correlation wlth postprandial TG 
Increment in particular lndlcates an Important role for muscle LPL in clearing exogenous TG 
from the circulation following a high fat challenge. Pulawa et al. (2007) also Identified skeletal 
muscle LPL activity as a predictor of plasma TG. Overexpression of human LPL in skeletal 
muscle in mice resulted in a dose-dependent decrease in plasma TG However, no 
correlations were evident in the EX or the EX-CHO trials. Interestingly, all indices of lipemia 
were related to V0,max in the EX trlal but not in the CON or EX-CHO trials It appears that 
LPL activity is a key determinant of serum TG in the unexercised state, though overridden by 
other factors, possibly associated with aerobic fitness, in the exerclsed state 
Although exercise did not significantly Increases LPL activity, a strong inverse 
correlation was observed between the change in LPL activity and the change in all indices of 
lipemia Similarly, muscle LPL activity was not significantly different to CON values in the EX- 
CHO trial, yet a strong inverse correlation was observed between the change in enzyme 
activity between trlals and the change in postprandial lipemia Others have reported inverse 
relationships between the change in postprandial lipemia and the change in muscle LPL 
activity (Herd et al., 2001) and post-heparin LPL activity (Gill et al , 2003), in the absence of 
s~gnificant exercise-stimulated increases in LPL activity These data suggest that with or 
without CHO refeeding, the exercise effect on LPL activity is an important determinant of the 
change in postprandial lipemia An increase in LPL activity may not be a permrsslve factor 
for a reduction in lipemia but where an increase in enzyme activity occurs, the attenuation of 
lipemia wrll be of greater magnitude 
Considerable inter-individual variation was evident in the LPL activity response to 
exerclse There appeared to be a clear increase in LPL activity in 3 subjects and a clear 
decrease In another 2 subjects The slmllarlty of the LPL actlvlty responses In the EX and 
EX-CHO trlals suggests that thls response IS repeatable and that the inter-lndlvldual vanatlon 
observed was not due to measurement error or poor experimental control Slmilar lnter- 
lndivldual variation was reported by Herd et al. (2001) though thls was not confirmed wlth an 
additional exercise trial Thls heterogeneity In the LPL actlvity response to acute exercise 
warrants further attention. All muscle flbres may not respond slmllarly to exercise Hamllton 
et al (1998) observed an exerc~se-stimulated Increase In LPL activity In fast glycolytlc rat 
muscle, but not In fast oxldatlve or slow muscle In the present study, those with the lowest 
CON trial values for LPL act~vlty exper~enced the greatest percentage Increase in enzyme 
activlty As muscle LPL actlvlty has been shown to be hlghly correlated wlth the percentage 
of slow fibres, (Jacobs et al , 1982), it IS plauslble that our hlgh responders (low lnltlal values) 
had a preponderance of fast flbres Llthell et al (1979) reported considerable Increases in 
LPL actlvity in less well-tralned lndlviduals following a competltlve cross-country skllng event, 
wlth only small Increases evldent In the well-tralned athletes. Pre-race IMTG stores were 
hlgher in slow fibres and a strong Inverse correlation was observed between pre-race IMTG 
stores and the Increase in LPL actlvlty. Taken together, these studles suggest that indlvlduals 
of low trainlng status, wlth low lnltlal muscle LPL actlvlty, low IMTG stores and a 
predominance of fast fibres may have the lowest inltial LPL activity and experience the 
greatest increase In actlvlty following a prolonged bout of exercise Klens and Richter (1998) 
suggested that IMTG are an Important source of fuel post-exercise during glycogen repletion, 
but are not utlllsed during exercae. It is plauslble that in slow fibres of tralned lndrviduls 
(highest IMTG), the supply of FFA to the mitochondria may be adequate to meet basal post- 
exerclse energy needs. In contrast, increases in LPL activity may be necessary in fast fibres 
so that FFA can be more efficiently sourced from tr~glyceride-rich lipoproteins in the 
circulation. This theory needs to be tested by determining the LPL activity response to 
prolonged acute exercise in conjunction with muscle fibre typing and individual flbre analysis 
Furthermore, this theory cannot account for the post-exerclse decrease in LPL activity 
observed in two subjects. 
To our knowledge this is the first study to compare the effects of CHO refeeding vs no 
refeeding on the LPL activity response to exercise in human skeletal muscle. Post-exercise 
dietary conditions have been shown to influence the LPL mRNA response to acute exercise in 
humans Increases in LPL mRNA have been demonstrated if a low CHO diet but not a hlgh 
CHO diet is consumed during the recovery period (Pilegaard et al , 2005) However, given 
that much of the influence of acute exercise and feeding on enzyme activity is post- 
translational (Ong et al., 1995, Simsolo et al., 1993, Bey and Hamilton, 2003), these changes 
in mRNA may not reflect changes in enzyme activity Data from Ong et al (1995) and Kiens 
and Richter (1998) suggest that post-exercise increases in LPL activity are reversed with 
carbohydrate feeding and in conjunction with muscle glycogen repletion According to both 
groups, the availability of carbohydrate lessens the needs for FFA in the post-exercise period, 
allowing LPL activity to return to baseline more quickly However, data from the present study 
do not support a role for carbohydrate refeedlng or muscle glycogen status in moderating the 
LPLA response to acute exercise The changes in LPL activity from CON trlal values were 
slmllar in the EX and EX-CHO tr~als. In add~tlon there was no correlation between LPL 
actlvity and muscle glycogen in the EX trial expressed relative to CON values or between LPL 
actrvlty and muscle glycogen in the EX-CHO trlal expressed relatrve to EX trial values. These 
data suggest that any Influence (positive or negative) of acute exerclse on muscle LPL actlvlty 
In humans in mediated by contractile mechanlsms rather than by substrate depletion 
The pronounced changes that occurred in postprandial llpemla across trials in the 
absence of signlflcant changes in LPL actlvlty, suggest that the effect of exerclse may be 
medlated in part by non-LPL mechanlsms Dlfferences in postprandlal llpemla brought about 
by carbohydrate refeeding also appear to be medlated by non-LPL mechanism These 
alternative mechanlsms are open to speculation Any Influence of exercise on serum TG 
concentratlons must be mediated by changes in TG uptake by muscle and adipose tlssue or 
by changes in hepatic TG synthesis and secretlon It 1s unllkely that adrpose tlssue LPL 
activlty contrlbuted to the observed changes in postprandial lipemia as it has been shown to 
be unchanged following acute exerclse In humans (Selp et al , 1995) and exerclse tralning in 
rats (Ong et al , 1995). 
Altered hepatic TG synthesis and VLDL-TG secretlon must therefore be considered 
as another potentlal mechanism expla~ning the changes in postprandlal llpemla in the EX and 
EX-CHO tr~als In thelr tracer study, Magkos et al (2006) found VLDL-TG secretion to be 
unchanged on the mornlng following acute exerclse, attributing the reduction in fastlng TG to 
clearance alone However, in three studles wlth rats, exercise training has been shown to 
reduce VLDL-TG secretlon by 32-50% wlth slrnllar reductions In serum tr~glycerrdes (Slmonell~ 
and Eaton, 1978, Mondon et al , 1984, Fukuda et al , 1991). In one study (Fukuda et al , 
1991), the decrease in hepatic TG secretion was accompanied by an increase in, ketones, 
indicative of increased hepatic fatty acrd metabolism The authors attributed the 
hypotriglycerrdemic effects of exercise to altered hepatic partitioning of long chain fatty acids, 
with the available fatty acids being directed towards oxidation rather than esterlficatlon in 
order to preserve depleted glycogen stores The restoration of liver glycogen With 
carbohydrate refeedlng would be expected to reverse any changes in hepatic fatty acid 
partitioning. Although muscle glycogen resynthesis appears to be prioritised over liver 
glycogen resynthesis during the first 2 h of post-exercise CHO refeeding (Maehlum et al., 
1978), cons~derable liver glycogen repletion undoubtedly occurred in the EX-CHO trial 
between the end of the exerclse bout and the start of the OFTT. In the present study, 
postprandial lipemia was partially restored in EX-CHO trlal as glycogen stores were repleted 
In addition, the ketone 3-hydroxybutyrate was markedly higher during the EX trial at all 
postprand~al timepoints, but similar to CON values when the exercise was followed by 
refeeding. Thus, limited Indirect evidence can be found in this study to support the 
hypothesis 
The findings of this study Indicate that the attenuation of postprand~al lipemla 
following acute exerclse is related to the associated energy deficit, in agreement with Gill et 
al., (2002b) and Tsetsonis et al , (1996) More specifically, changes in muscle andlor llver 
glycogen appear to mediate the effects of acute exercise not only on postprandial TG 
concentrations but also on postprandial FFA, postprandial 3-hydroxybutyrate and fasting 
HDL-C Postprandial insulin was not significantly Influenced by acute exerclse wlth or without 
carbohydrate refeeding in this study Malkova et al (1999) concluded that the nature of the 
substrate used during exercise, and consequently the magnitude of substrate depletion, did 
not influence the attenuating effect of prior exercise on postprandial lipemia However, the 
differences in glycogen stores achieved through manipulation in thew study were small, in 
comparison to the EX and EX-CHO trial differences achieved in the present study The 
importance of glycogen status identrfied in this study has rmplications when conducting and 
interpreting research studies involving acute exercise Previous studies of postprandial 
lipemia have generally employed a prolonged exercise bout on the day preceding an oral fat 
tolerance test, but have not controlled post-exercise nutrient intake. It is likely that major 
differences In post-exerclse carbohydrate intake would exacerbate inter-lndlvidual and inter. 
study variation in the response to exercise These results also lend support to the argument 
(Dela et al ,  1991) that the benefits of acute exercise may be overstated when studies to not 
take into account compensatory changes in dletary intake 
In spite of the novel experimental deslgn and novel findings, th~s  tudy 1s not without 
limitations. No measure of leg blood flow was employed Malkova et al (2000) documented 
a 34% decrease in postprandial lipemia on the day following a prolonged bout of exercise, 
coinciding with a 37% Increase in postprandial leg blood flow A post-exercise increase in TG 
clearance could occur in the absence of an Increase in LPL activity, mediated by an Increase 
(insulin-stimulated or otherwise) in leg muscle blood flow The determ~nation of LPL activlty 
from biopsied samples of muscle measures the maxlmal capaclty of muscle to hydrolyse TG 
ex vivo. Enzyme actlvlty may be modulated m vivo by a range of st~mulatory and inhibitory 
factors Thus changes In muscle LPL actlvlty ex vivo do not necessarily represent changes In 
the clearance of TG by muscle in vivo Uslng a tracer methodology, Magkos et al (2006) 
reported an increase In VLDL-TG clearance following acute exerclse, In the absence of any 
Increase in muscle LPL mass Due to a scarcity of muscle, it was not poss~ble to determine 
heparin-releasable LPL activity separately from total muscle LPL activity In theory, heparin- 
releasable LPL actlvlty represents the extracellular fract~on bound to the capillary endothellurn 
and may more accurately reflect the capaclty of muscle to clear TG from the clrculabon 
Flnally, ~t IS unclear if LPL activ~ty changed durlng the postprand~al perlod as each 
exper~mental tr~al involved only one muscle blopsy K~ens et al (1989) have shown muscle 
LPL act~vity to decrease durlng euglycem~c hyperinsulinem~c cond~tions, particularly in lnsulln 
sensitive individuals 
In conclusion, it IS l~kely that mult~ple mechanisms med~ate the exerclse attenuat~on of 
postprand~al l~pemla Our data suggest that unllke postprandlal l~pemla, muscle LPL activity 
1s not s~gn~ficantly altered by acute exerclse. Our data also suggest that unl~ke postprandial 
I~pemia, the LPL response to exerclse is not to be influenced by CHO refeedlng Although the 
changes in LPL activ~ty brought about by acute exerclse clearly Influence the magn~tude of 
the reduction In l~pemra, it IS likely that hypotriglyceridem~c Influence of exemse 1s also 
medlated by factors associated wlth glycogen depletion. The search for generalised 
mechanlstlc theorles may also be overslmpl~stlc however The literature contains many 
examples of lnconcluslve or apparently conflicting stud~es. Large inter-~nd~v~dual differences 
were observed In the LPL activlty response to exercise. Attempts to further eluc~date the role 
of muscle LPL actlvlty and glycogen-related factors In rned~atlng the exerclse attenuat~on of 
llpemla may prove difficult, wlthout f~rst ~dentlfying the lnd~v~dual factors that Interact w~th 
these maln effects 
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APPENDIX A1 
DUBLIN CITY UNIVERSITY 
RESEARCH -INFORMED CONSENT FORM 
I. Proiect Title: 
Influence Of Acute Exerose On Postprand~al Llpaemra And Endothel~al Dysfunction in Men Of 
Varying Body Mass Index 
II. Introduction to this studv: 
The way the body processes the fat we eat IS one of the factors that influences our r~sk of developing 
heart disease After a slngle fatty meal, the level of fat In the bloodstream Increases at flrst and then 
decreases again over an 8 hour period lndiv~duals who are not capable of processing fatty meals 
efficiently have a high concentration of fat In the~r bloodstream over a prolonged period They are at 
higher rrsk of heart d~sease 
111. 1 am beinq asked to participate in this research studv. The studv has the followincl PurDoses: 
1 To measure the rlse and fall of fat In the bloodstream after a fatty meal 
2 To examine the effect of a slngle exercise sesslon on the way we process the fat we eat 
IV. This research studv will take place at the Centre for Sport Science and Health. Dublin City 
University 
V. This is what will happen durincl the research studv: 
1. Dur~ng the flrst preliminary vlslt I will have a br~ef medical examlnatlon and perform an exercise 
test to determ~ne my fltness level. This w~ll lnvolve exerc~sing at increasing speeds on a treadm~ll 
unt~l I reach my maximal exerclse capacity For thls, and all subsequent exercise tests, I wlll be 
fitted with a mouthp~ece connected to a machlne to measure the compos~t~on of gases In my 
breath 1 w~l l  also have my we~ght, helght and body fat measured uslng fat calipers. 
2 On the second preliminary vislt, I will perform another exerclse test (not to exhaust~on on thls 
occas~on) to determine the speed that corresponds to 70-75%% of my maximum exerclse 
capacity 
3 The maln part of the study will lnvolve the collection of blood samples following consumptlon of 
two h~gh fat meals Before each fat meal, I will have a small plast~c tube, called a catheter, 
Inserted into a veln in my arm to facllltate the taklng of blood samples I will eat a fatty meal and 
then have a blood sample taken at regular intervals for 8 hours. During this t~me I will be free to 
read and work quietly The total amount of blood taken durlng thls visit will be approximately 100 
ml or 7 tablespoons 
4. On the evening before one of the fatty meals, I w~ll go to DCU to walk at 70-75% of my maxlmum 
fitness unt~l I burn between 600 and 700 calories Depending on my fltness level thls will take 
between 50 and 90 mlnutes On the evenlng before the other fatty meal test, I w~ll rest qu~etly at 
home. 
5. For 2 days before each fatty meal test I w~ll not be able to do any exercise or strenuous physlcal 
work (e g gardening) I will also not be able to drlnk alcohol. 
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6 For 2 days before the f~rst fatty meal test, I will record the food I eat in a dlary I wrll follow the 
same d~et  for the 2 days before the second fatty meal test 
7 i will be asked to glve my best effort durlng the max~mal and submaximal exerclse tests 
However, I will let the researchers know if I experience slgn~flcant chest paln or other discomfort 
durlng any of the exerclse sessions If I wlsh I can stop exerclslng at any tlme durlng any of the 
exerclse sessrons. . 
VI. Sometimes there are side effects from havinq blood drawn and petformina exercise tests. 
These side effects are often called risks, and for this proiect, the risks are: 
1 I may feel a sllght paln when the catheter is Inserted and I may develop a bruise where the blood 
sample is obtarned The pain and brurslng is usually mlld and a person trarned In blood drawlnq 
will obtaln my blood. The amount of blood drawn IS not harmful, however, if I have a history of 
anemra, I should lnform the investigator 
2. Exercise testlng carrles w~th it a very small r~sk of abnormal heart rhythms, heart attack, or death 
in less than one in 30,000 patlents Because I wrll be asked to give a maxlmum effort, I may 
experience some muscle soreness in my arms and legs following each maxlmal exerclse test 
It should be noted that if the experimental protocol IS adhered to that the Ilkellhood of these r~sks 
occurring 1s mrnlmal 
VII. There may be benefits from my participation in this studv. These are: 
1 Afker the study I wrll recerve a copy of my personal results whlch Include aerobrc fitness level, 
body fat, tr~glycerlde and cholesterol measurements as well as a summary of the overall results 
2 1 wrll be provided wlth rnformat~on regarding how eff~c~ently my body processes the fat I eat 
3 .  1 will be pa~d €25 for each fatty meal test that I take part In 
4. No other benef~ts have been promlsed me 
VIII. Mv confidentialitv will be auarded: 
Dublin C~ty Unlversrty will protect all the lnformatlon about me and my part In thls study My ~dent~ty or 
personal informat~on, w~l l  not be revealed, published or used in future studres The study frndlngs wlll 
form the bass for preparat~on of a postgraduate thesls, academic publrcat~ons, conference papers and 
other screntific 
IX. If I have auestions about the research proiect. I am free to call Dr. Niall Movna at 01-7008802 
X. Takina part in  this study is my decision If I do agree to take part In the study, I may w~thdraw at 
any polnt ~ncludlng during an exerclse test There will be no penalty if I w~thdraw before I have 
completed all stages of the study However, once I have completed the study I wlll not be allowed to 
have my personal lnformatlon and results removed from the database 
XI. Siqnature: 
I have read and understood the lnformat~on in thls form My quest~ons and concerns have been 
answered by the researchers, and I have a copy of thls consent form Therefore, I consent to take 
part in this research project entitled. "Influence Of Acute Exerc~se On Postprand~al Lipaemla And 
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APPENDIX A2 
DUBLIN CITY UNIVERSITY 
RESEARCH - INFORMED CONSENT FORM 
I. Prolect T~tle: tttect of Acute Exerclse and Muscle Glycogen on Postprand~al Llpemla 
II. Principle Investiqator: Dr. N~all M Moyna 
Ill. Introduction to this studv: 
Exerc~se IS known to reduce the amount of fat In your blood after you eat a hlgh fat meal However, 
the reasons for thls are not fully understood. One possib~l~ty IS that the reduction In the amount of fat 
In your blood followlng exerclse may be due to changes In the amount of related carbohydrate that 
are stored in your muscles Thls study w~ll examlne the effects of exerclse on the way the body 
processes fatty meals, w~th and w~thout an attempt to ref111 the carbohydrate stores that were depleted 
durlng the exerclse 
IV. I am beina asked to participate in this research studv. The studv has the followinq purposes: 
1 To examine the effects of exercise on the way the body processes fatty meals, wlth and without 
an attempt to refdl the carbohydrate that were used durlng the exerclse 
V. This research studv will take place at the Centre for Sport Science and Health, Dublin City 
University 
VI. This is what will happen durinq the research studv: 
1 Durrng the first prellm~nary vls~t I w~ll have a brief medlcal examination and perform an exerclse 
test to determlne my fitness level Thls will rnvolve exercising at Increasing speeds on a 
treadmill unt~l I reach my max~mal exercise capaclty For thls, and all subsequent exerclse 
tests, I will be fitted wlth a mouthplece connected to a machlne to measure the composltlon of 
gases in my breath. I will also have my we~ght, height and body fat measured using fat 
cal~pers 
2. On the second preliminary vislt, I w~ll perform another exercise test to determlne the speed that 
corresponds to 70-75%% of my maxlmum exercise capacity 
3 The maln part of the study will involve the collect~on of blood samples followlng consumption of 
h~gh fat meals on 3 d~fferent occasions. Before each of the 3 fatty meal tests, I will have a 
small plastlc tube, called a catheter, Inserted Into a veln In my arm to facll~tate the taklng of 
blood samples I will also have a small piece of muscle removed from my thigh (60-100mg) to 
measure how much carbohydrate is In my muscle. Thls will be done by a med~cal doctor, uslng 
a local anesthet~c I will eat a fatty meal and then have blood samples taken at regular Intervals 
for 6 hours Durlng thls t~me Iw~ll be free to read and work quletly The total amount of blood 
taken during each vis~t will be approximately 100 ml or 7 tablespoons. 
4. The day before the three fatty meal tests w~l l  be spent at DCU where I will follow a strict d~et. 
On the day before two of the fatty meal tests, I w~ll cycle at 70-75% of my maxlmum fitness for 
90 minutes followed by 10 one m~nute sprints On the day before the other fatty meal test, I wlll 
rest qu~etly 
5. For 3 days before each fatty meal test I w~ll not be able to do any exerclse or strenuous 
physical work (e g gardening) I will also not be able to drlnk alcohol. I w~ll have to follow 
exactly a d~et  agreed in advance 
6 1 wlll be asked to give my best effort durrng exerclse tests However, I will let the researchers 
know if I experlence s~gn~ficant chest pain or other d~scomfort durlng any of the exerclse 
Sessions If I wlsh I can stop exerclslng at any time during any of the exercise sesslons 
VII. Sometimes there are side effects from havinq blood drawn, muscle biopsied and 
performinq exercise tests. These side effects are often called risks, and for this proiect, 
the risks are: 
1. I may feel a slight pain when the catheter is inserted and I may develop a bruise where the blood 
sample is obtained The pain and bruising is usually mild and a person trained in blood drawing 
will obtain my blood. The amount of blood drawn is not harmful, however, if I have a history of 
anemia, I should inform the investigator 
2 1 may feel moderate pressure during insertion of the needle into the muscle and removal of 
muscle Some minor aching and slight localized cramping may occur, but these symptoms 
usually go away when the needle is withdrawn After the biopsy, the muscle is likely to be 
moderately sore for about 24 hours, similar to muscle soreness following unusually vigorous 
exercise or a muscle injury Some bruising may also occur A medical doctor will perform the 
biopsy 
Exerc~se testing carries w~th it a very small risk of abnormal heart rhythms, heart attack, or death 
in less than one in 30,000 patients. Because I will be asked to give a maximum effort, I may 
experience some muscle soreness in my arms and legs following each maximal exercise test 
VIII.There mav be benefits from mv participation in  this study. These are: 
1. After the study I will receive a copy of my personal results which include aerobic fitness and body 
fat levels along with blood concentratrons of tnglycerides, cholesterol, glucose and haemoglobin 
This will allow me to compare my results to values for normal healthy individuals 
2. 1 will be paid El00 for my participation in the study 
3. No other benefits have been promised me 
IX. Mv confidentialitv will be quarded: 
Dublln City University will protect all the inforrnation about me and my part in this study My identity 
or personal information, will not be revealed, published or used in future studies The study findings 
will form the basis for preparation of a postgraduate thesis, academic publications, conference papers 
and other scientific publications. Confidentiality of informatlon provided however, can only be 
protected within the limitations of the law. It is possible for data to be subject to subpoena, freedom 
of inforrnation claim or mandated reporting by some professions 
The original documentation, blood and muscle samples will be stored for 5 years Thereafter, the 
blood and muscle samples will be disposed, and all documents will be shredded 
X My confidentiality wil l  be guarded' If I am in a dependent relationship with any of the researchers 
my involvement in the project will not affect ongoing assessment~gradeslmanagement or treatment of 
health at DCU. 
XI. Dublin City University will not pay medical expenses or pay for pain and suffering, travel, lost 
wages, or other indirect costs of taking part in this project. If I have questions about the 
research project, I am free to call Dr. Niall Moyna at 01-7008802 
XII. If I have questions about the research in general, I am free to contact the Secretary, Research 
Ethics Committee, Office of the Vlce-Pres~dent for Research, Dublin City University, ph 01-7008000, 
fax 01 -7008002 
XIII.My participation in  this study is my own decision If I agree to take part in the study, I can stop at 
any time; There will be no penalty if I withdraw before I have completed the study 
XIV. Sianature: I have read and understood the informatlon in this form My questions and concerns 
have been answered bv the researchers, and I have a cowv of this consent form Therefore, I 
consent to take part in this research entitled. Effect d i ~ c u t e  Exercise and Muscle ~ l vcoaen  
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APPENDIX B 
Summary Postprandial Calculations 
1 Area under concentration vs postprandial tlme curve (AUC) 
AUC is calculated using the trapez~um rule, by dividing thls area into rectangles and triangles as 
shown below (areas 1-6) 
Area of triangle -  1/2 base x he~aht 
Area of rectangle - - base x helght 
0 2 4 6 
Time (h) 
AUC =Area 1 + Area 2 + Area 3 + Area 4 + Area 5 + Area 6 
= 21 3 mmol C' h 
2 Tme-averaged postprandial concentration 
= AUC I length of postprandlal period (6 h) 
=21  3mmolL"h16h 
= 3 55 mmol C' 
3 Postprandial increment 
= Tlme-averaged postprand~al concentration - Fast~ng concentration 
= 3.55 mmol L-' - 2 10 mmol L" 
= 1 45 mmol L-' 
